| FORM [N-6] |
|
| REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
|
| Pre-effective Amendment No. |
☒ |
| Post-Effective Amendment No. [23] |
☐ |
| and/or |
|
| REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 |
|
| Amendment No. [218] |
☒ |
| Approximate Date of Proposed Public Offering: Continuous. | |
| It is proposed that this filing will become effective (check appropriate box) | |
| ☐ |
immediately upon filing pursuant to paragraph (b) of Rule 485 |
| ☒ |
on May 1, 2026 pursuant to paragraph (b) of Rule 485 |
| ☐ |
60 days after filing pursuant to paragraph (a)(1) of Rule 485 |
| ☐ |
on (date) pursuant to paragraph (a)(1) of Rule 485 |
| If appropriate, check the following box: | |
| ☐ |
This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
| |
Page |
| 3 | |
| 6 | |
| 6 | |
| 6 | |
| 6 | |
| 9 | |
| 14 | |
| 16 | |
| 17 | |
| 17 | |
| 17 | |
| 17 | |
| 17 | |
| 18 | |
| 19 | |
| 20 | |
| 20 | |
| 20 | |
| 21 | |
| 21 | |
| 21 | |
| 22 | |
| 23 | |
| 23 | |
| 23 | |
| 24 | |
| 24 | |
| 25 | |
| 27 | |
| 28 | |
| 29 | |
| 29 | |
| 29 | |
| 29 | |
| 29 | |
| 30 | |
| 31 | |
| 32 | |
| 32 | |
| 33 | |
| 37 | |
| 37 | |
| 37 | |
| 38 | |
| 38 | |
| 38 | |
| 39 | |
| 39 |
| |
Page |
| 40 | |
| 40 | |
| 41 | |
| 42 | |
| 43 | |
| 45 | |
| 48 | |
| 49 | |
| 49 | |
| 51 | |
| 51 | |
| 52 | |
| 52 | |
| 52 | |
| 53 | |
| 53 | |
| 54 | |
| 54 | |
| 54 | |
| 54 | |
| 54 | |
| 54 | |
| 54 | |
| 55 | |
| 55 | |
| 56 | |
| 56 | |
| 56 | |
| 56 | |
| 56 | |
| 56 | |
| 56 | |
| 56 | |
| 57 | |
| 59 | |
| 59 | |
| 60 | |
| 60 | |
| 61 | |
| 66 | |
| 66 | |
| 67 | |
| 69 | |
| 74 | |
| 77 | |
| 80 |
| |
FEES AND EXPENSES |
Location in
Prospectus | ||
| Charges for Early
Withdrawals |
Early withdrawals under the Policy are subject to surrender
charges. • Policies with an application signed on
or after October 7, 2019. If you withdraw money from your Policy within 19 Policy years after you purchase the Policy or increase the Policy’s specified amount, you will be
assessed a surrender charge of up to 5% of the specified amount,
declining to 0% over that time period. • Policies with an
application signed before October 7, 2019. If you withdraw money from your Policy within 9 Policy years after you purchase
the Policy or increase the Policy’s specified amount, you will be
assessed a surrender charge of up to 4.5% of the specified
amount, declining to 0% over that time period.
For example, assuming your Policy has $100,000 in specified amount and
you make an early withdrawal, you could pay a surrender
charge of up to $5,000 if your Policy application was
signed on or after October 7, 2019 or $4,500 if your Policy
application was signed before October 7, 2019. |
Fee Table
Charges Under the
Policy – Surrender
Charge | ||
| Transaction Charges |
In addition to surrender charges, you may also be charged for other
transactions. You may be subject to charges upon making
premium payments, taking partial surrenders, transferring
accumulation value between investment options, requesting
Policy illustrations, and exercising certain riders. There
may also be taxes on premium payments. |
Fee Table
Charges Under the
Policy | ||
| Ongoing Fees and
Expenses (annual
charges) |
In addition to surrender charges and transaction charges, an investment
in the Policy is subject to certain ongoing fees and
expenses, including fees and expenses covering the cost of
insurance under the Policy, the cost of optional benefits
available under the Policy, and loan interest on outstanding Policy loans. Certain such fees and expenses are set based on characteristics of the
insured (e.g., age, sex, and rating classification). You should view your
Policy’s specifications page for rates applicable to
your Policy. You will also bear expenses associated with the
Funds under the Policy, as shown in the following
table: |
Fee Table
Charges Under the
Policy
APPENDIX A – FUNDS
AVAILABLE UNDER THE
POLICY | ||
| Annual Fee |
Minimum |
Maximum | ||
| Investment options |
0.31 |
2.44 | ||
| |
RISKS |
| ||
| Risk of Loss |
You can gain or lose money by investing in this Policy, including
possible loss of your principal investment.
|
Principal Risks of
Investing in the Policy | ||
| Not a Short- Term
Investment |
• This Policy is not designed for short-term investing and may not be
appropriate for an investor who needs ready access to cash.
• If you fully or partially surrender the Policy, you may be subject to income
taxes and significant surrender charges. • A full surrender terminates the Policy, including all Policy benefits. A fully
surrendered Policy cannot be reinstated. • Partial surrenders reduce your death benefit and may reduce or terminate
other Policy benefits. Partial surrenders are not available until after
the first Policy year, must be at least $500, and must not
reduce the death benefit below $100,000.
|
Principal Risks of
Investing in the Policy
POLICY
TRANSACTIONS | ||
| Risks Associated with |
• An investment in this Policy is subject to the risk of poor investment
performance and can vary depending on the performance of the
investment options available under the Policy.
|
Principal Risks of
Investing in the Policy | ||
| |
RISKS |
Location in
Prospectus | ||
| Investment Options |
• Each investment option (including the Fixed Account) has its own unique
risks. • You should review the investment options before making an investment
decision. |
| ||
| Insurance Company
Risks |
An investment in the Policy is subject to the risks related to us,
American General Life Insurance Company
(“AGL”). Any obligations (including under the
Fixed Account), guarantees, or benefits of the Policy are subject to our claims-paying ability. More information about us is available upon request by
calling our Administrative Center at 1-800-340-2765 or by visiting
www.corebridgefinancial.com/AGVUL. |
Principal Risks of
Investing in the Policy
GENERAL
INFORMATION –
American General Life
Insurance Company
Fixed Account | ||
| Contract Lapse |
Insufficient premium payments, fees and expenses, poor investment
performance, partial surrenders, and unpaid loans or loan
interest may cause the Policy to lapse. Your policy lapse
may also be considered a tax reportable event. There is a
cost associated with reinstating a lapsed Policy. Death
benefits will not be paid if the Policy has lapsed. |
Principal Risks of
Investing in the Policy
Policy Lapse and
Reinstatement | ||
| |
RESTRICTIONS |
| ||
| Investments |
• Certain investment options may not be available under your Policy. • We will assess a charge for each transfer between variable investment
options after the 12th transfer in a Policy year. • Your transfers between the variable investment options are subject to
policies designed to deter market timing. • You may transfer amounts from the Fixed Account only during the 60 days
following each Policy anniversary, and the transferrable amount is
limited to the greater of 25% of the Fixed Account’s
unloaned accumulation value or the amount you transferred
from the Fixed Account during the prior Policy
year. • The minimum transfer amount from an investment option is
$500. If less than $500 would remain in an investment
option after a transfer, the entire amount must be
transferred. We reserve the right to remove or substitute
Funds as investment options |
Variable Investment
Options
Policy Features –
Changing Your
Investment Option
Allocation
Fixed Account
Additional Rights We
Have
APPENDIX A – FUNDS
AVAILABLE UNDER THE
POLICY | ||
| Optional Benefits |
• Additional restrictions and limitations apply under the Policy’s optional
benefits. • Withdrawals that exceed limits specified by the terms of an optional benefit
may affect the availability of the benefit by reducing the benefit by an
amount greater than the value withdrawn and could terminate
the benefit. • If you own or exercise certain optional benefits, not all
investment options are available. You must invest in
accordance with the applicable investment requirements. We
reserve the right to modify the investment requirements at
any time. |
Other Benefits
Available Under the
Policy – Optional
Benefits
Additional Information
About Policy Riders | ||
| |
TAXES |
Location in
Prospectus | ||
| Tax Implications |
• You should consult with a tax professional to determine the tax
implications of an investment in and payments received under the
Policy. • If you purchased the Policy through a tax-qualified plan,
there is no additional tax benefit under the Policy.
Earnings under your Policy are taxed at ordinary income tax
rates when withdrawn. If your Policy is a modified
endowment contract, you may have to pay a tax penalty if you
take a withdrawal before age 59½. • The tax treatment of withdrawals and loans under the Policy may differ. |
Federal Tax
Considerations | ||
| |
CONFLICTS OF
INTEREST |
| ||
| Investment
Professional
Compensation |
Your financial representative may receive compensation for selling this
Policy to you in the form of commissions, additional cash
compensation, and/or non-cash compensation. We may share
the revenue we earn on this Policy with your financial
representative’s firm. Revenue sharing arrangements and
commissions may provide selling firms and/or their registered
representatives with an incentive to favor sales of our
policies over other variable life insurance policies (or
other investments) with respect to which a selling firm
does not receive the same level of additional compensation. |
Federal Tax
Considerations | ||
| Exchanges |
Some financial representatives may have a financial incentive to offer
you a new policy in place of the one you already own. You
should exchange a policy you already own only if you
determine, after comparing the features, fees, and risks of
both policies, that it is better for you to purchase the new
contract rather than continue to own your existing policy.
|
Charges Under the
Policy-Distribution of
the Policies | ||
| Transaction Fees | ||
| Charge |
When Charge is Deducted |
Amount Deducted |
| Premium Expense Charge |
Upon receipt of each premium
payment |
|
| For Policies with an application
received on or after May 30,
20201 |
| |
| Minimum Charge |
2% as a percentage of the remaining premium payment after
deduction of any premium taxes | |
| Maximum Charge |
25% as a percentage of the remaining premium payment after
deduction of any premium taxes | |
| Charge for a representative
insured – 38 year old male,
preferred non-tobacco, with a
specified amount of $360,000 |
Year 1: 20%
Years 2-10: 20.3%
Years 11+ : 10.1% | |
| For Policies with an application
signed on or after October 7,
2019 through May 29, 20201 |
|
|
| Minimum Charge |
|
2% as a percentage of the remaining premium payment after
deduction of any premium taxes |
| Maximum Charge |
|
25% as a percentage of the remaining premium payment after
deduction of any premium taxes |
| Charge for a representative
insured – 38 year old male,
preferred non-tobacco, with a
specified amount of $360,000 |
|
Year 1-5: 15%
Years 2-10: 11%
Years 11+: 5.7% |
| For Policies with an application
signed before October 7, 20192 |
|
10% as a percentage of the remaining premium payment after
deduction of any premium taxes |
| Premium Taxes3 |
Upon receipt of each premium
payment |
3.5% of the premium payment |
| Surrender Charge4 |
Upon a partial or full surrender |
|
| For Policies with an application
signed on or after October 7,
2019 |
|
|
| Minimum Charge |
|
$3 per $1,000 of specified amount |
| Maximum Charge |
|
$50 per $1,000 of specified amount |
| Charge for a representative
insured – 38 year old male,
preferred non-tobacco, with a
specified amount of $360,000 |
|
$24 per $1,000 of specified amount |
| Transaction Fees | ||
| Charge |
When Charge is Deducted |
Amount Deducted |
| For Policies with an application
signed before October 7, 2019 |
|
|
| Minimum Charge |
$2 per $1,000 of specified amount | |
| Maximum Charge |
$45 per $1,000 of specified amount | |
| Charge for a representative
insured – 38 year old male,
preferred non-tobacco, with a
specified amount of $360,000 |
$19 per $1,000 of specified amount | |
| Partial Surrender Processing
Fee |
Upon a partial surrender |
The lesser of $25 or 2.0% of the amount of the partial
surrender
(Current charge: The lesser of $10 or 2.0% of the amount of
the partial surrender) |
| Transfer Fees5 |
Upon a transfer of
accumulation value after the
first 12 transfers in a Policy
year |
$25 for each transfer
(Current charge: $25 for each transfer) |
| Illustration Charge |
Upon each request after the
first in a Policy year |
$25
(Current charge: $0) |
| Overloan Protection Rider |
At time of rider exercise |
5.0% of accumulation value
(Current charge: 3.5% of accumulation value) |
| Terminal Illness Rider –
Administrative Fee |
At time of rider claim |
$250 (Current charge: $150) |
| Periodic Charges Other Than Annual Fund Expenses |
||
| Charge |
When Charge is
Deducted |
Amount Deducted |
| Base Policy Charges | ||
| Cost of Insurance1 |
Monthly |
|
| For Policies with an application signed on or after
October 7, 2019 |
|
|
| Minimum charge |
|
$0.03 per $1,000 of net amount at risk2 |
| Maximum charge |
|
$83.33 per $1,000 of net amount at risk |
| Charge for a representative insured – 38 year old
male, preferred non-tobacco, with a specified
amount of $360,000 |
|
$0.11 per $1,000 of net amount at risk3 |
| For Policies with an application signed before
October 7, 2019 |
|
|
| Minimum charge |
|
$0.02 per $1,000 of net amount at risk4 |
| Maximum charge |
|
$83.33 per $1,000 of net amount at risk |
| Charge for a representative insured – 38 year old
male, preferred non-tobacco, with a specified
amount of $360,000 |
|
$0.11 per $1,000 of net amount at risk5 |
| Monthly Charge per $1,000 of Specified
Amount6 |
Monthly |
|
| For Policies with an application signed on or after
October 7, 2019 |
|
|
| Minimum charge |
|
$0.11 per $1,000 of specified amount |
| Maximum charge |
|
$1.59 per $1,000 of specified amount |
| Charge for a representative insured – 38 year old
male with a specified amount of
$360,000 |
|
$0.34 per $1,000 of specified amount |
| For Policies with an application signed before
October 7, 2019 |
|
|
| Minimum charge |
|
$0.07 per $1,000 of specified amount |
| Maximum charge |
|
$1.27 per $1,000 of specified amount |
| Charge for a representative insured – 38 year old
male with a specified amount of
$360,000 |
|
$0.27 per $1,000 of specified amount |
| Periodic Charges Other Than Annual Fund Expenses |
||
| Charge |
When Charge is
Deducted |
Amount Deducted |
| Daily Charge (Mortality and Expense Risk Fee)7 |
Daily |
0.70% as an annualized percentage of
accumulation value invested in the variable
investment options |
| Flat Monthly Charge |
Monthly |
$10 |
| Loan Interest Spread8 |
Annually |
0.75% as a percentage of outstanding loans and
loan interest |
| Optional Benefit Charges | ||
| Accidental Death Benefit Rider9 |
Monthly |
|
| Minimum Charge |
|
$0.07 per $1,000 of rider coverage |
| Maximum Charge |
|
$0.15 per $1,000 of rider coverage |
| Charge for a Representative Insured – 38 year old
male |
|
$0.09 per $1,000 of rider coverage |
| Children’s Term Life Insurance Rider
|
Monthly |
$0.48 per $1,000 of rider coverage |
| Spouse Term Rider9 |
Monthly |
|
| Minimum Charge |
|
$0.07 per $1,000 of rider coverage |
| Maximum Charge |
|
$7.31 per $1,000 of rider coverage |
| Charge for a representative insured – 38 year old
male, preferred non-tobacco
|
|
$0.14 per $1,000 of rider coverage |
| Waiver of Monthly Deduction Rider9 |
Monthly |
|
| Minimum Charge |
|
$0.01 per $1,000 of net amount at risk
attributable to the Policy |
| Maximum Charge |
|
$0.64 per $1,000 of net amount at risk
attributable to the Policy |
| Charge for a representative insured – 38 year
old |
|
$0.02 per $1,000 of net amount at risk
attributable to the Policy |
| Terminal Illness Rider – Interest on Rider
Benefits |
At the time the rider
benefit is paid and each
Policy anniversary
thereafter |
As a percentage of rider benefits, greatest of : (1)
current yield on 90 day U.S. Treasury Bills; or (2)
Moody’s Corporate Bond Yield Average Monthly
Average Corporates for month of October
preceding calendar year for which loan interest
rate is determined; or (3) interest rate used to
calculate cash values in Fixed Account at the time
the charge is assessed, plus 1%10 |
| Waiver of Specified Premium Rider9 |
Monthly |
|
| Minimum Charge |
|
$0.05 per $1 of benefit payable under the rider |
| Maximum Charge |
|
$0.26 per $1 of benefit payable under the rider |
| Charge for a representative insured – 38 year old
male |
|
$0.07 per $1 of benefit payable under the rider |
| Accelerated Access SolutionSM /
Chronic Illness Accelerated Death Benefit
Rider9 |
Monthly |
|
| Minimum Charge |
|
$0.04 per $1,000 of rider net amount at risk |
| Maximum Charge |
|
$4.70 per $1,000 of rider net amount at risk |
| Charge for a representative insured – 38 year old
male, preferred non-tobacco, with a specified
amount of $360,000 |
|
$0.09 per $1,000 of rider net amount at risk |
| Lapse Protection Benefit Rider11 |
Monthly |
$0.0008 per $1,000 of rider net amount at risk |
| Annual Fund Expenses |
Minimum |
Maximum |
| Expenses that are deducted from Fund assets, including management fees,
distribution and/or service (12b-1) fees, and other
expenses. |
0.31 |
2.44 |
| The following is the Contact Information for Policies for which an application
was signed after June 30, 2017. | |||
| ADMINISTRATIVE CENTER: |
HOME OFFICE: |
PREMIUM PAYMENTS: | |
| (Express Delivery)
VUL Administration
P.O. Box 9318 Amarillo,
Texas 79105-9318
1-800-340-2765
Fax: 1-844-430-2639
(Except premium
payments) |
(U.S. Mail)
VUL Administration
P.O. Box 818016
Cleveland, Ohio 44181 |
2919 Allen Parkway
Houston, Texas 77019
1-800-340-2765 |
(Express Delivery) American General Life Insurance Company DeluxeATTN: Corebridge Box 650103 3000 Kellway Drive, Suite 120 Carrollton, TX 75006 (U.S. Mail) American General Life Insurance Company P.O. Box 650103 Dallas, TX 75265-0103 |
| The following is the Contact Information for Policies for which an
application was signed before July 1, 2017 and received no later
than July 10, 2017. | |||
| ADMINISTRATIVE CENTER: |
HOME OFFICE: |
PREMIUM PAYMENTS: | |
| (Express Delivery)
VUL Administration
P.O. Box 9318 Amarillo,
Texas 79105-9318
1-800-340-2765
Fax: 1-844-430-2639
(Except premium
payments) |
(U.S. Mail)
VUL Administration
P.O. Box 818016
Cleveland, Ohio 44181 |
2919 Allen Parkway
Houston, Texas 77019
1-800-340-2765 |
(Express Delivery) American General Life Insurance Company Deluxe Lockbox 993 5450 N. Cumberland Ave. Chicago, IL 60656 (U.S. Mail) American General Life Insurance Company P.O. Box 993 Chicago, IL 60132 |
| APPLICABLE PERCENTAGES UNDER
CASH VALUE ACCUMULATION TEST
POLICIES WITH AN APPLICATION SIGNED ON OR AFTER OCTOBER 7, 2019
| ||||||||||
| Insured Person’s
Attained Age |
40 |
45 |
50 |
55 |
60 |
65 |
70 |
75 |
99 |
100+ |
| % |
481% |
406% |
343% |
290% |
246% |
210% |
181% |
158% |
103% |
100% |
| APPLICABLE PERCENTAGES UNDER
CASH VALUE ACCUMULATION TEST
POLICIES WITH AN APPLICATION SIGNED BEFORE OCTOBER 7, 2019 | ||||||||||
| Insured Person’s
Attained Age |
40 |
45 |
50 |
55 |
60 |
65 |
70 |
75 |
99 |
100+ |
| % |
418% |
352% |
298% |
253% |
218% |
189% |
167% |
148% |
104% |
100% |
| APPLICABLE PERCENTAGES UNDER
GUIDELINE PREMIUM TEST
POLICIES WITH AN APPLICATION SIGNED BEFORE OCTOBER 7, 2019 | |||||||||
| Insured Person’s
Attained Age |
40 |
45 |
50 |
55 |
60 |
65 |
70 |
75 |
99+ |
| % |
250% |
215% |
185% |
150% |
130% |
120% |
115% |
105% |
100% |
| Standard Benefits (No Additional Charge) | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions / Limitations |
| Planned Periodic
Premiums |
Allows you to select a premium
payment plan to help you pay
premiums on a regular basis |
•No additional charge •Billing occurs monthly, quarterly, semi-annually, or
annually •Payment is not mandatory, but insufficient premium payments may cause the Policy to lapse |
| Dollar Cost Averaging
(DCA) Program |
Automatically transfers
accumulation value from a variable
investment option of your choice to
one or more other variable
investment options on a regular
basis |
•No additional charge •Must have at least $5,000 (for policies with an application
signed before October 7, 2019) or $500 (for policies with an
application signed on or after October 7, 2019) of
accumulation value in the transferring variable investment
option to start dollar cost averaging
•Minimum amount per transfer is $100 •Transfers may occur monthly, quarterly, semi-annually, or
annually
•Only one instruction may be maintained at any time •No transfers to or from the Fixed Account
•Not available while automatic rebalancing is in effect •Transfers do not count against free transfer limits
•We reserve the right to modify, suspend, or terminate this program at any time |
| Automatic Rebalancing |
Automatically rebalances your
accumulation value in the variable
investment options to correspond to
your premium allocation
designation |
•No additional charge •Must have at least $5,000 of accumulation value to use
automatic rebalancing, unless lapse protection benefit rider is
in effect, in which case there is no minimum
•Rebalances may occur quarterly, semi-annually, or annually •Only one instruction may be maintained at any time
•No rebalancing for the Fixed Account •Not available while DCA instructions are in effect
•Rebalances do not count against free transfer limits |
| Account Value
Enhancement |
May provide for a credit to
accumulation value at the end of the
21st Policy year and at the end of
each Policy year thereafter |
•No additional charge •Credit for any Policy year can be 0.01% or greater, as a
percentage of unloaned accumulation value, at our complete
discretion
•Enhancement is fully vested when credited |
| Enhanced Surrender
Value / Return of
Premium Rider |
May increase the amount payable if
you surrender your Policy after a
certain number of Policy years |
•Available only under Policies with an application signed on or
after October 7, 2019
•Automatically added at time of Policy issue •No additional charge
•Enhancement to surrender value is subject to maximum limit •Partial surrenders may significantly reduce or terminate the
benefit
•May not be reinstated after termination |
| Standard Benefits (No Additional Charge) | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions / Limitations |
| Guaranteed Minimum
Cash Value Rider |
Provides a guaranteed minimum
cash value upon a full surrender of
the Policy |
•Available only under Policies applied for on or after October 7, 2019 •Automatically added after first premium payment
•No additional charge •Benefit will be paid upon full surrender only if certain
conditions are satisfied
•Partial surrenders and loans may significantly reduce the benefit •Certain events will automatically terminate the
benefit •May not be reinstated after termination |
| Overloan Protection
Rider |
May keep your Policy from lapsing
due to accrued interest on
outstanding Policy loans |
•Available only under Policies with an application signed before October 7, 2019 •Automatically added at time of Policy issue
•Additional charge applies upon exercise •Ability to exercise is subject to conditions that many Policy
owners are unlikely to satisfy
•Exercise of benefit may have negative tax consequences. Please consult your tax or legal advisors. •Upon exercise, any portion of accumulation value not offset by
outstanding Policy loans will be transferred to or remain in
the Fixed Account
•Significant additional/different restrictions and limitations will apply throughout the remaining life of the Policy upon exercise (e.g., the death benefit will be calculated differently) •No guarantee that the benefit will prevent Policy
lapse |
| 20-Year Benefit Rider |
Provides conditional protection
against Policy lapse for up to 20
Policy years |
•Available only under Policies with an application signed before
October 7, 2019
•Automatically added at time of Policy issue if the optional lapse protection benefit rider was not elected •Automatically added to Policy if optional lapse protection
benefit rider is terminated before Policy year 20
•No additional charge •Must pay monthly guarantee premiums to keep in force
•Certain actions (e.g., changes in specified amount) will result in recalculation of required monthly guarantee premiums •Terminates on the earlier of the 20th Policy anniversary or the
Policy anniversary nearest the insured’s 95th
birthday •Partial surrenders and loans may cause the rider to terminate •Cannot be reinstated after termination
•No guarantee that the benefit will prevent Policy lapse |
| Optional Benefits | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions/ Limitations |
| Accidental Death Benefit
Rider |
Pays an additional death benefit if
the insured person dies from certain
accidental causes |
•Additional charge applies
•Available only at time of Policy issue |
| Optional Benefits | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions/ Limitations |
| Children’s Term Life
Insurance Rider |
Provides term life insurance
coverage on the eligible children of
the Policy’s insured person |
•Additional charge applies •Available at time of Policy issue or any time
thereafter •Automatically terminates at the earlier of the Policy anniversary nearest the insured’s 65th birthday or the Policy maturity date |
| Spouse Term Rider |
Provides term life insurance on the
spouse of the Policy’s insured
person |
•Available only under Policies applied for on or before May 17, 2019 •Available only at time of Policy issue
•Additional charge applies •Automatically terminates on the Policy anniversary nearest the
spouse’s 75th birthday |
| Terminal Illness Rider |
Provides a right to request a benefit
if the Policy’s insured person is
certified with a terminal illness |
•Available at time of Policy issue or any time thereafter •Not available in all states
•Additional charges apply •Must be certified as having a terminal illness and less than 24
months to live (12 months in Florida)
•Benefit limited to 50% of death benefit (excluding any rider benefits), not to exceed $250,000 •Benefit payment, plus interest and an additional fee, becomes
a lien against future Policy benefits and the cash surrender
value
•Policy will terminate if the total lien, plus any other Policy loans, exceeds the current death benefit |
| Waiver of Monthly
Deduction Rider |
Provides a waiver of all monthly
charges from accumulation value so
long as the Policy’s insured person
is totally disabled |
•Available only at time of Policy issue •Not available if initial specified amount is greater than
$5,000,000
•Additional charge applies •Insured must be younger than age 56 at time of
purchase •Waived charges are deducted from cash value, but not accumulation value •Outstanding loan interest is not waived – nonpayment of loan
interest may cause the Policy to lapse
•Specified amount and death benefit option may not be changed while charges are being waived •No riders may be added while charges are being waived
•No guarantee that the benefit will prevent Policy lapse |
| Waiver of Specified
Premium Rider |
Pays a monthly benefit in the event
the Policy’s insured person
becomes totally disabled |
•Available only under Policies with an application submitted on
or after May 1, 2017
•Available only at time of Policy issue •Not available in all states
•Additional charge applies •Insured must be age 55 or younger at time of
application •Benefit is determined on date of issue based on planned periodic premiums, subject to maximum benefit limits •Benefit becomes payable 180 days after total disability
begins •New claim cannot be made after the Policy anniversary following the insured person reaching age 60 •No guarantee that the benefit will prevent Policy
lapse |
| Optional Benefits | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions/ Limitations |
| Death Benefit
Installment Rider /
Select Income Rider |
Provides for payment to the
beneficiary of all or a part of the
death benefit in installment
payments |
•Available only under Policies with an application submitted on or after May 1, 2017 •Available only at time of Policy issue
•Not available in all states •No additional charge
•Amount and number of payments are subject to limitations •Cannot be removed from the Policy once issued
•Installment payments may be taxable |
| Lapse Protection
Benefit Rider |
Provides conditional protection
against Policy lapse |
•Availability and charge differ based on date of Policy
application:
•For Policies with an application signed before October 7, 2019, available for election only at time of Policy issue and an additional charge applies (i.e., an optional benefit) •For Policies with an application signed on or after October 7,
2019, automatically added at time of Policy issue and no
additional charge applies (i.e., a standard
benefit) •Rider’s reference amount (the Continuation Guarantee (“CG”)
Account) must be greater than or equal to zero to keep rider in
force
•CG Account value has no cash value and no impact on death benefit amount or accumulation value •CG Account value is reduced by monthly deductions, partial
surrenders, surrender charges due to decreases in specified
amount, and Policy loans
•Cash surrender value must be sufficient to cover any loan interest to keep rider in force •Investment requirements limit available investment
options •CG Enhancement not available until second Policy anniversary •Generally must enroll in automatic rebalancing
•No guarantee that the benefit will prevent Policy lapse |
| Optional Benefits | ||
| Name of Benefit |
Purpose |
Brief Description of Restrictions/ Limitations |
| Accelerated Access
SolutionSM / Chronic
Illness Accelerated
Death Benefit Rider |
Provides accelerated benefits if the
Policy’s insured person is certified
as being chronically ill and all
eligibility requirements are met |
•Available only at time of Policy issue
•Available only if terminal illness rider is also elected •Not available in all states
•Additional charge applies •Eligibility requirements (e.g., certification of chronic illness)
must be met for each 12 month benefit period
•Benefit payments reduce the specified amount, accumulation value, and other Policy values on a proportionate basis •Cannot receive benefits until end of elimination period unless
waived
•Lifetime benefit payments subject to a maximum limit •Outstanding liens against the Policy reduce lifetime maximum
benefit
•All accumulation value and premium payments must be allocated to the Fixed Account during a benefit period •Specified amount cannot be increased during benefit
period •Investment requirements, applicable upon exercise, limit available investment options •Rider will terminate if the terminal illness rider or other
accelerated death benefit is exercised
•Rider will terminate if the lifetime maximum benefit is reduced to zero •Rider will terminate if a partial surrender or loan is taken
during a benefit period |
| Surrender Charge for Polices with an application signed on or after October 7,
2019 for a 38 Year Old Male | ||||||||||||||||||||
| Policy Year |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
| Surrender Charge Per
$1,000 of Specified
amount |
$24 |
$23 |
$23 |
$23 |
$22 |
$22 |
$22 |
$21 |
$21 |
$20 |
$20 |
$20 |
$19 |
$19 |
$19 |
$15 |
$11 |
$7 |
$3 |
$0 |
| Surrender Charge for Policies with an application signed before October 7, 2019
for a 38 Year Old Male | ||||||||||
| Policy Year |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| Surrender Charge Per $1,000 of Specified amount |
$19 |
$19 |
$19 |
$19 |
$18 |
$15 |
$11 |
$7 |
$3 |
$0 |
| Defined Term |
Page to See in this Prospectus |
| accumulation value |
7 |
| Administrative Center |
23 |
| automatic rebalancing |
10 |
| basis |
87 |
| beneficiary |
68 |
| cash surrender value |
7 |
| cash value |
8 |
| cash value accumulation test |
39 |
| close of business |
30 |
| Code |
31 |
| Contact Information |
21 |
| cost of insurance rates |
73 |
| daily charge |
72 |
| date of issue |
30 |
| dollar cost averaging |
35 |
| Fixed Account |
29 |
| free look |
33 |
| full surrender |
8 |
| Fund, Funds |
7 |
| good order |
30 |
| grace period |
17 |
| guarantee period benefit |
33 |
| guideline premium test |
39 |
| insured person |
1 |
| investment options |
82 |
| lapse |
17 |
| lien |
50 |
| loan (also see “Policy loans” in this Index) |
8 |
| loan interest |
75 |
| Lowest specified amount |
48 |
| maturity date |
8 |
| modified endowment contract |
82 |
| monthly deduction days |
31 |
| monthly guarantee premium |
33 |
| monthly insurance charge |
39 |
| net amount at risk |
31 |
| net premium |
34 |
| Option 1 and Option 2 |
8 |
| outstanding loan amount |
65 |
| partial surrender |
8 |
| payment Options |
69 |
| planned periodic premiums |
33 |
| Policy loans |
67 |
| Policy months |
30 |
| Policy years |
31 |
| preferred loans |
9 |
| premium class |
71 |
| premium payments |
32 |
| reinstate, reinstatement |
80 |
| Defined Term |
Page to See in this Prospectus |
| required minimum death benefit |
39 |
| required minimum death benefit percentage |
40 |
| Separate Account VL-R |
22 |
| seven-pay test |
82 |
| specified amount |
7 |
| surrender charge period |
64 |
| target premium |
79 |
| transfers |
34 |
| valuation date |
30 |
| valuation period |
30 |
| variable investment options |
26 |
| Type |
Fund – Share Class
Adviser/
Sub-Adviser (if applicable) |
Current
Expenses |
Average Annual Total Returns
(as of 12/31/2025) | ||
| 1 Year |
5 Year |
10 Year | |||
| Balanced |
American Funds IS Asset Allocation Fund – Class 2
Adviser: Capital Research and Management CompanySM |
0.54% |
15.85% |
8.97% |
9.77% |
| |
Franklin Templeton Franklin Mutual Shares VIP Fund – Class
2 Adviser: Franklin Mutual Advisers,
LLC |
0.94% |
11.52% |
9.21% |
7.53% |
| |
SunAmerica ST SA JPMorgan Diversified Balanced Portfolio – Class 1
Shares* Adviser: SunAmerica Asset
Management, LLC Sub-Adviser: J.P. Morgan
Investment Management Inc. |
0.72% |
12.95% |
6.06% |
7.54% |
| |
VALIC Co. I Dynamic Allocation Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: SunAmerica Asset
Management, LLC Sub-Adviser:
AllianceBernstein L.P. |
0.83% |
11.33% |
5.60% |
7.49% |
| Commodity |
PIMCO CommodityRealReturn® Strategy Portfolio –
Administrative Class* Adviser: Pacific
Investment Management Company LLC |
2.28% |
18.79% |
10.55% |
6.54% |
| Domestic Equity |
Alger Capital Appreciation Portfolio – Class I-2 Shares
Adviser: Fred Alger Management, LLC |
50.93% |
32.87% |
16.33% |
18.17% |
| |
LVIP American Century® Value Fund*
Adviser: Lincoln Investment Advisors
Corporation Sub-Adviser: American Century
Investment Management, Inc. |
0.71% |
16.02% |
11.65% |
10.23% |
| |
American Funds IS Growth Fund – Class 2
Adviser: Capital Research and Management
Company |
0.59% |
31.63% |
18.83% |
16.58% |
| |
American Funds IS Growth-Income Fund – Class 2
Adviser: Capital Research and Management
Company |
0.53% |
24.23% |
13.02% |
12.20% |
| |
Fidelity® VIP ContrafundSM Portfolio – Service Class
2 Adviser: Fidelity Management &
Research Company (FMR) Sub-Adviser: FMR Co.,
Inc. |
0.81% |
21.19% |
15.08% |
15.49% |
| |
Fidelity® VIP Equity-Income Portfolio –
Service Class 2 Adviser: Fidelity Management
& Research Company (FMR) Sub-Adviser:
FMR Co., Inc. |
0.72% |
18.75% |
12.23% |
11.32% |
| |
Fidelity® VIP Growth Portfolio – Service
Class 2 Adviser: Fidelity Management &
Research Company (FMR) Sub-Adviser: FMR Co.,
Inc. |
0.81% |
14.61% |
13.41% |
17.15% |
| |
Fidelity® VIP Mid Cap Portfolio – Service Class 2
Adviser: Fidelity Management & Research Company
(FMR) Sub-Adviser: FMR Co.,
Inc. |
0.82% |
11.49% |
9.83% |
10.31% |
| |
Franklin Templeton Franklin Small Cap Value VIP Fund – Class
2* Adviser: Franklin Mutual Advisers,
LLC |
0.90% |
7.65% |
8.86% |
9.81% |
| |
Invesco V.I. Growth and Income Fund – Series I Shares
Adviser: Invesco Advisers, Inc. |
0.75% |
15.62% |
12.85% |
10.73% |
| |
Janus Henderson Enterprise Portfolio – Service Shares
Adviser: Janus Capital Management LLC |
0.97% |
7.41% |
7.35% |
12.51% |
| Type |
Fund – Share Class
Adviser/
Sub-Adviser (if applicable) |
Current
Expenses |
Average Annual Total Returns
(as of 12/31/2025) | ||
| 1 Year |
5 Year |
10 Year | |||
| |
Janus Henderson Forty Portfolio – Service Shares
Adviser: Janus Capital Management LLC |
0.83% |
17.86% |
11.37% |
15.96% |
| |
MFS® VIT New Discovery Series –
Initial Class* Adviser: Massachusetts
Financial Services Company |
0.87% |
12.96% |
-0.28% |
10.74% |
| |
MFS® VIT Research Series – Initial
Class* Adviser: Massachusetts Financial
Services Company |
0.74% |
12.85% |
11.15% |
12.93% |
| |
Neuberger Berman AMT Mid Cap Growth Portfolio – Class I*
Adviser: Neuberger Berman Investment Advisers
LLC |
0.90% |
5.45% |
4.47% |
10.96% |
| |
Seasons ST SA Multi Managed Mid Cap Value Portfolio – Class
3 Adviser: SunAmerica Asset Management,
LLC Sub-Adviser: Massachusetts Financial
Services Company |
1.25% |
7.03% |
9.93% |
9.27% |
| |
SunAmerica ST SA Wellington Capital Appreciation
Portfolio – Class 3
Adviser: SunAmerica Asset Management, LLC
Sub-Adviser: Wellington Management Company
LLP |
0.97% |
14.26% |
8.54% |
15.75% |
| |
VALIC Co. I Mid Cap Index Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: BlackRock Investment
Management LLC |
0.35% |
6.95% |
8.68% |
10.34% |
| |
VALIC Co. I Mid Cap Value Fund
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: Boston Partners Global
Investors, Inc. d/b/a Boston Partners
Sub-Adviser: Wellington Management Company
LLP |
0.83% |
7.23% |
10.19% |
9.29% |
| |
VALIC Co. I Nasdaq-100® Index Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: BlackRock Investment
Management LLC |
0.42% |
20.42% |
14.73% |
19.06% |
| |
VALIC Co. I Science & Technology Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: Allianz Global
Investors U.S. LLC Sub-Adviser: T. Rowe
Price Associates, Inc. Sub-Adviser:
Wellington Management Company LLP |
0.91% |
22.57% |
11.59% |
18.92% |
| |
VALIC Co. I Small Cap Index Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: BlackRock Investment
Management LLC |
0.38% |
12.23% |
5.69% |
9.27% |
| |
VALIC Co. I Stock Index Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: BlackRock Investment
Management LLC |
0.23% |
17.55% |
14.08% |
14.46% |
| |
VALIC Co. I U.S. Socially Responsible Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: SunAmerica Asset
Management, LLC |
0.35% |
14.73% |
11.77% |
12.91% |
| Fixed Income |
American Funds IS American High-Income Trust – Class 2*
Adviser: Capital Research and Management CompanySM |
0.58% |
8.24% |
5.60% |
6.96% |
| |
LVIP JPMorgan Core Bond Fund
Adviser: Lincoln Investment Advisors
Corporation Sub-Adviser: J.P. Morgan
Investment Management Inc. |
0.47% |
7.40% |
-0.04% |
2.11% |
| |
PIMCO Global Bond Opportunities Portfolio (Unhedged) – Administrative
Class Adviser: Pacific Investment Management
Company LLC |
1.08% |
12.75% |
0.15% |
2.46% |
| |
PIMCO Real Return Portfolio – Administrative Class
Adviser: Pacific Investment Management Company
LLC |
1.07% |
7.85% |
1.21% |
3.21% |
| |
PIMCO Short-Term Portfolio – Administrative Class
Adviser: Pacific Investment Management Company
LLC |
0.62% |
4.67% |
3.25% |
2.76% |
| Type |
Fund – Share Class
Adviser/
Sub-Adviser (if applicable) |
Current
Expenses |
Average Annual Total Returns
(as of 12/31/2025) | ||
| 1 Year |
5 Year |
10 Year | |||
| |
PIMCO Total Return Portfolio – Administrative Class
Adviser: Pacific Investment Management Company
LLC |
0.79% |
8.89% |
0.02% |
2.36% |
| |
SunAmerica ST SA Goldman Sachs Government and Quality
Bond Portfolio – Class 3 1 Adviser: SunAmerica Asset Management, LLC Sub-Adviser: Sachs Asset Management International |
0.83% |
6.31% |
-1.02% |
1.21% |
| |
VALIC Co. I Core Bond Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: PineBridge Investments
LLC |
0.48% |
7.64% |
-0.16% |
2.36% |
| International
Equity |
American Funds IS Global Growth Fund – Class 2
Adviser: Capital Research and Management CompanySM |
0.66% |
21.63% |
8.23% |
12.17% |
| |
American Funds IS International Fund – Class 2
Adviser: Capital Research and Management
Company |
0.78% |
26.76% |
3.40% |
7.00% |
| |
Invesco V.I. Global Fund – Series I Shares
Adviser: Invesco Advisers, Inc. |
0.81% |
15.32% |
7.28% |
11.00% |
| |
Invesco V.I. Global Real Estate Fund – Series I Shares
Adviser: Invesco Advisers, Inc.
Sub-Adviser: Invesco Asset Management
Limited |
1.02% |
7.85% |
1.73% |
2.44% |
| |
Invesco V.I. EQV International Equity Fund – Series I Shares1 Adviser: Invesco Advisers, Inc. |
0.90% |
0.62% |
3.23% |
4.36% |
| |
VALIC Co. I Emerging Economies Fund
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: J.P. Morgan Investment
Management Inc. |
1.02% |
16.50% |
3.68% |
6.22% |
| |
VALIC Co. I International Equities Index Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser:BlackRock Investment
Management LLC |
0.42% |
30.81% |
8.47% |
7.82% |
| |
VALIC Co. I International Value Fund*
Adviser: The Variable Annuity Life Insurance
Company Sub-Adviser: Templeton Global
Advisors Limited |
0.81% |
39.97% |
10.60% |
8.10% |
| Money Market |
Fidelity® VIP Government Money Market Portfolio
– Service Class 2 Adviser: Fidelity
Management & Research Company (FMR)
Sub-Adviser: Fidelity Investments Money Management,
Inc. |
0.50% |
3.60% |
2.85% |
1.80% |
| At 8% Per Annum | |||||
| End
of
Policy
Year |
Annual
Premium |
End of Year
Accumulation
Value |
End of
Year
Cash
Value |
End of
Year
Death
Benefit |
End of
Year
CG
Account
Value |
| 1 |
$ 3,052 |
$491 |
- |
$360,000 |
$233 |
| 15 |
$ 3,052 |
$31,953 |
$25,113 |
$360,000 |
$7,937 |
| 30 |
$ 3,052 |
$134,489 |
$134,489 |
$360,000 |
$34,483 |
| 40 |
$ 3,052 |
$282,708 |
$282,708 |
$423,836 |
$61,425 |
| 41 |
$ 3,052 |
$302,946 |
$302,946 |
$443,332 |
$64,426 |
| 44 |
$ 3,052 |
$370,390 |
$370,390 |
$506,064 |
$73,679 |
| 50 |
$ 3,052 |
$538,218 |
$538,218 |
$655,442 |
$91,901 |
| 59 |
$ 3,052 |
$890,864 |
$7890,864 |
$971,933 |
$111,428 |
| 83 |
$ 3,052 |
$5,041,864 |
$5,041,864 |
$5,041,864 |
$14,076 |
| At 6% Per Annum | |||||
| End
of
Policy
Year |
Annual
Premium |
End of Year
Accumulation
Value |
End of
Year
Cash
Value |
End of
Year
Death
Benefit |
End of
Year
CG
Account
Value |
| 1 |
$ 3,052 |
$465 |
- |
$ 360,000 |
$233 |
| 15 |
$ 3,052 |
$27,749 |
$20,909 |
$ 360,000 |
$7,937 |
| 30 |
$ 3,052 |
$93,171 |
$93,171 |
$ 360,000 |
$34,483 |
| 40 |
$ 3,052 |
$149,805 |
$149,805 |
$ 360,000 |
$61,425 |
| 41 |
$ 3,052 |
$155,082 |
$155,082 |
$ 360,000 |
$64,426 |
| 44 |
$ 3,052 |
$169,107 |
$169,107 |
$ 360,000 |
$73,679 |
| 50 |
$ 3,052 |
$174,866 |
$174,866 |
$ 360,000 |
$91,901 |
| 59 |
$ 3,052 |
$0 |
$105,193 |
$ 360,000 |
$111,428 |
| 83 |
$ 3,052 |
- |
- |
$ 360,000 |
$14,076 |
| Prospectus
Provision or
Rider |
Availability or Variation |
Issue State |
| Free Look |
If the Owner is 60 or above the free look period is extended to
30 days. These Owners may request their initial premium or
any premium submitted during the free look period be
allocated to the investment options immediately instead of
being placed in the money-market account. If premium is
allocated to investment options the free look amount will be
the policy’s account value as of the day the policy is
returned to the Company. If the Owner did not request the
premium to be allocated to the investment options the free
look amount will be all premiums paid and any policy
fee. |
California |
| Death Benefit Installment Rider |
Not available for sale. |
New Hampshire |
| Terminal Illness Rider |
Terminal Illness Riders issued prior to 9/29/2017: Time period
in definition of Terminal Illness – less than 12
months to live. Maximum interest rate does not include
reference to current yield on 90-day U.S. Treasury
Bills. |
Connecticut |
| Terminal Illness Rider |
Maximum Administrative Fee is $100. |
Florida |
| Waiver of Specified Premium
Rider |
Rider is called Total Disability Monthly Benefit Rider.
|
California, Georgia, New Jersey |
| Waiver of Specified Premium
Rider |
Rider is called Premium Waiver Rider. |
Texas |
| Waiver of Specified Premium
Rider |
Not available for sale. |
Massachusetts, Montana,
Virginia |
| Waiver of Monthly Deduction |
For total disability beginning on or after age 60, benefits are
payable while total disability continues until termination
date of the rider. |
California |
| 20 Year Benefit Rider |
Not available for sale. |
Vermont |
| 20 Year Benefit Rider |
Rider title changed to Monthly No-Lapse Premium Rider,
Monthly Guarantee Premium is referred to as Monthly No-Lapse
Premium and the Guarantee Period is referred to as No-Lapse
Period. |
Maryland |
| Accelerated Access SolutionSM
Rider |
Accelerated benefit is paid to owner, not owner or owner’s
estate.
Lifetime maximum benefit section – (Last paragraph, last 2 sentences) replace with the following: The lifetime maximum benefit will be reduced by the sum of all death benefit amounts you previously elected to accelerate under prior claims made under the rider, if any, or under any other accelerated death benefit endorsement or rider attached to the policy.Add Monthly Benefit section: You may request that an annualized benefit be paid in place of the monthly benefits payable during a benefit period. For any benefit period after the first benefit period, you must provide a written request to us at least 90 days in advance of the beginning of such benefit period to request an annualized benefit. You may also, at least 90 days in advance of the beginning of a benefit period , make a standing request to elect an annualized payment in place of monthly benefits as to each future benefit period as it arises. If such an election is made and
you subsequently desire to receive monthly benefits, you must
submit to us your written election to receive monthly
benefits at least 90 days in advance of the beginning of the
next benefit period. |
California |
| Prospectus
Provision or
Rider |
Availability or Variation |
Issue State |
| |
Replace language in Lump sum option section with the
following:
You may request to receive the accelerated benefit payable in a
lump sum. The lump sum payment will equal the death benefit
accelerated, less the following deductions:1. An actuarial
discount determined by us; and
2. If applicable, payment of a pro rata amount of outstanding
policy loans.We will determine the actuarial discount
applicable to a given lump sum payment using factors
including, but not limited to, the following:
1. Our assessment of the expected future mortality of the
Insured; and
2. An interest rate that will not exceed the greater of the yield on
90-day U.S.Treasury Bills or the then current maximum
statutory adjustable policy loan interest rate.
Replace language in Claims section with the following:Upon
receipt of the notice of claim, we will mail a claim form to
you within 15 days. If the claim form is not sent within
this 15-day period, you will be deemed to have complied with
the requirements of the rider as to proof of loss if you
submit written proof covering the character and the extent
of the occurrence or loss for which claim is
made. Replace first two sentences in Impact on Policy section with the
following:Each accelerated benefit payment will reduce certain
policy components by a proportional amount. This proportion
will equal the amount of the reduction in death benefit that
results from the accelerated benefit payment, divided by the
death benefit immediately before the payment.
Replace language in Incontestability section with the
following:We will not contest the rider after it has been in force
during the Insured’s lifetime for two (2) years from
the rider date of issue. The rider can only be contested
based on a statement made in the application for the rider
if the statement is attached to the policy. The statement
upon which the contest is made must be material to the risk
accepted or the hazard assumed by us.
Replace language in Reinstatement section with the
following:Reinstatement of the rider will be on the same or
more favorable terms as reinstatement of the policy to which
the rider is attached. If the rider is reinstated, you will have the
same rights after reinstatement as you had under the rider
immediately before the due date of the defaulted
premium. The following should be deleted from Limitations section:This
benefit is not intended to allow third parties to cause you to
involuntarily access the policy proceeds payable to the
named |
|
| Prospectus
Provision or
Rider |
Availability or Variation |
Issue State |
| |
Beneficiary. Therefore, the Accelerated Benefit will not be
available if you are required to request it for any third party,
including any creditor, government agency, trustee in
bankruptcy or any other person or as the result of a court
order. |
|
| Accelerated Access SolutionSM
Rider |
Accelerated Access SolutionSM Riders issued prior to
7/20/2017:
Accelerated Benefit is paid to owner, not owner or owner’s
estate.
The maximum interest rate will not exceed the greater of:1. The
Moody’s Corporate Bond Yield Average – Monthly
Average Corporates (hereafter referred to as
“Moody’s Bond Yield Average”) for the
month of October preceding the calendar year for which the
loan interest rate is determined; or 2. The interest rate
used to calculate Cash Values under the Policy during the
period for which the interest rate is being determined, plus
1%. The following should be deleted from Limitations section: The
Accelerated Benefit will not be available if You are required to
request it for any third party, including any creditor,
government agency, trustee in bankruptcy or any other person
or as the result of a court order. |
Connecticut |
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| |
GUARANTEED PERIOD |
|
GUARANTEED PERIOD | ||||
| AGE OF PAYEE |
10 Years |
15 Years |
20 Years |
AGE OF PAYEE |
10 Years |
15 Years |
20 Years |
| 10 |
$1.62 |
$1.62 |
$1.62 |
50 |
$2.87 |
$2.85 |
$2.82 |
| 11 |
1.63 |
1.63 |
1.63 |
51 |
2.94 |
2.91 |
2.87 |
| 12 |
1.65 |
1.65 |
1.65 |
52 |
3.01 |
2.98 |
2.93 |
| 13 |
1.66 |
1.66 |
1.66 |
53 |
3.08 |
3.04 |
2.99 |
| 14 |
1.68 |
1.68 |
1.68 |
54 |
3.15 |
3.11 |
3.05 |
| 15 |
1.70 |
1.70 |
1.69 |
55 |
3.23 |
3.19 |
3.12 |
| 16 |
1.71 |
1.71 |
1.71 |
56 |
3.31 |
3.26 |
3.18 |
| 17 |
1.73 |
1.73 |
1.73 |
57 |
3.40 |
3.34 |
3.25 |
| 18 |
1.75 |
1.75 |
1.75 |
58 |
3.49 |
3.42 |
3.32 |
| 19 |
1.77 |
1.77 |
1.77 |
59 |
3.58 |
3.51 |
3.39 |
| 20 |
1.79 |
1.79 |
1.79 |
60 |
3.68 |
3.60 |
3.46 |
| 21 |
1.81 |
1.81 |
1.81 |
61 |
3.79 |
3.69 |
3.53 |
| 22 |
1.83 |
1.83 |
1.83 |
62 |
3.90 |
3.79 |
3.61 |
| 23 |
1.85 |
1.85 |
1.85 |
63 |
4.01 |
3.88 |
3.68 |
| 24 |
1.87 |
1.87 |
1.87 |
64 |
4.14 |
3.98 |
3.75 |
| 25 |
1.89 |
1.89 |
1.89 |
65 |
4.27 |
4.09 |
3.82 |
| 26 |
1.92 |
1.92 |
1.91 |
66 |
4.40 |
4.19 |
3.89 |
| 27 |
1.94 |
1.94 |
1.94 |
67 |
4.54 |
4.30 |
3.96 |
| 28 |
1.97 |
1.97 |
1.96 |
68 |
4.69 |
4.41 |
4.03 |
| 29 |
1.99 |
1.99 |
1.99 |
69 |
4.84 |
4.52 |
4.09 |
| 30 |
2.02 |
2.02 |
2.02 |
70 |
5.00 |
4.63 |
4.15 |
| 31 |
2.05 |
2.05 |
2.04 |
71 |
5.16 |
4.74 |
4.21 |
| 32 |
2.08 |
2.08 |
2.07 |
72 |
5.33 |
4.85 |
4.26 |
| 33 |
2.11 |
2.11 |
2.10 |
73 |
5.51 |
4.95 |
4.31 |
| 34 |
2.14 |
2.14 |
2.13 |
74 |
5.69 |
5.06 |
4.35 |
| 35 |
2.17 |
2.17 |
2.17 |
75 |
5.87 |
5.16 |
4.39 |
| 36 |
2.21 |
2.21 |
2.20 |
76 |
6.06 |
5.25 |
4.43 |
| 37 |
2.25 |
2.24 |
2.23 |
77 |
6.24 |
5.34 |
4.46 |
| 38 |
2.28 |
2.28 |
2.27 |
78 |
6.43 |
5.43 |
4.49 |
| 39 |
2.32 |
2.32 |
2.31 |
79 |
6.62 |
5.50 |
4.51 |
| 40 |
2.36 |
2.36 |
2.35 |
80 |
6.81 |
5.58 |
4.53 |
| 41 |
2.40 |
2.40 |
2.39 |
81 |
6.81 |
5.58 |
4.53 |
| 42 |
2.45 |
2.44 |
2.43 |
82 |
6.81 |
5.58 |
4.53 |
| 43 |
2.49 |
2.49 |
2.47 |
83 |
6.81 |
5.58 |
4.53 |
| 44 |
2.54 |
2.53 |
2.51 |
84 |
6.81 |
5.58 |
4.53 |
| 45 |
2.59 |
2.58 |
2.56 |
85 |
6.81 |
5.58 |
4.53 |
| 46 |
2.64 |
2.63 |
2.61 |
86 |
6.81 |
5.58 |
4.53 |
| 47 |
2.70 |
2.68 |
2.66 |
87 |
6.81 |
5.58 |
4.53 |
| 48 |
2.75 |
2.74 |
2.71 |
88 |
6.81 |
5.58 |
4.53 |
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| |
GUARANTEED PERIOD |
|
GUARANTEED PERIOD | ||||
| AGE OF PAYEE |
10 Years |
15 Years |
20 Years |
AGE OF PAYEE |
10 Years |
15 Years |
20 Years |
| 49 |
2.81 |
2.79 |
2.76 |
89 |
6.81 |
5.58 |
4.53 |
| |
|
|
|
90 |
6.81 |
5.58 |
4.53 |
| Payments are based upon the age, nearest birthday, of the Payee when the first
installment is payable in 2015. If monthly installments for two or
more specified periods for a given age are the same, the specified period of longer duration will apply. | |||||||
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| AGE OF PAYEE |
GUARANTEED PERIOD |
AGE OF PAYEE |
GUARANTEED PERIOD | ||||
| Female |
10 Years |
15 Years |
20 Years |
Female |
10 Years |
15 Years |
20 Years |
| 10 |
$1.55 |
$1.55 |
$1.55 |
50 |
$2.65 |
$2.64 |
$2.62 |
| 11 |
1.57 |
1.57 |
1.57 |
51 |
2.70 |
2.69 |
2.67 |
| 12 |
1.58 |
1.58 |
1.58 |
52 |
2.76 |
2.75 |
2.72 |
| 13 |
1.60 |
1.59 |
1.59 |
53 |
2.82 |
2.80 |
2.78 |
| 14 |
1.61 |
1.61 |
1.61 |
54 |
2.88 |
2.87 |
2.84 |
| 15 |
1.62 |
1.62 |
1.62 |
55 |
2.95 |
2.93 |
2.90 |
| 16 |
1.64 |
1.64 |
1.64 |
56 |
3.02 |
3.00 |
2.96 |
| 17 |
1.66 |
1.66 |
1.65 |
57 |
3.10 |
3.07 |
3.02 |
| 18 |
1.67 |
1.67 |
1.67 |
58 |
3.17 |
3.14 |
3.09 |
| 19 |
1.69 |
1.69 |
1.69 |
59 |
3.25 |
3.22 |
3.16 |
| 20 |
1.71 |
1.71 |
1.71 |
60 |
3.34 |
3.30 |
3.23 |
| 21 |
1.72 |
1.72 |
1.72 |
61 |
3.43 |
3.39 |
3.30 |
| 22 |
1.74 |
1.74 |
1.74 |
62 |
3.53 |
3.47 |
3.38 |
| 23 |
1.76 |
1.76 |
1.76 |
63 |
3.63 |
3.57 |
3.45 |
| 24 |
1.78 |
1.78 |
1.78 |
64 |
3.74 |
3.66 |
3.53 |
| 25 |
1.80 |
1.80 |
1.80 |
65 |
3.85 |
3.76 |
3.61 |
| 26 |
1.82 |
1.82 |
1.82 |
66 |
3.97 |
3.87 |
3.69 |
| 27 |
1.84 |
1.84 |
1.84 |
67 |
4.10 |
3.97 |
3.76 |
| 28 |
1.87 |
1.87 |
1.86 |
68 |
4.23 |
4.08 |
3.84 |
| 29 |
1.89 |
1.89 |
1.89 |
69 |
4.37 |
4.20 |
3.92 |
| 30 |
1.91 |
1.91 |
1.91 |
70 |
4.52 |
4.31 |
3.99 |
| 31 |
1.94 |
1.94 |
1.93 |
71 |
4.68 |
4.43 |
4.06 |
| 32 |
1.96 |
1.96 |
1.96 |
72 |
4.85 |
4.55 |
4.13 |
| 33 |
1.99 |
1.99 |
1.99 |
73 |
5.02 |
4.67 |
4.19 |
| 34 |
2.02 |
2.02 |
2.01 |
74 |
5.20 |
4.79 |
4.25 |
| 35 |
2.05 |
2.04 |
2.04 |
75 |
5.39 |
4.91 |
4.31 |
| 36 |
2.08 |
2.07 |
2.07 |
76 |
5.58 |
5.03 |
4.36 |
| 37 |
2.11 |
2.10 |
2.10 |
77 |
5.78 |
5.14 |
4.40 |
| 38 |
2.14 |
2.14 |
2.13 |
78 |
5.98 |
5.24 |
4.44 |
| 39 |
2.17 |
2.17 |
2.17 |
79 |
6.19 |
5.34 |
4.47 |
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| AGE OF PAYEE |
GUARANTEED PERIOD |
AGE OF PAYEE |
GUARANTEED PERIOD | ||||
| Female |
10 Years |
15 Years |
20 Years |
Female |
10 Years |
15 Years |
20 Years |
| 40 |
2.21 |
2.20 |
2.20 |
80 |
6.40 |
5.43 |
4.50 |
| 41 |
2.24 |
2.24 |
2.23 |
81 |
6.40 |
5.43 |
4.50 |
| 42 |
2.28 |
2.28 |
2.27 |
82 |
6.40 |
5.43 |
4.50 |
| 43 |
2.32 |
2.32 |
2.31 |
83 |
6.40 |
5.43 |
4.50 |
| 44 |
2.36 |
2.36 |
2.35 |
84 |
6.40 |
5.43 |
4.50 |
| 45 |
2.40 |
2.40 |
2.39 |
85 |
6.40 |
5.43 |
4.50 |
| 46 |
2.45 |
2.44 |
2.43 |
86 |
6.40 |
5.43 |
4.50 |
| 47 |
2.49 |
2.49 |
2.47 |
87 |
6.40 |
5.43 |
4.50 |
| 48 |
2.54 |
2.53 |
2.52 |
88 |
6.40 |
5.43 |
4.50 |
| 49 |
2.59 |
2.58 |
2.57 |
89 |
6.40 |
5.43 |
4.50 |
| |
|
|
|
90 |
6.40 |
5.43 |
4.50 |
| Payments are based upon the age, nearest birthday, of the Payee when the first
installment is payable in 2015. If monthly installments for two or
more specified periods for a given age are the same, the specified period of longer duration will apply. | |||||||
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| AGE OF PAYEE |
GUARANTEED PERIOD |
AGE OF PAYEE |
GUARANTEED PERIOD | ||||
| Male |
10 Years |
15 Years |
20 Years |
Male |
10 Years |
15 Years |
20 Years |
| 10 |
$1.63 |
$1.63 |
$1.63 |
50 |
$2.93 |
$2.90 |
$2.86 |
| 11 |
1.65 |
1.65 |
1.64 |
51 |
3.00 |
2.97 |
2.92 |
| 12 |
1.66 |
1.66 |
1.66 |
52 |
3.06 |
3.03 |
2.98 |
| 13 |
1.68 |
1.68 |
1.68 |
53 |
3.14 |
3.10 |
3.04 |
| 14 |
1.70 |
1.69 |
1.69 |
54 |
3.21 |
3.17 |
3.10 |
| 15 |
1.71 |
1.71 |
1.71 |
55 |
3.29 |
3.25 |
3.17 |
| 16 |
1.73 |
1.73 |
1.73 |
56 |
3.38 |
3.33 |
3.24 |
| 17 |
1.75 |
1.75 |
1.75 |
57 |
3.47 |
3.41 |
3.30 |
| 18 |
1.77 |
1.77 |
1.76 |
58 |
3.56 |
3.49 |
3.37 |
| 19 |
1.79 |
1.79 |
1.78 |
59 |
3.66 |
3.58 |
3.44 |
| 20 |
1.81 |
1.81 |
1.80 |
60 |
3.76 |
3.67 |
3.51 |
| 21 |
1.83 |
1.83 |
1.82 |
61 |
3.87 |
3.76 |
3.59 |
| 22 |
1.85 |
1.85 |
1.85 |
62 |
3.99 |
3.86 |
3.66 |
| 23 |
1.87 |
1.87 |
1.87 |
63 |
4.11 |
3.96 |
3.73 |
| 24 |
1.89 |
1.89 |
1.89 |
64 |
4.23 |
4.06 |
3.80 |
| 25 |
1.92 |
1.92 |
1.91 |
65 |
4.37 |
4.16 |
3.87 |
| 26 |
1.94 |
1.94 |
1.94 |
66 |
4.51 |
4.27 |
3.94 |
| 27 |
1.97 |
1.96 |
1.96 |
67 |
4.65 |
4.38 |
4.00 |
| 28 |
1.99 |
1.99 |
1.99 |
68 |
4.80 |
4.49 |
4.07 |
| 29 |
2.02 |
2.02 |
2.01 |
69 |
4.95 |
4.59 |
4.13 |
| 30 |
2.05 |
2.05 |
2.04 |
70 |
5.12 |
4.70 |
4.19 |
| OPTION 3 TABLE
INSTALLMENTS FOR LIFE WITH SPECIFIED MINIMUM
PERIOD | |||||||
| AGE OF PAYEE |
GUARANTEED PERIOD |
AGE OF PAYEE |
GUARANTEED PERIOD | ||||
| Male |
10 Years |
15 Years |
20 Years |
Male |
10 Years |
15 Years |
20 Years |
| 31 |
2.08 |
2.07 |
2.07 |
71 |
5.28 |
4.81 |
4.24 |
| 32 |
2.11 |
2.10 |
2.10 |
72 |
5.45 |
4.91 |
4.29 |
| 33 |
2.14 |
2.14 |
2.13 |
73 |
5.63 |
5.02 |
4.33 |
| 34 |
2.17 |
2.17 |
2.16 |
74 |
5.80 |
5.12 |
4.38 |
| 35 |
2.21 |
2.20 |
2.20 |
75 |
5.99 |
5.21 |
4.41 |
| 36 |
2.24 |
2.24 |
2.23 |
76 |
6.17 |
5.30 |
4.44 |
| 37 |
2.28 |
2.27 |
2.27 |
77 |
6.35 |
5.39 |
4.47 |
| 38 |
2.32 |
2.31 |
2.30 |
78 |
6.54 |
5.47 |
4.50 |
| 39 |
2.36 |
2.35 |
2.34 |
79 |
6.72 |
5.54 |
4.52 |
| 40 |
2.40 |
2.39 |
2.38 |
80 |
6.90 |
5.61 |
4.54 |
| 41 |
2.44 |
2.44 |
2.42 |
81 |
6.90 |
5.61 |
4.54 |
| 42 |
2.49 |
2.48 |
2.46 |
82 |
6.90 |
5.61 |
4.54 |
| 43 |
2.54 |
2.53 |
2.51 |
83 |
6.90 |
5.61 |
4.54 |
| 44 |
2.59 |
2.57 |
2.55 |
84 |
6.90 |
5.61 |
4.54 |
| 45 |
2.64 |
2.62 |
2.60 |
85 |
6.90 |
5.61 |
4.54 |
| 46 |
2.69 |
2.67 |
2.65 |
86 |
6.90 |
5.61 |
4.54 |
| 47 |
2.75 |
2.73 |
2.70 |
87 |
6.90 |
5.61 |
4.54 |
| 48 |
2.80 |
2.78 |
2.75 |
88 |
6.90 |
5.61 |
4.54 |
| 49 |
2.86 |
2.84 |
2.81 |
89 |
6.90 |
5.61 |
4.54 |
| |
|
|
|
90 |
6.90 |
5.61 |
4.54 |
| Payments are based upon the age, nearest birthday, of the Payee when the first
installment is payable in 2015. If monthly installments for two or
more specified periods for a given age are the same, the specified period of longer duration will apply. | |||||||
| For Life
Consumer Portal and eDelivery, or to view and Print
Policy or Fund prospectuses visit us at
www.corebridgefinancial.com/lifeportal |
| Exhibit No. |
Description |
Location |
| (a) |
Board of Directors Resolution. |
|
| (1) |
Incorporated by reference to initial filing of Form S-6
Registration Statement (File No. 333-42567) of
American General Life Insurance Company Separate
Account VL-R filed on December 18, 1997. | |
| (b) |
Custodian Agreements. |
Inapplicable. |
| (c) |
Underwriting Contracts. |
|
| (1) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-4 Registration Statement (File
No. 333-40637) of American General Life Insurance
Company Separate Account D filed on November 8, 2002. | |
| (2) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2019.
| |
| (d) |
Contracts. |
|
| (1) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (2) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (3) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (4) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (5) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on December 17,
2004. | |
| (6) |
Incorporated by reference to initial filing of Form N-6
Registration Statement (File No. 333-196172) of
American General Life Insurance Company Separate
Account VL-R filed on May 22, 2014. | |
| (7) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (8) |
Incorporated by reference to initial filing of Form N-6 Registration Statement (File No. 333-196172) of American General Life Insurance Company Separate Account VL-R filed on May 22, 2014. |
| Exhibit
No. |
Description |
Location |
| (9) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (10) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on December 12,
2006. | |
| (11) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on December 12,
2006. | |
| (12) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on December 12,
2006. | |
| (13) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2018.
| |
| (14) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (15) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-137817) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (16) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 29, 2016.
| |
| (17) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 29, 2016.
| |
| (18) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (19) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (20) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (21) |
Incorporated by reference to Post-Effective Amendment No. 3 to Form N-6 Registration Statement (File No. 333-196172) of American General Life Insurance Company Separate Account VL-R filed on April 28, 2017. |
| Exhibit
No. |
Description |
Location |
| (22) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (23) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (24) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (25) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2019.
| |
| (26) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2019.
| |
| (27) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (28) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (29) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (30) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (e) |
Applications. |
|
| (1) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2019.
| |
| (2) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (3) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (4) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on June 24, 2019. | |
| (f) |
Depositor’s Certificate of Incorporation and
By-Laws. |
|
| (1) |
Incorporated by reference to Initial Registration
Statement on Form S-1, filed on February 21, 2024,
Accession No. 0001193125-24-040282. | |
| (2) |
|
|
| Exhibit
No. |
Description |
Location |
| (3) |
Incorporated by reference to Post-Effective Amendment
No. 11 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on August 12,
2005. | |
| (g) |
Reinsurance Contracts. |
|
| (1) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (2) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (3) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (4) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (5) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2014.
| |
| (h) |
Participation Agreements. |
|
| (1)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-42567) of American General Life Insurance
Company Separate Account VL-R filed on March 23,
1998. | |
| (1)(b) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form S-6 Registration Statement (File
No. 333-42567) of American General Life Insurance
Company Separate Account VL-R filed on October 11,
2000. | |
| (1)(c) |
Incorporated by reference to initial filing of Form N-6
Registration Statement (File No. 333-103361) of
American General Life Insurance Company Separate
Account VL-R filed on February 21, 2003. | |
| (1)(d) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-143072) of American General Life Insurance
Company Separate Account VL-R filed on August 22,
2007. | |
| (1)(e) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on August 28,
2008. | |
| (1)(f) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 2, 2011. | |
| (2)(a) |
Incorporated by reference to Post-Effective Amendment No. 6 to Form N-6 Registration Statement (File No. 333-43264) of American General Life Insurance Company Separate Account VL-R filed on April 30, 2003. |
| Exhibit
No. |
Description |
Location |
| (3)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-89897) of American General Life Insurance
Company Separate Account VL-R filed on January 21,
2000. | |
| (3)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 2, 2005. | |
| (3)(c) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (4)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-4 Registration Statement (File
No. 333-137892) of American General Life Insurance
Company (formerly AIG SunAmerica Life Assurance
Company) Variable Separate Account filed on April 26,
2007. | |
| (4)(b) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (4)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (4)(d) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (5)(a) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (5)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (6)(a) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (6)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (7)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on December 2,
2004. | |
| (7)(b) |
Incorporated by reference to Post-Effective Amendment No. 1 to Form N-6 Registration Statement (File No. 333-129552) of American General Life Insurance Company Separate Account VL-R filed on May 1, 2006. |
| Exhibit
No. |
Description |
Location |
| (7)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-143072) of American General Life Insurance
Company Separate Account VL-R filed on August 22,
2007. | |
| (7)(d) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-153068) of American General Life Insurance
Company Separate Account VL-R filed on December 3,
2008. | |
| (7)(e) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2014.
| |
| (7)(f) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (8)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2010. | |
| (8)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (9)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (9)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on August 28,
2008. | |
| (9)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (9)(d) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 29, 2016.
| |
| (10)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-42567) of American General Life Insurance
Company Separate Account VL-R filed on March 23,
1998. | |
| (10)(b) |
Incorporated by reference to Post-Effective Amendment No. 2 to Form S-6 Registration Statement (File No. 333-80191) of American General Life Insurance Company Separate Account VL-R filed on September 20, 2000. |
| Exhibit
No. |
Description |
Location |
| (10)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on August 28,
2008. | |
| (10)(d) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (10)(e) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (11)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-89897) of American General Life Insurance
Company Separate Account VL-R filed on January 21,
2000. | |
| (11)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-89897) of American General Life Insurance
Company Separate Account VL-R filed on January 21,
2000. | |
| (11)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-137817) of American General Life Insurance
Company Separate Account VL-R filed on December 14,
2006. | |
| (11)(d) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (12)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (12)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-129552) of American General Life Insurance
Company Separate Account VL-R filed on March 30,
2006. | |
| (12)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-144594) of American General Life Insurance
Company Separate Account VL-R filed on October 2,
2007. | |
| (12)(d) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2012.
| |
| (12)(e) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (13)(a) |
Filed herewith |
| Exhibit
No. |
Description |
Location |
| (14)(a) |
Filed herewith | |
| (15)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-4 Registration Statement (File
No. 333-40637) of American General Life Insurance
Company Separate Account D filed on February 12, 1998.
| |
| (15)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-4 Registration Statement (File
No. 333-70667) of American General Life Insurance
Company Separate Account D filed on March 18, 1999. | |
| (15)(c) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (15)(d) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form S-6 Registration Statement (File
No. 333-42567) of American General Life Insurance
Company Separate Account VL-R filed on October 11,
2000. | |
| (15)(e) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-4 Registration Statement (File
No. 333-109206) of American General Life Insurance
Company Separate Account D filed on December 17,
2003. | |
| (15)(f) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on August 28,
2008. | |
| (15)(g) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2010. | |
| (15)(h) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 2, 2011. | |
| (15)(i) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (15)(j) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (16)(a) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (16)(b) |
Incorporated by reference to Post-Effective Amendment
No. 3 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 28, 2017.
| |
| (16)(c) |
Incorporated by reference to Post-Effective Amendment No. 3 to Form N-6 Registration Statement (File No. 333-196172) of American General Life Insurance Company Separate Account VL-R filed on April 28, 2017. |
| Exhibit
No. |
Description |
Location |
| (17)(a) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2003.
| |
| (18)(a) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (19)(a) |
Incorporated by reference to Form N-6 Registration
Statement (File No. 333-185761) of American General
Life Insurance Company Separate Account II filed on
January 2, 2013. | |
| (20)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (20)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-137817) of American General Life Insurance
Company Separate Account VL-R filed on December 14,
2006. | |
| (21)(a) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-87307) of American General Life Insurance
Company Separate Account VL-R filed on October 10,
2000. | |
| (21)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form S-6 Registration Statement (File
No. 333-65170) of American General Life Insurance
Company Separate Account VL-R filed on December 3,
2001. | |
| (21)(c) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-153068) of American General Life Insurance
Company Separate Account VL-R filed on December 3,
2008. | |
| (21)(d) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (22)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (23)(a) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (24)(a) |
Incorporated by reference to Post-Effective Amendment No. 2 to Form S-6 Registration Statement (File No. 333-80191) of American General Life Insurance Company Separate Account VL-R filed on September 20, 2000. |
| Exhibit
No. |
Description |
Location |
| (24)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2009. | |
| (24)(c) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (24)(d) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2018.
| |
| (25)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-80191) of American General Life Insurance
Company Separate Account VL-R filed on September 20,
2000. | |
| (25)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (26)(a) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (27)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form S-6 Registration Statement (File
No. 333-65170) of American General Life Insurance
Company Separate Account VL-R filed on April 24, 2002.
| |
| (27)(b) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (28)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (29)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (30)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (31)(a) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (31)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (32)(a) |
Incorporated by reference to Post-Effective Amendment No. 5 to Form N-6 Registration Statement (File No. 333-151576) of American General Life Insurance Company Separate Account VL-R filed on April 30, 2013. |
| Exhibit
No. |
Description |
Location |
| (33)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (34)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (35)(a) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2010. | |
| (36)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (37)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (38)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (39)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (39)(b) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2015. | |
| (40)(a) |
Incorporated by reference to Post-Effective Amendment
No. 5 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2013.
| |
| (41)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (41)(a) |
Incorporated by reference to Post-Effective Amendment
No. 7 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 1, 2007. | |
| (42)(a) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2014.
| |
| (i) |
Administrative Contracts. |
|
| (1)(a) |
Incorporated by reference to Post-Effective Amendment
No. 8 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2004. | |
| (1)(b) |
Incorporated by reference to Post-Effective Amendment No. 8 to Form N-6 Registration Statement (File No. 333-43264) of American General Life Insurance Company Separate Account VL-R filed on May 3, 2004. |
| Exhibit
No. |
Description |
Location |
| (1)(c) |
Incorporated by reference to Post-Effective Amendment
No. 8 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2004. | |
| (1)(d) |
Incorporated by reference to Post-Effective Amendment
No. 8 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2004. | |
| (1)(e) |
Incorporated by reference to Post-Effective Amendment
No. 8 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2004. | |
| (1)(f) |
Incorporated by reference to Post-Effective Amendment
No. 8 to Form N-6 Registration Statement (File
No. 333-43264) of American General Life Insurance
Company Separate Account VL-R filed on May 3, 2004. | |
| (1)(g) |
Incorporated by reference to Post-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-118318) of American General Life Insurance
Company Separate Account VL-R filed on May 2, 2005. | |
| (1)(h) |
Incorporated by reference to Post-Effective Amendment
No. 4 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2018.
| |
| (j) |
Other Material Contracts. |
|
| (1) |
Incorporated by reference to Post-Effective Amendment
No. 6 to Form N-6 Registration Statement (File
No. 333-151576) of American General Life Insurance
Company Separate Account VL-R filed on April 30, 2014.
| |
| (2) |
Incorporated by reference to Post-Effective Amendment
No. 2 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on April 29, 2016.
| |
| (k) |
Legal Opinion. |
|
| (1) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (l) |
Actuarial Opinion. |
|
| (1) |
Incorporated by reference to Pre-Effective Amendment
No. 1 to Form N-6 Registration Statement (File
No. 333-196172) of American General Life Insurance
Company Separate Account VL-R filed on November 3,
2014. | |
| (m) |
Calculation. |
None |
| (n) |
Other Opinions. |
|
| (1) |
Filed herewith | |
| (o) |
Omitted Financial Statements. |
None |
| (p) |
Initial Capital Agreements. |
None |
| (q) |
Redeemability Exemption. |
|
| Exhibit
No. |
Description |
Location |
| (1) |
Filed herewith | |
| (r) |
Form of Initial Summary Prospectus |
None |
| (s) |
Powers of Attorney. |
|
| (1) |
Incorporated by reference to Post-Effective Amendment No. 10 to Form N-4, File No. 333-277203, filed on October 24, 2025, Accession No. 0001193125-25-25000. |
| NAMES, POSITIONS AND OFFICES HELD WITH DEPOSITOR | |
| Christopher B. Smith (7) |
Director, Chairman of the Board and President |
| Christopher P. Filiaggi (7) |
Director, Senior Vice President and Chief Financial Officer |
| Jonathan J. Novak (1) |
Director, President, Institutional Markets |
| Bryan A. Pinsky (2) |
Director, President, Individual Retirement and Life Insurance |
| Lisa M. Longino (7) |
Director, Executive Vice President and Chief Investment Officer |
| David Ditillo (5) |
Director, Executive Vice President and Chief Information Officer |
| Emily W. Gingrich (4) |
Director, Senior Vice President, Chief Actuary and Corporate Illustration Actuary |
| Eric G. Tarnow |
Director, Senior Vice President, Head of Life Insurance |
| Terri N. Fiedler (3) |
Director |
| Elizabeth B. Cropper (7) |
Executive Vice President and Chief Human Resources Officer |
| John P. Byrne III (3) |
President, Financial Distributor |
| Steven D. (“Doug”) Caldwell, Jr. (7) |
Executive Vice President and Chief Risk Officer |
| Christina M. Haley (2) |
Senior Vice President, Individual Retirement Products |
| Patricia M. Schwartz (2) |
Senior Vice President, Head of Valuation and Financial Reporting, and Appointed Actuary |
| Sai P. Raman (6) |
Senior Vice President, Institutional Markets |
| Mallary L. Reznik (2) |
Senior Vice President, General Counsel and Assistant Secretary |
| Jeannette N. Pina (7) |
Senior Vice President, Corporate Secretary |
| Jonathan A. Gold (7) |
Senior Vice President and Deputy Investment Officer |
| Brigitte K. Lenz |
Vice President and Controller |
| Jennifer Powell (3) |
Vice President and Chief Compliance Officer, and 38a-1 Compliance Officer |
| Brian O. Moon (7) |
Vice President and Treasurer |
| Mersini G. Keller |
Vice President and Tax Officer |
| Angel R. Ramos |
Vice President and Tax Officer |
| Aimy T. Tran (2) |
Vice President, Product Filing |
| Tyra G. Wheatley |
Vice President, Product Filing |
| Korey L. Dalton |
Vice President |
| Christopher J. Hobson (2) |
Vice President |
| Jennifer N. Miller |
Vice President |
| Marjorie D. Brothers (3) |
Assistant Secretary |
| Alison Chen (1) |
Assistant Secretary |
| William Langston (7) |
Assistant Secretary |
| Angela G. Bates (4) |
Anti-Money Laundering and Economic Sanctions Compliance Officer |
| Joey D. Zhou (3) |
Illustration Actuary |
| Michael F. Mulligan (1) |
Head of International Pension Risk Transfer |
| Ethan D. Bronsnick (7) |
Head of U.S. Pension Risk Transfer and Head of Structured Settlements |
| Aileen V. Apuy |
Manager, State Filings |
| Connie C. Merer (1) |
Assistant Manager, State Filings |
| Melissa H. Cozart (3) |
Privacy Officer |
| Thomas Bartolomeo |
Chief Information Security Officer |
| Name and Principal Business Address* |
Positions and Offices with Underwriter Corebridge Capital Services, Inc. |
| Christina Nasta |
Director, Chairman of the Board, President and Chief Executive Officer |
| John P. Byrne III (1) |
Director |
| Nicholas G. Intrieri |
Director |
| Ryan Tapak |
Director |
| Eric Taylor |
Director |
| Cynthia L. Burnette (1) |
Vice President, Chief Financial Officer, Chief Operations Officer, Treasurer and Controller |
| Michael Fortey (1) |
Chief Compliance Officer |
| Jeannette N. Pina |
Senior Vice President and Corporate Secretary |
| Mersini G. Keller |
Vice President, Tax Officer |
| Anish Cheeran (1) |
Vice President, Tax Officer |
| Angel Ramos (1) |
Vice President, Tax Officer |
| Katarzyna Halasiewicz(1) |
Vice President, Tax Officer |
| Mallary L. Reznik (2) |
Vice President |
| Marjorie Brothers (1) |
Assistant Secretary |
| Allison Chen (2) |
Assistant Secretary |
| William Langston |
Assistant Secretary |
| BY: |
AMERICAN GENERAL LIFE INSURANCE COMPANY (On behalf of the Registrant and itself) |
| BY: |
/s/ CHRISTOPHER FILIAGGI CHRISTOPHER FILIAGGI
DIRECTOR, SENIOR VICE PRESIDENT AND CHIEF
FINANCIAL OFFICER |
| Signature |
Title |
Date |
| *CHRISTOPHER B. SMITH CHRISTOPHER B. SMITH |
Director, Chairman of the Board, and President (Principal Executive Officer) |
April 22, 2026 |
| | ||
| *CHRISTOPHER V. FILIAGGI CHRISTOPHER V. FILIAGGI |
Director, Senior Vice President, and Chief Financial Officer (Principal Financial Officer) (Principal Accounting Officer) |
April 22, 2026 |
| | ||
| *TERRI N. FIEDLER TERRI N. FIEDLER |
Director |
April 22, 2026 |
| | ||
| *DAVID DITILLO DAVID DITILLO |
Director |
April 22, 2026 |
| | ||
| *LISA M. LONGINO LISA M. LONGINO |
Director |
April 22, 2026 |
| | ||
| *JONATHAN J. NOVAK JONATHAN J. NOVAK |
Director |
April 22, 2026 |
| | ||
| *BRYAN A. PINSKY BRYAN A. PINSKY |
Director |
April 22, 2026 |
| | ||
| *ERIC G. TARNOW ERIC G. TARNOW |
Director |
April 22, 2026 |
| | ||
| *EMILY W. GINGRICH EMILY W. GINGRICH |
Director |
April 22, 2026 |
| | ||
| *BY:/s/ TRINA SANDOVAL
TRINA SANDOVAL
Attorney-in-Fact
(Pursuant to Powers of
Attorneypreviously filed) |
Director |
April 22, 2026 |
FUND PARTICIPATION AGREEMENT
THIS AGREEMENT (the “Agreement”), made and entered into January 1, 2026 (the “Effective Date”) by and among American General Life Insurance Company, organized under the laws of the state of Texas (the “Company”), on behalf of itself and each separate account of the Company named in Schedule A to this Agreement, as may be amended from time to time (each account referred to as the “Account” and collectively as the “Accounts”); Seasons Series Trust, an open-end management investment company organized under the laws of the Commonwealth of Massachusetts under a Declaration of Trust dated October 11, 1995, as amended and restated to date (the “Fund”); and SunAmerica Asset Management, LLC, a limited liability company organized under the laws of Delaware and investment adviser to the Fund (the “Adviser”).
WHEREAS, the Fund engages in business as an open-end management investment company; and
WHEREAS, beneficial interests in the Fund are divided into several series of shares, each representing the interest in a particular managed portfolio of securities and other assets (the “Portfolios”) and such shares are issued to separate accounts of insurance companies to fund variable insurance products and certain qualified pension and retirement plans; and
WHEREAS, the Company, as depositor, has established the Accounts to serve as investment vehicles for certain variable annuity contracts and variable life insurance policies offered by the Company set forth on Schedule A (the “Contracts”); and
WHEREAS, the Accounts are duly organized, validly existing segregated asset accounts, established by resolutions of the Board of Directors of the Company under the insurance laws of the state of Texas, to set aside and invest assets attributable to the Contracts; and
WHEREAS, the Company intends to purchase shares of the Portfolios named in Schedule B, as such schedule may be amended from time to time (the “Designated Portfolios”) on behalf of the Accounts to fund the Contracts; and
WHEREAS, an order of the Securities and Exchange Commission (the “Commission” or “SEC”) dated November 5, 2014, (File No. 812-14226) grants certain separate accounts supporting variable life insurance policies, their life insurance company depositors, and their principal underwriters, exemptions from Sections 9(a), 13(a), 15(a) and 15(b) of the Investment Company Act of 1940 (the “1940 Act”), and from Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary for such separate accounts to purchase and hold Fund shares at the same time that such shares are sold to or held by separate accounts of affiliated and unaffiliated insurance companies supporting either variable annuity contracts or variable life insurance policies, or both, the investment adviser or sub-advisers to a Fund, any general account of an insurance company depositor of such separate accounts (representing seed money investments in the Fund), and/or by qualified pension and retirement plans (the “SEC Order”); and
WHEREAS, the Fund’s principal underwriter (“Distributor”) is a broker-dealer registered as such under the Securities Exchange Act of 1934 (“1934 Act”) and a member of the Financial Industry Regulatory Authority (“FINRA”).
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund and the Adviser hereby agree as follows:
ARTICLE I: SALE OF FUND SHARES
1.1 The Fund agrees to sell to the Company those shares of the Designated Portfolios which each Account orders (based on orders placed by Contract owners on that Business Day, as defined below), executing such orders on a daily basis at the net asset value (and with no sales charges) next computed after receipt by the Fund or its designee of the order for the shares of the Fund. For purposes of this Section 1.1, the Company will be the designee of the Fund for receipt of such orders from each Account and receipt by such designee will constitute receipt by the Fund; provided that the Fund receives notice of such order by 11:00 a.m. Eastern Time on the next following Business Day or such later time as permitted by Section 1.8 hereof. “Business Day” will mean any day on which the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the Securities and Exchange Commission.
1.2 The Fund agrees to redeem for cash, upon the Company’s request, any full or fractional shares of the Fund held by the Company (based on orders placed by Contract owners on that Business Day), executing such requests on a daily basis at the net asset value next computed after receipt and acceptance by the Fund or its agent of the request for redemption. For purposes of this Section 1.2, the Company will be the designee of the Fund for receipt of requests for redemption from each Account and receipt by such designee will constitute receipt by the Fund; provided the Fund receives notice of such requests for redemption by 11:00 a.m. Eastern Time on the next following Business Day or such later time as permitted by Section 1.8 hereof. After consulting with the Company, the Fund reserves the right to delay payment of redemption proceeds, but in no event may any such delay by the Fund in paying redemption proceeds cause Company or any Account to fail to meet its obligations under Section 22(e) of the 1940 Act.
1.3(a) Fund/SERV Transactions. If the parties choose to use the National Securities Clearing Corporation’s Mutual Fund Settlement, Entry and Registration Verification (“Fund/SERV”) or any other NSCC service, the following provisions shall apply:
The Company and the Fund or their respective designees will each be bound by the rules of the National Securities Clearing Corporation (“NSCC”) and the terms of any NSCC agreement filed by it or their respective designees with the NSCC. Without limiting the generality of the following provisions of this section, the Company and the Fund or its designee will each perform any and all duties, functions, procedures and responsibilities assigned to it and as otherwise established by the NSCC applicable to Fund/SERV, the Mutual Fund Profile Service, the Networking Matrix Level utilized and any other relevant NSCC service or system (collectively, the “NSCC Systems”).
Any information transmitted through the NSCC Systems by any party or its designee to the other or its designee and pursuant to this Agreement will be accurate, complete, and in the format prescribed by the NSCC. Each party or its designee will adopt, implement and maintain procedures reasonably designed to ensure the accuracy of all transmissions through the NSCC Systems and to limit the access to, and the inputting of data into, the NSCC Systems to persons specifically authorized by such party.
On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company in good form on each Business Day. The Company shall communicate to the Fund or its designee for that Business Day, by the NSCC, the net aggregate purchase or redemption orders (if any) for each Account received by the Closing Time on such Business Day in accordance with Section 1.1 (for net purchases) or Section 1.2 (for net redemptions), as applicable. All orders received by the Company after the Closing Time on a Business Day shall not be transmitted to the NSCC prior to the following Business Day. The
2
Company will wire payment for net purchase orders in immediately available funds, to an NSCC settling bank account designated by the Fund, in accordance with NSCC rules and procedures on the Business Day following the Business Day on which such purchase orders are communicated in proper form to the NSCC. The Fund will wire payment for net redemption orders in immediately available funds, to an NSCC settling bank account designated by the Company, in accordance with NSCC rules and procedures no later than on the Business Day following the Business Day on which such purchase orders are communicated in proper form to the NSCC.
(b) Manual Transactions. If the parties choose not to use Fund/SERV, if there are technical problems with Fund/SERV, or if the parties are not able to transmit or receive information through Fund/SERV, the following provisions shall apply:
On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company in good form on such Business Day. The Company will place separate orders to purchase or redeem shares of each Designated Portfolio. Each order shall describe the net amount of shares and dollar amount of each Designated Portfolio to be purchased or redeemed. In the event of net purchases, the Company shall pay for net purchase orders by wiring federal funds to Fund or its designated custodial account (by 2:00 pm EST) on the next Business Day after an order to purchase Designated Portfolio shares is made in accordance with the provisions of Section 1.1 hereof (or such later time as permitted by Section 1.8 hereof). Upon receipt by the Fund of the payment, such funds shall cease to be the responsibility of the Company and shall become the responsibility of the Fund. In the event of net redemptions, the Fund shall pay the net redemption proceeds by wiring federal funds to the Company or its designated custodial account (by 2:00 pm EST) on the next Business Day after an order to redeem a Designated Portfolio’s shares is made in accordance with the provision of Section 1.2 hereof. Upon receipt by the Company of the payment, such funds shall cease to be the responsibility of the Fund and shall become the responsibility of the Company.
1.4 The Fund agrees to make shares of the Designated Portfolios available continuously for purchase at the applicable net asset value per share by the Company on behalf of the Accounts on those days on which the Fund calculates its Designated Portfolio net asset value pursuant to rules of the Commission and the Fund shall calculate such net asset value on each day which the NYSE is open for regular trading; provided, however, that the Board of Directors of the Fund (the “Fund Board”) may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund Board, acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio.
1.5 The Company agrees to purchase and redeem the shares of the Designated Portfolios offered by the then current prospectus and statement of additional information of the Fund in accordance with the provisions of such prospectus and statement of additional information to the extent not inconsistent with the terms and conditions of this Agreement.
1.6 Issuance and transfer of the Fund’s shares will be by book entry only. Stock certificates will not be issued to the Company or to any Account. Purchase and redemption orders for Fund shares will be recorded in an appropriate title for each Account or the appropriate sub-account of each Account.
1.7 The Fund will furnish same day notice to the Company of the declaration of any income, dividends or capital gain distributions payable on each Designated Portfolio’s shares. The Company hereby elects to receive all such dividends and distributions as are payable on the Portfolio shares in the form of additional
3
shares of that Portfolio at the ex-dividend date net asset values. The Company reserves the right to revoke this election and to receive all such dividends and distributions in cash. The Fund will notify the Company of the number of shares so issued as payment of such income, dividends and distributions.
1.8 The Fund will make the net asset value per share for each Designated Portfolio available to the Company via electronic means on each Business Day as soon as reasonably practical after the net asset value per share is calculated and will use its best efforts to make such net asset value per share available by 7:00 p.m., Eastern Time, each Business Day. In the event that the Fund is unable to meet the 7:00 p.m. time stated herein, it shall provide additional time for the Company to place orders for the purchase and redemption of Fund shares and wire net payments for the purchase of Fund shares. Such additional time shall be equal to the additional time which the Fund takes to make the net asset value available to the Company. If the Fund provides the Company materially incorrect net asset value per share information (as determined under SEC guidelines), the Fund shall make an adjustment to the number of shares purchased or redeemed for the Accounts to reflect the correct net asset value per share, and the Adviser shall bear the cost of correcting such errors and shall reimburse the Company for any expenses incurred related to correction of the net asset value (including correcting Contract owner accounts). Any material error in the calculation or reporting of net asset value per share, dividend or capital gain information shall be reported to the Company upon discovery by the Fund. Upon timely notification of any overpayment by the Fund to a Contract owner due to a materially incorrect net asset value calculation (as determined by SEC guidelines), the Company shall reasonably cooperate with the Fund and Adviser to remit back to the Fund any such overpayment that has not been paid or credited to the Contract owner, subject to the Adviser’s obligation to reimburse the Company for any reasonable costs and expenses associated with such correction.
ARTICLE II: REPRESENTATIONS AND WARRANTIES
2.1 The Company represents and warrants that interests under the Contracts are or will be registered under the Securities Act of 1933 (the “1933 Act”), or are exempt from registration thereunder, and that the Contracts will be issued and sold and distributed in compliance with all applicable federal and state laws. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Account as a separate account under applicable law and that each Account is or will be registered as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts, or is exempt from registration thereunder, and that it will maintain such registration for so long as any Contracts are outstanding, as applicable. The Company will amend the registration statement under the 1933 Act for the Contracts and the registration statement under the 1940 Act for the Account from time to time as required in order to effect the continuous offering of the Contracts or as may otherwise be required by applicable law. The Company will register and qualify the Contracts for sale in accordance with the securities laws of the various states only if and to the extent deemed necessary by the Company.
2.2 Subject to compliance by each Designated Portfolio with the requirements of Subchapter M and Section 817(h) of the Internal Revenue Code of 1986, as amended (“Code”), the regulations thereunder, or any successor provision, the Company represents and warrants that the Contracts are currently and at the time of issuance will be treated as life insurance, or annuity contracts under applicable provisions of the Code, that it will maintain such treatment and that it will notify the Fund immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
2.3 The Company is, and shall carry out its activities under this Agreement, in compliance with all applicable anti-money laundering laws, rules and regulations including, but not limited to, the U.S.A. PATRIOT Act of 2001, P.L. 107-56. The Company further represents that it has policies and procedures in place reasonably designed to detect money laundering and terrorist financing, including the reporting of
4
suspicious activity.
2.4 The Fund and Adviser each represents and warrants that shares of the Designated Portfolio(s) sold pursuant to this Agreement will be registered under the 1933 Act and duly authorized for issuance in accordance with applicable law and that the Fund is and will remain registered as an open-end management investment company under the 1940 Act for as long as such shares of the Designated Portfolio(s) are sold. The Fund will amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. The Fund will register and qualify the shares of the Designated Portfolio(s) for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Fund.
2.5 The Fund currently intends for one or more classes of shares of the Portfolios (each, a “Class”) to make payments pursuant to a plan (“Plan”) adopted pursuant to Rule 12b-1 under the 1940 Act, although it may determine to discontinue such practice in the future. To the extent that any Class of the Fund finances its distribution expenses pursuant to a Plan adopted under Rule 12b-1, the Fund undertakes to comply, in all material respects, with any then current SEC interpretations concerning Rule 12b-1 or any successor provisions.
2.6 The Fund and Adviser represent and warrant that the Fund is lawfully organized and validly existing under the laws of the State of Massachusetts and that the Fund does and will comply in all material respects with applicable provisions of the 1940 Act and any applicable regulations thereunder. The Fund and Adviser represent and warrant that the Fund’s operations, and that of each Designated Portfolio, does and will comply with applicable federal and state law.
2.7 The Fund and Adviser represent and warrant that all of the Fund’s directors, officers, employees, investment advisers, and other individuals/entities having access to the funds and/or securities of the Fund are and continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage as required currently by Rule 17g-(1) of the 1940 Act or related provisions as may be promulgated from time to time. The aforesaid bond includes coverage for larceny and embezzlement and is issued by a reputable bonding company.
2.8 The Fund is, and shall carry out its activities under this Agreement, in compliance with all applicable anti-money laundering laws, rules and regulations including, but not limited to, the U.S.A. PATRIOT Act of 2001, P.L. 107-56. The Fund further represents that it has policies and procedures in place reasonably designed to detect money laundering and terrorist financing, including the reporting of suspicious activity.
2.9 The Adviser represents and warrants that it is lawfully organized and validly existing under the laws of its state of organization; it is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and will remain duly registered under all applicable federal and state securities laws; and that it will perform its obligations for the Fund in accordance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
2.10 The Fund represents and warrants that the Distributor is lawfully organized and validly existing under the laws of its state of organization; it is registered as a broker-dealer under the Securities Exchange Act of 1934, as amended (the “1934 Act”) and will remain duly registered under all applicable federal and state securities laws, and is a member in good standing of the Financial Industry Regulatory Authority (“FINRA”) and serves as principal underwriter of the Fund and that it will perform its obligations for the Fund in accordance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
5
ARTICLE III: FUND COMPLIANCE
3.1 The Fund and Adviser represent and warrant that each Designated Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that they will maintain such qualification (under Subchapter M or any successor or similar provision), and that they will notify the Company immediately upon having a reasonable basis for believing that it has ceased to so qualify or that it might not so qualify in the future.
3.2 The Fund and the Adviser acknowledge that the Fund has obtained the SEC Order granting exemptions from various provisions of the 1940 Act and the rules thereunder to separate accounts supporting variable life insurance policies to the extent necessary to permit them to hold Fund shares when Fund shares also are sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated insurance companies supporting either variable annuity contracts or variable life insurance policies, or both, investment adviser or sub-advisers, or by qualified pension and retirement plans.
3.3 The Fund and Adviser acknowledge that currently or in the future, the Fund’s shares may become available for investment by separate accounts for other insurance companies, which may or may not be affiliated persons (as that term is defined in the 1940 Act) of the Company (collectively with the Company, “Participating Insurers”). In such event, (a) the Fund shall undertake that its Board of Trustees (“Board”) will monitor the Fund for existence of material irreconcilable conflicts that may arise between the contract owners of Participating Insurers, for the purpose of identify and remedying any such conflict and (b) Sections 3.4, 3.5, and 3.6 shall apply. In discharging its responsibilities under Sections 3.4, 3.5, and 3.6 hereinafter, the Company will cooperate and coordinate, to the extent necessary, with the Board and with other Participating Insurers. The Fund agrees that it will require, as a condition to participation, that all Participating Insurers shall have obligations and responsibilities regarding conflicts of interest corresponding to those that are agreed to herein by the Company pursuant to Sections 3.4, 3.5, 3.6 and this Section 3.3.
3.4 Upon request by the Fund’s Board, the Company will report any potential or existing conflicts of which it is or becomes aware between any of its Contract owners or between any of its Contract owners and contract owners of other Participating Insurers. The Company will be responsible for assisting the Fund’s Board in carrying out its responsibilities to identify material conflicts by providing the Board with all information available to it that is reasonably necessary for the Board to consider any issues raised, including information as to a decision by the Company to disregard voting instructions of its Contract owners.
3.5 The Board’s determination of the existence of an irreconcilable material conflict and its implications shall be made known promptly by it to the Company and other Participating Insurers. An irreconcilable material conflict may arise of a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance tax, or securities laws or regulations, or a public ruling, private letter ruling, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract owners and variable life insurance contract owners or by contract owners of different Participating Insurers; or (f) a decision by a Participating Insurer to disregard the voting instructions of variable contract owners.
3.6 If it is determined by a majority of the Board or a majority of its disinterested Trustees that a material irreconcilable conflict exists that affects the interests of the Company Contract owners, the Company shall, in cooperation with other Participating Insurers whose contract owners’ interests are also affected by the conflict, take whatever steps are necessary to remedy or eliminate the irreconcilable material-conflict, which
6
steps could include: (a) withdrawing the assets allocable to the separate accounts named in Schedule A from the Fund or any portfolio and reinvesting such assets in a different investment medium, including another Portfolio of the Fund, or submitting the question of whether such segregation should be implemented to a vote of all affected Contract owners and, as appropriate, segregating the assets of any particular group (e.g., annuity contract owners or life insurance contract owners) that votes in favor of such segregation, or offering to the affected contract owners of the option of making such a change; and (b) establishing a new registered management investment company or managed separate account. The Company shall take such steps at its expense if the conflict affects solely the interests of the owners of the Company Contracts, but shall bear only its equitable portion of any such expense if the conflict also affects the interest of the contract owners of one or more Participating Insurers other than the Company, provided, that this sentence shall not be construed to require the Fund to bear any portion of such expense. If a material irreconcilable conflict arises because of the Company’s decision to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at Fund’s election, to withdraw the separate accounts named in Schedule A invested in the Fund, and no charge or penalty will be imposed against the separate accounts named in Schedule A as a result of such a withdrawal. The Company agrees to take such remedial action as may be required under this Section 3.6 with a view only to the interests of its Contract owners. For purposes of this Section 3.6, a majority of the disinterested members of the Board shall determine whether or not any proposed action adequately remedies any irreconcilable conflict, but in no event will Fund be required to establish a new funding medium for any variable contracts. The Company shall not be required by this Section 3.6 to establish a new funding medium for any variable contract if an offer to do so has been declined by vote of a majority of affected contract owners.
3.7 The Trust and Adviser represent and warrant that each Designated Portfolio is currently, or, if newly organized, will be, qualified as a regulated investment company under Subchapter M of the Code, and that each Designated Portfolio will maintain such qualification (under Subchapter M or any successor or similar provision) and that no other Participating Insurance Companies will purchase shares in any Designated Portfolio for any purpose or under any circumstances that would preclude the Company from “looking through” to the investments of each Designated Portfolio in which it invests, pursuant to the “look through” rules found in Treasury Regulation Section 1.817-5. The Trust, its designee, or the Adviser will notify the Company immediately upon having a reasonable basis for believing that any Designated Portfolio has ceased to so qualify, or that any might not so qualify in the future, within the grace periods afforded by the Code or regulations (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting the Code or the regulations).
The Trust and Adviser represent and warrant that for each quarter each Designated Portfolio does and will at all times invest money from the Contracts in such a manner as to ensure that the Contracts will be treated as variable contracts under the Code and the regulations issued thereunder; including, but not limited to, that the Trust will at all times comply with the diversification requirements of Section 817(h) of the Code and any regulations thereunder applicable to variable contracts as defined in Section 817(d) of the Code and any amendments or other modifications or successor provisions to such Sections or regulations (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting those Sections or regulations), as if those requirements applied directly to each such Portfolio. The Trust will notify the Company immediately upon having a reasonable basis for believing that the Trust or a Portfolio thereunder has ceased to comply with the diversification requirements or that the Trust or Portfolio might not comply with the diversification requirements in the future. In the event of a breach of this representation and warranty the Trust will take all reasonable steps to adequately diversify the Trust so as to achieve compliance within the grace period afforded by Treasury Regulation Section 1.817-5.
3.8 The Fund and Adviser represent and warrant that the Fund is and shall maintain compliance with Rule
7
38a-1 under the 1940 Act and Adviser represents and warrants that the Adviser is and shall maintain compliance with Rule 206(4)-7 under the Advisers Act.
ARTICLE IV: PROSPECTUS AND PROXY STATEMENTS/VOTING
4.1 At least annually (or in the case of a prospectus supplement, when that supplement is issued), the Fund will timely provide the Company with as many copies of the current Fund prospectus and statement of additional information (describing only the Designated Portfolio(s)) and any supplements thereto as the Company may reasonably request for distribution, at the Fund’s expense, to Contract owners at the time of Contract fulfillment and confirmation. To the extent that the Designated Portfolio(s) are one or more of several Portfolios of the Fund, the Fund shall bear the cost of providing the Company only with disclosure related to the Designated Portfolio(s).
4.2 The Fund on behalf of one or more Designated Portfolios will provide the Company upon its request with copies of summary prospectuses and supplements thereto in the same manner and at the same time that the Fund provides the Company with statutory prospectuses. The Fund represents and warrants that the summary prospectuses and any supplements provided thereto will comply with the requirements of Rule 498 applicable to its Designated Portfolios.
4.3 The Company represents and warrants that its use of the summary prospectuses and supplements, its website and the manner and procedures related to its hosting of the summary prospectuses and supplements on its website will at all times comply with the requirements of Rule 498. The Fund, at its sole cost and expense, shall provide the Company with summary prospectuses containing the appropriate hyperlinks required by Rule 498 and such other documentation that may be required by Rule 498.
4.4 The Fund may require the Company to terminate the use of the summary prospectuses by providing the Company with at least one hundred and thirty-five (135) days’ prior written notice. The Fund agrees that the Company is not required to distribute the summary prospectuses to its Contract owners and that any use will be in the discretion of the Company. The Company shall provide the Fund with at least thirty (30) days’ prior written notice of its intended use of the summary prospectuses and at least sixty (60) days’ prior written notice of its intent to terminate use of the summary prospectuses.
4.5 The Fund shall be responsible for preparing, hosting on its website, and providing to the Company upon request, the materials required by Rule 30e-1 (“Rule 30e-1”) under the 1940 Act and Item 27A(i) of Form N-1A (collectively, the “Required Materials”) which may include, among other things:
| (a) | Current Annual and Semi-Annual Reports to Shareholders (i.e., Tailored Shareholder Reports); |
| (b) | Current Annual and Semi-Annual Financial Statements; and |
| (c) | Portfolio Holdings for Most Recent First and Third Fiscal Quarters. |
4.6 The Fund shall host and maintain the website specified in paragraph (b)(2)(i) of Rule 30e-1, so that the relevant Required Materials are publicly accessible, free of charge, at that website, in accordance with the conditions set forth in that paragraph.
4.7 The Fund shall be responsible for the content and substance of the Required Materials as provided to the Company, including, but not limited to, the accuracy and completeness of the Required Materials. Without limiting the generality of the foregoing in any manner, the Fund shall be responsible for ensuring that the Required Materials as provided to the Company:
8
| (a) | Meet the applicable standards of the 1933 Act, the 1934 Act, the 1940 Act, and all rules and regulations under those Acts; and |
| (b) | Do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. |
4.8 The Fund, or its designee, shall, at its expense, as the Company may reasonably request from time to time, provide the Company with sufficient paper copies of the then current Required Materials, so that the Company may maintain a supply of such current paper documents sufficient in its reasonable judgment to meet anticipated requests from Contract owners pursuant to Rule 30e-1. Such Company requests shall be fulfilled reasonably promptly, but in no event more than seven (7) business days after the request from the Company is received by the Fund.
4.9 Alternatively, if requested by the Company in lieu thereof, the Fund or its designee shall provide such electronic or other documentation (including “camera ready” copies of the current Required Materials as set in type), and such other assistance as is reasonably necessary to have the then current Required Materials printed for distribution (pursuant to requests from Contract owners; see paragraph (b)(3) of Rule 30e-1, as applicable); the reasonable costs of providing the electronic documentation and of such printing to be borne by the Fund.
4.10 The Fund shall be responsible for preparing and providing the following “Fund Documents,” as specified in paragraph (j)(1)(iii) of Rule 498A:
| (a) | Summary Prospectus for the Designated Portfolios; |
| (b) | Statutory Prospectus for the Designated Portfolios; |
| (c) | Statement of Additional Information (“SAI”) for the Designated Portfolios; and |
| (d) | Most Recent Annual and Semi-Annual Reports to Shareholders (under Rule 30e-1 under the 1940 Act) for the Designated Portfolios. |
4.11 The Fund shall provide the Fund Documents specified in Sections 4.10(a), (b), and (c) above to the Company (or its designee) on a timely basis (to facilitate the required website posting) and provide updated versions as necessary, to facilitate a continuous offering of the Fund’s securities and the Contracts. The Fund shall provide the Shareholder Reports specified in Section 4.10(d) above within 60 days after the close of each of the Fund’s reporting periods (in accordance with Rule 30e-1 under the 1940 Act).
4.12 The Fund shall provide the Fund Documents to the Company (or its designee) in an electronic format that is suitable for website posting, and in a format, or formats, that:
| (a) | are both human-readable and capable of being printed on paper in human-readable format (in accordance with paragraph (h)(2)(i) of Rule 498A); |
| (b) | permit persons accessing the Statutory Prospectus and SAI to move directly back and forth between each section heading in a table of contents of such document and the section of the document referenced in that section heading (that is, these documents must include linking, in accordance with paragraph (h)(2)(ii) of Rule 498A); and |
9
| (c) | permit persons accessing the Fund Documents to permanently retain, free of charge, an electronic version of such materials that meet the requirements of subsections (a) and (b) above (in accordance with paragraph (h)(3) of Rule 498A). |
4.13 The Company shall host and maintain the website specified in paragraph (j)(1)(iii) of Rule 498A, so that the Fund Documents are publicly accessible, free of charge, at that website, in accordance with the conditions set forth in that paragraph, provided that the Fund fulfills its obligations under this Agreement. The Fund shall pay the Company a reasonable fee as compensation for the Company hosting the website specified in (j)(1)(iii) of Rule 498A. As of the Effective Date, the Fund and/or the Advisor shall pay the Company quarterly 50% of the Company’s hosting fees paid under the Company’s website hosting service provider agreement to host the website specified in paragraph (j)(1)(iii) of Rule 498A.
Within six (6) months from the Effective Date, the Company and the Adviser shall collaborate in good faith to determine whether an alternative solution to the website specified in paragraph (j)(1)(iii) of Rule 498A is feasible. If the parties mutually agree that an alternative solution is feasible and cost effective, they shall: (i) equally share the costs of implementation; (ii) equally share any cost savings resulting from such implementation; and (iii) negotiate in good faith appropriate terms regarding the Company’s customer experience standards and indemnification requirements.
4.14 The Company shall ensure that an Initial Summary Prospectus is used for each currently offered Contract described under the related registration statement, in accordance with paragraph (j)(1)(i) of Rule 498A. The Fund shall ensure that a summary prospectus is used for the Designated Portfolios, in accordance with paragraph (j)(1)(ii) of Rule 498A.
4.15 The Fund shall be responsible for the content and substance of the Fund Documents as provided to the Company, including, but not limited to, the accuracy and completeness of the Fund Documents. Without limiting the generality of the foregoing in any manner, the Fund shall be responsible for ensuring that the Fund Documents as provided to the Company:
| (a) | Meet the applicable standards of the 1933 Act, the 1934 Act, the 1940 Act, and all rules and regulations under those Acts; and |
| (b) | Do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. |
4.16 The Fund shall, at its expense, as the Company may reasonably request from time to time, provide the Company with sufficient paper copies of the then current Fund Documents, so that the Company may maintain a supply of such current paper documents sufficient in its reasonable judgment to meet anticipated requests from existing Contract owners (see paragraphs (i)(1) and (j)(3) of Rule 498A). Such Company requests shall be fulfilled reasonably promptly, but in no event more than three (3) business days after the request from the Company is received by the Fund.
| (a) | Alternatively, if requested by the Company in lieu thereof, the Fund or its designee shall provide such electronic or other documentation (including “camera ready” copies of the current Fund Documents as set in type), and such other assistance as is reasonably necessary to have the then current Fund Documents printed for distribution; the reasonable costs of providing the electronic documentation and of such printing and mailing to be borne by the Fund with respect to existing Contract owners only. |
10
| (b) | The Fund shall reimburse the Company for the reasonable costs of printing and mailing the Fund Documents to existing Contract owners. |
The Company shall bear any costs associated with the printing and mailing of Fund Documents to prospective Contract owners.
4.17 The Fund shall provide such data regarding each Designated Portfolio’s expense ratios and investment performance as the Company shall reasonably request, to facilitate the registration and sale of the Contracts. Without limiting the generality of the foregoing, the Fund shall provide the following Fund expense and performance data on a timely basis to facilitate the Company’s preparation of its annually updated registration statements for the Contracts (and as otherwise reasonably requested by the Company), but in no event later than eighty (80) calendar days after the close of each Designated Portfolio’s fiscal year:
| (a) | the gross “Annual Fund Company Expenses” for each Designated Portfolio calculated in accordance with Item 3 of Form N-1A, before any expense reimbursements or fee waiver arrangements; and |
| (b) | the net “Annual Fund Company Expenses” (aka “Total Annual Fund Operating Expenses”) for each Designated Portfolio calculated in accordance with Item 3 of Form N-1A, that include any expense reimbursements or fee waiver arrangements, and the period for which the expense reimbursements or fee waiver arrangement is expected to continue and whether it can be terminated by the Fund; and |
| (c) | the “Average Annual Total Returns” for each Designated Portfolio (before taxes) as calculated pursuant to Item 4(b)(2)(iii) of Form N-1A (for the 1, 5, and 10-year periods). |
4.18 The Fund, at its expense, will provide the Company or its mailing agent with copies of its proxy material, if any, reports to shareholders/Contract owners and other permissible communications to shareholders/Contract owners in such quantity as the Company will reasonably require. The Company will distribute this proxy material, reports and other communications to existing Contract owners, and will bill the Fund for the reasonable cost of such distribution.
4.19 If and to the extent required by law, the Company will:
(a) solicit voting instructions from Contract owners;
(b) vote the shares of the Designated Portfolios held in the Account in accordance with instructions received from Contract owners; and
(c) vote shares of the Designated Portfolios held in the Account for which no timely instructions have been received, in the same proportion as shares of such Designated Portfolio for which instructions have been received from the Company’s Contract owners,
so long as and to the extent that the Commission continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. The Company reserves the right to vote Fund shares held in any segregated asset account in its own right, to the extent permitted by law. The Company will be responsible for assuring that the Accounts participating in the Fund calculates voting privileges in a manner consistent with all legal requirements.
11
4.20 The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular, the Fund either will provide for annual meetings (except insofar as the Commission may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, to comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of the 1940 Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the Commission’s interpretation of the requirements of Section 16(a) with respect to periodic elections of directors and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE V: SALES MATERIAL AND INFORMATION
5.1 The Company will furnish, or will cause to be furnished, to the Fund or the Adviser, each piece of sales literature or other promotional material in which the Fund or the Adviser is named, at least ten (10) Business Days prior to its use. No such material will be used if the Fund or the Adviser reasonably objects to such use within five (5) Business Days after receipt of such material.
5.2 The Company will not give any information or make any representations or statements on behalf of the Fund, Adviser, or Distributor, or concerning the Fund, Adviser, or Distributor, in connection with the sale of the Contracts other than the information or representations contained in the registration statement, prospectus or SAI for Fund shares, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Fund, or in published reports for the Fund which are in the public domain or approved by the Fund or the Adviser or their designees for distribution, or in sales literature or other material provided by the Fund or by the Adviser, except with permission of the Fund or the Adviser or their designees. The Fund and the Adviser agree to respond to any request for approval on a prompt and timely basis.
5.3 The Fund or the Adviser will furnish, or will cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company or its separate account is named, at least ten (10) Business Days prior to its use. No such material will be used if the Company or its designee reasonably objects to such use within five (5) Business Days after receipt of such material.
5.4 The Fund and the Adviser will not give any information or make any representations or statements on behalf of the Company or concerning the Company, each Account, or the Contracts other than the information or representations contained in a registration statement, prospectus or SAI for the Contracts, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in published reports for each Account or the Contracts which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other material provided by the Company, except with written permission of the Company. The Company agrees to respond to any request for approval on a prompt and timely basis.
5.5 The Fund will provide to the Company at least one complete copy of all registration statements, prospectuses, SAIs, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Fund or its shares, within a reasonable time after filing of each such document with the Commission or FINRA.
5.6 The Company will provide to the Fund at least one complete copy of all definitive prospectuses, definitive SAI, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no action letters, and all amendments to any of the above, that relate to the Contracts or each Account, within a reasonable time after filing of each such document with the
12
Commission or FINRA (except that with respect to post-effective amendments to such prospectuses and SAIs and sales literature and promotional material, only those prospectuses and SAIs and sales literature and promotional material that relate to or refer to the Fund will be provided.) In addition, the Company will provide to the Fund at least one complete copy of (i) a registration statement that relates to the Contracts or each Account, containing representative and relevant disclosure concerning the Fund; and (ii) any post-effective amendments to any registration statements relating to the Contracts or such Account that refer to or relate to the Fund.
5.7 The Fund and Adviser will provide the Company with as much notice as is reasonably practicable of any proxy solicitation for any Designated Portfolio, and of any material change in the Fund’s registration statement, particularly any material change resulting in a material change to the registration statement or prospectus or statement of additional information for any Account. The Fund and Adviser will cooperate with the Company so as to enable the Company to solicit proxies from Contract owners or to make changes to its prospectus, statement of additional information or registration statement, in an orderly manner. The Fund and Adviser will make reasonable efforts to attempt to have changes affecting Contract prospectuses become effective simultaneously with the annual updates for such prospectuses.
5.8 For purposes of this Article V, the phrase “sales literature or other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media, (i.e., on-line networks such as the Internet or other electronic messages)), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, registration statements, prospectuses, SAIs, shareholder reports, and proxy materials and any other material constituting sales literature or advertising under FINRA rules, the 1933 Act or the 1940 Act.
5.9 The Fund, the Adviser and the Company agree to adopt and implement procedures reasonably designed to ensure that information concerning the Company, the Fund, the Adviser or the Distributor, respectively, and their respective affiliated companies, that is intended for use only by brokers or agents selling the Contracts is properly marked as “Not For Use With The Public” and that such information is only so used.
ARTICLES VI: FEES, COSTS AND EXPENSES
6.1 The Fund will pay no fee or other compensation to the Company under this Agreement, except as provided below: (a) if the Fund or any Designated Portfolio adopts and implements a plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution and shareholder servicing expenses, then, subject to obtaining any required exemptive orders or other regulatory approvals, the Fund may make payments to the Company or to the underwriter for the Contracts if and in such amounts agreed to by the Fund in writing; (b) the Fund may pay fees to the Company for administrative services provided to Contract owners that are not primarily intended to result in the sale of shares of the Designated Portfolio or of underlying Contracts as separately agreed to in writing.
6.2 The Fund shall bear its expenses relating to the Fund’s performance of its obligations under this Agreement to the extent permitted by law, except as expressly provided otherwise herein. The Company shall bear its expenses relating to the performance of the Company’s obligations under this Agreement to the extent permitted by law, except as expressly provided otherwise herein. All shares of the Designated Portfolios will be duly authorized for issuance and registered in accordance with applicable federal law and, to the extent deemed advisable by the Fund, in accordance with applicable state law, prior to sale.
13
ARTICLE VII: RULE 22c-2 AGREEMENT
7.1 Definitions. As used in this section of the Agreement relating to Rule 22c-2 under the 1940 Act (the “Rule”), the following terms shall have the following meanings, unless a different meaning is clearly required by the contexts:
| (a) | The term “Fund” does not include any “excepted funds” as defined in the Rule, which includes any: (i) money market fund; (ii) fund that issues securities that are listed on a national exchange; or (iii) fund that affirmatively permits short-term trading of its securities, if its prospectus clearly and prominently discloses that the fund permits short-term trading of its securities and that such trading may result in additional costs for the fund. The term “Fund” shall also include the Fund’s designee (i.e., principal underwriter or transfer agent). |
| (b) | The term “Fund Policies” means policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Designated Portfolio resulting from short-term trading, as described in the applicable Designated Portfolio’s current prospectus. |
| (c) | The term “Shares” means the interests of Shareholders corresponding to the redeemable securities of record issued by a Designated Portfolio under the 1940 Act that are held through Accounts established by the Company. |
| (d) | The term “Shareholders” shall mean those contract or policy owners of the Company that hold an interest in a Designated Portfolio, directly or indirectly through Contracts issued by the Company on behalf of the Accounts. |
| (e) | The term “Shareholder-Initiated Transfer Purchase” means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Designated Portfolio, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Designated Portfolio as a result of “dollar cost averaging” programs, asset allocation programs or any other automatic rebalancing programs; (ii) required transactions pursuant to a Contract living or death benefit; (iii) one-time step-up in Contract value pursuant to a Contract death or living benefit; (iv) transactions that are executed as a result of allocation of assets to a Designated Portfolio through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; or (v) pre-arranged transfers at the conclusion of a required free look period. |
| (f) | The term “Shareholder-Initiated Transfer Redemption” means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract out of a Designated Portfolio, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Designated Portfolio as a result of annuity payouts, loans, systematic withdrawal programs, asset allocation programs and automatic rebalancing programs; (ii) transactions that are executed as a result of any deduction of charges or fees under a Contract; (iii) transactions within a Contract out of a Designated Portfolio as a result of scheduled withdrawals or surrenders from a Contract; (iv) transactions |
14
| that are executed as a result of payment of a death benefit from a Contract; or (v) transactions that are executed as a result of minimum distributions required by applicable federal tax law. |
| (g) | The term “written” includes electronic and facsimile writings and transmissions and such other means as the Parties may agree from time-to-time. |
7.2. Agreement to Provide Information. Company agrees to provide the Fund the taxpayer identification number (“TIN”), the Individual/International Taxpayer Identification Number (“ITIN”) or other government-issued identifier, (or an equivalent identifying number), of any or all Shareholder(s) of the Account, and the amount, date and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an Account maintained by the Company (“Transaction Information”). It is understood that Company intends to provide the Transaction Information regarding each Designated Portfolio daily, but the Fund may, from time to time, make a written request (“Request”) regarding a specific Designated Portfolio or for a specific period in accordance with this Agreement.
Unless otherwise specifically requested by the Fund, Company shall only be required to provide information relating to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions.
7.3 Period Covered by Request. Any Request must set forth a specific period for which the Transaction Information is being sought (the “Covered Period”), but the Covered Period shall not include any day that is earlier than 90 days prior to the day Company received the Request. The Fund may request Transaction Information older than 90 days from the date of the Request as it deems necessary to investigate compliance with Fund Policies.
7.4 Form and Timing of Response/Indirect Intermediaries. Requests must be in “Good Form.” Good Form means the Request (i) is made using the “Request for Information” form attached as Exhibit A, (ii) includes all the information required by the form, except as noted therein; (iii) is signed by a duly authorized officer of the Fund; and (iv) is received by Company.
Company agrees to transmit the Transaction Information on its books and records to the Fund promptly, but in any event not later than five (5) business days, or as otherwise agreed to by the Parties, after receipt of a Request. The format for the Transaction Information provided to the Fund (either daily or as part of a Request) shall be via file transfer protocol (FTP) formal or other agreed upon method.
If requested by the Fund in writing, Company agrees to use best efforts to determine whether any specific Shareholder about whom it has Transaction Information is itself a financial intermediary (“Indirect Intermediary”) and, upon further request by the Fund, to promptly either (i) provide (or arrange to have provided) the Transaction Information for those Shareholders who hold an account with an Indirect Intermediary, or (ii) restrict or prohibit the Indirect Intermediary from purchasing, in nominee name on behalf of others, Shares of the Designated Portfolio. Company additionally agrees to inform the Fund whether it plans to perform (i) or (ii).
7.5 Limitations on Use of Information. The Fund agrees not to use the information received pursuant to this Agreement for any purpose other than as necessary to comply with the provisions of the Rule without prior written consent of Company, or for any purpose not permitted under the privacy provisions of Title V of the Gramm-Leach-Bliley Act (Public Law 106-102) and comparable state laws.
7.6 Agreement to Restrict Trading. Company agrees to execute written instructions from the Fund to restrict or prohibit further purchases or exchanges of Shares by a Shareholder that has been identified by the
15
Fund as having engaged in transactions of the Fund’s Shares (directly or indirectly through the Company’s Account) that violate Fund Policies.
Any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions as set forth in Section 7.2. Company will execute such instructions with respect to the Shareholder, but only for the Contract through which such transactions in the Designated Portfolio’s Shares occurred in violation of the Fund’s Policies.
7.7 Form of Instructions. Instructions to restrict trading must be in “Good Form.” Good Form means that the instructions (i) are made using the “Instructions to Restrict Trading” form attached at Exhibit B; (ii) include all the information required by the form; (iii) are signed by a duly authorized officer of the Fund; and (iv) are received by Company. Upon request of the Company, the Fund agrees to provide to the Company, along with the Instructions to Restrict Trading form, information regarding those trades of the Contract holder that violated the Fund’s Policies.
7.8 Timing of Response. Company agrees to execute instructions as soon as reasonably practicable, but not later than five (5) business days, or as otherwise agreed to by the Parties, after receipt of the instructions by the Company.
7.9 Confirmation by Company. Company will provide written confirmation regarding any instructions executed on behalf of the Fund pursuant to this Agreement. The confirmation will be provided via FTP format as soon as reasonably practicable, but not later than ten (10) business days, or as otherwise agreed to by the Parties, after the instructions have been executed.
ARTICLE VIII: INDEMNIFICATION
8.1 INDEMNIFICATION BY THE COMPANY
(a) The Company agrees to indemnify and hold harmless the Fund and the Adviser, and each person, if any, who controls the Fund or the Adviser within the meaning of such terms under the federal securities laws and any director, trustee, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.1) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or actions in respect thereof (including reasonable legal and other expenses), to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale, acquisition, or holding of the Fund shares or the Contracts and:
(1) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement, prospectus or SAI for the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Fund or the Adviser for use in the registration statement, prospectus or SAI for the Contracts or in the Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
16
(2) arise out of or as a result of statements or representations by or on behalf of the Company (other than statements or representations contained in the Fund registration statement, prospectus, SAI or sales literature or other promotional material of the Fund, or any amendment or supplement to the foregoing, not supplied by the Company or its designee) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of untrue statement or alleged untrue statement of a material fact contained in the Fund registration statement, prospectus, SAI or sales literature or other promotional material of the Fund (or amendment or supplement) or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make such statements not misleading in light of the circumstances in which they were made, if such a statement or omission was made in reliance upon and in conformity with information furnished to the Fund by or on behalf of the Company or its designee; or
(4) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to meet the qualifications specified in Section 2.2 of this Agreement); or
(5) arise out of any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach by the Company of this Agreement;
except to the extent provided in Sections 8.1(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Company otherwise may have.
(b) No party will be entitled to indemnification under Section 8.1(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard of its obligations or duties under this Agreement.
(c) The Indemnified Parties promptly will notify the Company of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Fund shares or the Contracts or the operation of the Fund.
8.2 INDEMNIFICATION BY THE ADVISER
(a) The Adviser agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of such terms under the federal securities laws and any director, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or actions in respect thereof (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale, acquisition, or holding of the Fund shares or the Contracts and:
(1) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or SAI for the Fund or sales literature or other promotional material of the Fund (or any amendment or supplement to any of the foregoing), or arise
17
out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Adviser or Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature of the Fund (or any amendment or supplement thereto) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(2) arise out of or as a result of statements or representations (other than statements or representations contained in the Contracts or in the Contract or Fund registration statements, prospectuses or statements of additional information or sales literature or other promotional material for the Contracts, or any amendment or supplement to the foregoing, not supplied by the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively) or wrongful conduct of the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI or sales literature or other promotional material covering the Contracts (or any amendment or supplement thereto), or the omission or alleged omission to state therein a material fact required to be stated or necessary to make such statement or statements not misleading in light of the circumstances in which they were made, if such statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Adviser or the Fund or persons under the control of the Adviser or the Fund; or
(4) arise as a result of any failure by the Adviser or Fund to provide the services and furnish the materials under the terms of this Agreement; or
(5) arise out of or result from any material breach of any representation and/or warranty made by the Adviser or the Fund in this Agreement, or arise out of or result from any other material breach of this Agreement by the Adviser or the Fund;
except to the extent provided in Sections 8.2(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Adviser otherwise may have.
(b) No party will be entitled to indemnification under Section 8.2(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard or its obligations or duties under this Agreement.
(c) The Indemnified Parties will promptly notify the Adviser and the Fund of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Contracts or the operation of the Account.
8.3 INDEMNIFICATION BY THE FUND
(a) The Fund agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of such terms under the federal securities laws and any director, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.3) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with
18
the written consent of the Fund) or action in respect thereof (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements, are related to the sale, acquisition, or holding of the Fund shares or the Contracts, or operations of the Fund and:
(1) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or SAI for the Fund or sales literature or other promotional material of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission of such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Adviser or Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature of the Fund (or any amendment or supplement thereto) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(2) arise out of or as a result of statements or representations (other than statements or representations contained in the Contracts or in the Contract or Fund registration statements, prospectuses or statements of additional information or sales literature or other promotional material for the Contracts or of the Fund, or any amendment or supplement to the foregoing, not supplied by the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively) or wrongful conduct of the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI or sales literature or other promotional material covering the Contracts (or any amendment or supplement thereto), or the omission or alleged omission to state therein a material fact required to be stated or necessary to make such statement or statements not misleading in light of the circumstances in which they were made, if such statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Adviser or the Fund or persons under the control of the Adviser or the Fund; or
(4) arise as a result of any failure by the Fund to provide the services and furnish the materials under the terms of this Agreement; or
(5) arise out of or result from any material breach of any representation and/or warranty made by the Fund in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund; or
(6) arise out of or result from the incorrect or untimely calculation or reporting of daily net asset value per share or dividend or capital gain distribution rate;
except to the extent provided in Sections 8.3(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Fund otherwise may have.
(b) No party will be entitled to indemnification under Section 8.3(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard of its obligations and duties under this Agreement.
19
(c) The Indemnified Parties will promptly notify the Fund of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Contracts or the operation of the Account.
8.4 INDEMNIFICATION PROCEDURE
Any person obligated to provide indemnification under this Article VIII (“Indemnifying Party”) for the purpose of this Section 8.4) will not be liable under the indemnification provisions of this Article VIII with respect to any claim made against a party entitled to indemnification under this Article VIII (“Indemnified Party”) for the purpose of this Section 8.4) unless such Indemnified Party will have notified the Indemnifying Party in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim will have been served upon such Indemnified Party (or after such party will have received notice of such service on any designated agent), but failure to notify the Indemnifying Party of any such claim will not relieve the Indemnifying Party from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of the indemnification provision of this Article VIII, except to the extent that the failure to notify results in the failure of actual notice to the Indemnifying Party and such Indemnifying Party is damaged solely as a result of failure to give such notice. In case any such action is brought against the Indemnified Party, the Indemnifying Party will be entitled to participate, at its own expense, in the defense thereof. The Indemnifying Party also will be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from the Indemnifying Party to the Indemnified Party of the Indemnifying Party’s election to assume the defense thereof, the Indemnified Party will bear the fees and expenses of any additional counsel retained by it, and the Indemnifying Party will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation, unless:
(a) the Indemnifying Party and the Indemnified Party will have mutually agreed to the retention of such counsel; or
(b) the named parties to any such proceeding (including any impleaded parties) include both the Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. The Indemnifying Party will not be liable for any settlement of any proceeding effected without its written consent but if settled with such consent or if there is a final judgment for the plaintiff, the Indemnifying Party agrees to indemnify the Indemnified Party from and against any loss or liability by reason of such settlement or judgment. A successor by law of the parties to this Agreement will be entitled to the benefits of the indemnification contained in this Article VIII. The indemnification provisions contained in this Article VIII will survive any termination of this Agreement.
ARTICLE IX: APPLICABLE LAW
9.1 This Agreement will be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York without reference to its conflicts of law provisions. To the extent that the applicable laws of the State of New York or any of the provisions herein conflict with the applicable provisions of the Act or other federal laws and regulations which may be applicable, the latter shall control. The parties to this Agreement hereby irrevocably agree to submit to the jurisdiction of the courts located in the State of New York for any action or proceeding arising out of this Agreement, and hereby irrevocably agree that all claims in respect of such action or proceeding shall be heard or determined in such courts.
20
9.2 This Agreement will be subject to the provisions of the 1933 Act, the 1934 Act and the 1940 Act, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the Commission may grant and the terms hereof will be interpreted and construed in accordance therewith.
ARTICLE X: TERMINATION
10.1 This Agreement will terminate:
(a) at the option of any party, with or without cause, with respect to one, some or all of the Designated Portfolios, upon six (6) month’s advance written notice to the other parties or, if later, upon receipt of any required exemptive relief or orders from the SEC, unless otherwise agreed in a separate written agreement among the parties; or
(b) at the option of the Company, upon written notice to the other parties, with respect to any Portfolio if shares of the Designated Portfolio are not reasonably available to meet the requirements of the Contracts as determined in good faith by the Company; or
(c) at the option of the Company, upon written notice to the other parties, with respect to any Portfolio in the event any of the Portfolio’s shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by Company; or
(d) at the option of the Fund, upon written notice to the other parties, upon institution of formal proceedings against the Company by FINRA, the Commission or any other regulatory body regarding the Company’s duties under this Agreement or related to the sale of the Contracts, the administration of the Contracts, the operation of the Account, or the purchase of the Fund shares, provided that the Fund determines in its sole judgment, exercised in good faith, that any such proceeding would have a material adverse effect on the Company’s ability to perform its obligations under this Agreement; or
(e) at the option of the Company, upon written notice to the other parties, upon institution of formal proceedings against the Fund, the Adviser, or the Distributor by FINRA, the Commission or any other regulatory body, provided that the Company determines in its sole judgment, exercised in good faith, that any such proceeding would have a material adverse effect on the Fund’s or the Adviser’s ability to perform its obligations under this Agreement; or
(f) at the option of the Company, upon written notice to the other parties, with respect to any Designated Portfolio, if a Designated Portfolio ceases to qualify as a Regulated Investment Company under Subchapter M of the Code, or under any successor or similar provision, or if the Company reasonably and in good faith believes that the Designated Portfolio may fail to so qualify; or
(g) at the option of any party to this Agreement, upon written notice to the other parties, upon another party’s material breach of any provision of this Agreement; or
(h) at the option of the Company, if the Company determines in its sole judgment exercised in good faith that the Fund, the Adviser or Distributor has suffered a material adverse change in its business, operations or financial condition since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Fund, Adviser or Distributor and hence to the Company; or
21
(i) at the option of the Fund or the Adviser, if the Fund or Adviser respectively, determines in its sole judgment exercised in good faith that the Company has suffered a material adverse change in its business, operations or financial condition since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Fund or the Adviser, such termination to be effective sixty (60) days’ after receipt by the other parties of written notice of the election to terminate.
10.2 NOTICE REQUIREMENT
No termination of this Agreement will be effective unless and until the party terminating this Agreement gives prior written notice to all other parties of its intent to terminate, which notice will set forth the basis for the termination.
10.3 EFFECT OF TERMINATION
Notwithstanding any termination of this Agreement, the Fund, the Adviser and the Distributor will, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”). Specifically, without limitation, the owners of the Existing Contracts will be permitted to reallocate investments in the Designated Portfolios (as in effect on such date), redeem investments in the Designated Portfolios and/or invest in the Designated Portfolios upon the making of additional purchase payments under the Existing Contracts.
10.4 SURVIVING PROVISIONS
Notwithstanding any termination of this Agreement, each party’s obligations under Article VIII to indemnify other parties will survive and not be affected by any termination of this Agreement. In addition, with respect to Existing Contracts, all provisions of this Agreement also will survive and not be affected by any termination of this Agreement.
ARTICLE XI: NOTICES
Any notice will be deemed duly given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other parties.
22
If to the Company:
American General Life Insurance Company
2727-A Allen Parkway
Houston, TX 77019
Attn: Legal Department
If to the Fund:
Seasons Series Trust
One World Trade Center
285 Fulton Street, Suite 49M
New York, NY 10007
Attention: General Counsel
If to the Adviser:
SunAmerica Asset Management, LLC
One World Trade Center
285 Fulton Street, Suite 49M
New York, NY 10007
Attention: General Counsel
ARTICLE XII: MISCELLANEOUS
12.1 All persons dealing with the Fund must look solely to the property of the Fund for the enforcement of any claims against the Fund as neither the directors, officers, agents or shareholders assume any personal liability for obligations entered into on behalf of the Fund.
12.2 The Fund and the Adviser acknowledge that the identities of the customers of the Company or any of its affiliates (collectively the “Protected Parties” for purposes of this Section 12.2), information maintained regarding those customers, and all computer programs and procedures developed by the Protected Parties or any of their employees or agents in connection with the Company’s performance of its duties under this Agreement are the valuable property of the Protected Parties. The Fund and the Adviser agree that if they come into possession of any list or compilation of the identities of or other information about the Protected Parties’ customers, or any other property of the Protected Parties, other than such information as may be independently developed or compiled by the Fund or the Adviser from information supplied to them by the Protected Parties’ customers who also maintain accounts directly with the Fund or the Adviser, the Fund and the Adviser will hold such information or property in confidence and refrain from using, disclosing or distributing any of such information or other property except: (a) with the Company’ s prior written consent; or (b) as required by law or judicial process. The Fund and the Adviser acknowledge that any breach of the agreements in this Section 12.2 would result in immediate and irreparable harm to the Protected Parties for which there would be no adequate remedy at law and agree that in the event of such a breach, the Protected Parties will be entitled to equitable relief by way of temporary and permanent injunctions, as well as such other relief as any court of competent jurisdiction deems appropriate.
12.3 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
23
12.4 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together will constitute one and the same instrument.
12.5 If any provision of this Agreement will be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement will not be affected thereby.
12.6 This Agreement will not be assigned by any party hereto without the prior written consent of all the parties hereto.
12.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal law.
12.8 The parties to this Agreement acknowledge and agree that this Agreement shall not be exclusive in any respect.
12.9 Each party to this Agreement will cooperate with each other party and all appropriate governmental authorities (including without limitation the Commission, FINRA and state insurance regulators) and will permit each other and such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
12.10 Each party represents that the execution and delivery of this Agreement and the consummation of the transactions contemplated herein have been duly authorized by all necessary corporate or board action, as applicable, by such party and when so executed and delivered this Agreement will be the valid and binding obligation of such party enforceable in accordance with its terms.
12.11 The schedules to this Agreement (each, a “Schedule,” collectively, the “Schedules”) form an integral part hereof and are incorporated herein by reference. The parties to this Agreement may agree in writing to amend the Schedules to this Agreement from time to time to reflect changes in or relating to the Contracts, the Accounts or the Designated Portfolios of the Fund or other applicable terms of this Agreement. References herein to any Schedule are to the Schedule then in effect, taking into account any amendments thereto.
12.12 Each Designated Portfolio agrees to consult in advance with the Company concerning any decision to elect or not to pass through the benefit of any foreign tax credits to the Designated Portfolio’s shareholders pursuant to Section 853 of the Code.
24
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and behalf by its duly authorized representative as of the date first above-written.
| SEASONS SERIES TRUST | ||
| By: |
/s/ Kate Fuentes | |
| Name: Kate Fuentes | ||
| Title: Chief Legal Officer, Vice President and Secretary | ||
| SUNAMERICA ASSET MANAGEMENT, LLC | ||
| By: |
/s/ John Genoy | |
| Name: John Genoy | ||
| Title: President and Chief Operating Officer | ||
| AMERICAN GENERAL LIFE INSURANCE COMPANY | ||
| By: |
| |
|
Name: Bryan Pinsky | ||
|
Title: President | ||
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and behalf by its duly authorized representative as of the date first above-written.
| SEASONS SERIES TRUST | ||
| By: |
| |
|
Name: Kate Fuentes | ||
|
Title: Chief Legal Officer, Vice President and Secretary | ||
|
SUNAMERICA ASSET MANAGEMENT, LLC | ||
|
By: |
| |
|
Name: John Genoy | ||
|
Title: President and Chief Operating Officer | ||
|
AMERICAN GENERAL LIFE INSURANCE COMPANY | ||
|
By: |
/s/ Bryan Pinsky | |
|
Name: Bryan Pinsky | ||
|
Title: President | ||
Exhibit A
Request for Information Form
We hereby request that American General Life Insurance Company provide the Transaction Information indicated below.
Please provide the following information about the Transaction Information requested:
| Contract Number* | ||||
| Tax Identification Number**: | ||||
| Fund Name: | ||||
| Portfolio Name: | ||||
| Portfolio Manager: | ||||
| Covered Period***: | ||||
| Requesting Person****: | ||
| Signature: | ||
| Date: | ||
| Telephone Number: | ||
| Facsimile Number: | ||
| * | or participant account number if applicable. Failure to complete this item shall not prevent this Form from being in Good Form. |
| ** | or Individual/International Taxpayer Identification Number (ITIN), other government-issued identifier or equivalent identifying number. Failure to complete this item shall not prevent this Form from being in Good Form. |
| *** | the covered period shall not include any day that is earlier than 180 days prior to the day Intermediary received this form in Good Form. |
| **** | person must be duly authorized person as previously provided by the Fund. |
PLEASE E-MAIL THIS FORM TO SaamcoLegal@venerable.com,
ATTENTION “RULE 22C-2 INFORMATION REQUEST”
PLEASE COMPLETE EACH ITEM.
INCOMPLETE FORMS WILL NOT BE PROCESSED.
Exhibit B
Instructions to Restrict Trading Form
American General Life Insurance Company is hereby instructed to restrict purchase or exchanges into the Fund indicated below by the Contract indicated below.
Please provide the following information about the Contract to be restricted:
| Contract Number* | ||||
| Tax Identification Number**: | ||||
Please provide the following information about the Portfolio to be restricted:
| Fund Name: | ||||
| Portfolio Name: | ||||
| Portfolio Manager: | ||||
Please provide the following information about the time period for which trading should be restricted:
| Start Date***: | ||||
| End Date: | ||||
| Requesting Person****: | ||
| Signature: | ||
| Date: | ||
| Telephone Number: | ||
| Facsimile Number: | ||
| * | or participant account number if applicable. |
| ** | or Individual/International Taxpayer Identification Number (ITIN), other government-issued identifier or equivalent identifying number. |
| *** | Start date will be no earlier than 48 hours after receipt of form in “Good Form.” |
| **** | person must be duly authorized person as previously provided by the Fund. |
PLEASE E-MAIL THIS FORM TO SaamcoLegal@venerable.com,
ATTENTION “RULE 22C-2 RESTRICTION”
PLEASE COMPLETE EACH ITEM.
INCOMPLETE FORMS WILL NOT BE PROCESSED.
Schedule A
The following Separate Accounts and associated Contracts of American General Life Insurance Company are permitted in accordance with the provisions of this Agreement to invest in Designated Portfolios of the Fund shown in Schedule B:
NAME OF SEPARATE ACCOUNT CONTRACTS FUNDED BY SEPARATE ACCOUNT
Variable Separate Account
Variable Annuity Account Five
Variable Annuity Account Seven
AGL Separate Account VL-R
Schedule B
The Separate Account(s) shown on Schedule A may invest in the following Portfolio(s) of the Fund.
| SA Allocation Aggressive Portfolio |
|
SA Allocation Balanced Portfolio |
|
SA Allocation Moderate Portfolio |
|
SA Allocation Moderately Aggressive Portfolio |
|
SA American Century Inflation Managed Portfolio |
|
SA Columbia Focused Value Portfolio |
|
SA Franklin Allocation Moderately Aggressive Portfolio |
|
SA Multi-Managed Diversified Fixed Income Portfolio |
|
SA Multi-Managed International Equity Portfolio |
|
SA Multi-Managed Large Cap Growth Portfolio |
|
SA Multi-Managed Large Cap Value Portfolio |
|
SA Multi-Managed Mid Cap Growth Portfolio |
|
SA Multi-Managed Mid Cap Value Portfolio |
|
SA Multi-Managed Small Cap Portfolio |
FUND PARTICIPATION AGREEMENT
THIS AGREEMENT (the “Agreement”), made and entered into January 1, 2026 (the “Effective Date”) by and among American General Life Insurance Company, organized under the laws of the state of Texas (the “Company”), on behalf of itself and each separate account of the Company named in Schedule A to this Agreement, as may be amended from time to time (each account referred to as the “Account” and collectively as the “Accounts”); SunAmerica Series Trust, an open-end management investment company organized under the laws of the Commonwealth of Massachusetts under a Declaration of Trust dated September 11, 1992, as amended and restated to date (the “Fund”); and SunAmerica Asset Management, LLC, a limited liability company organized under the laws of Delaware and investment adviser to the Fund (the “Adviser”).
WHEREAS, the Fund engages in business as an open-end management investment company; and
WHEREAS, beneficial interests in the Fund are divided into several series of shares, each representing the interest in a particular managed portfolio of securities and other assets (the “Portfolios”) and such shares are issued to separate accounts of insurance companies to fund variable insurance products and certain qualified pension and retirement plans; and
WHEREAS, the Company, as depositor, has established the Accounts to serve as investment vehicles for certain variable annuity contracts and variable life insurance policies offered by the Company set forth on Schedule A (the “Contracts”); and
WHEREAS, the Accounts are duly organized, validly existing segregated asset accounts, established by resolutions of the Board of Directors of the Company under the insurance laws of the state of Texas, to set aside and invest assets attributable to the Contracts; and
WHEREAS, the Company intends to purchase shares of the Portfolios named in Schedule B, as such schedule may be amended from time to time (the “Designated Portfolios”) on behalf of the Accounts to fund the Contracts; and
WHEREAS, an order of the Securities and Exchange Commission (the “Commission” or “SEC”) dated November 5, 2014, (File No. 812-14226) grants certain separate accounts supporting variable life insurance policies, their life insurance company depositors, and their principal underwriters, exemptions from Sections 9(a), 13(a), 15(a) and 15(b) of the Investment Company Act of 1940 (the “1940 Act”), and from Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary for such separate accounts to purchase and hold Fund shares at the same time that such shares are sold to or held by separate accounts of affiliated and unaffiliated insurance companies supporting either variable annuity contracts or variable life insurance policies, or both, the investment adviser or sub-advisers to a Fund, any general account of an insurance company depositor of such separate accounts (representing seed money investments in the Fund), and/or by qualified pension and retirement plans (the “SEC Order”); and
WHEREAS, the Fund’s principal underwriter (“Distributor”) is a broker-dealer registered as such under the Securities Exchange Act of 1934 (“1934 Act”) and a member of the Financial Industry Regulatory Authority (“FINRA”).
NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund and the Adviser hereby agree as follows:
ARTICLE I: SALE OF FUND SHARES
1.1 The Fund agrees to sell to the Company those shares of the Designated Portfolios which each Account orders (based on orders placed by Contract owners on that Business Day, as defined below), executing such orders on a daily basis at the net asset value (and with no sales charges) next computed after receipt by the Fund or its designee of the order for the shares of the Fund. For purposes of this Section 1.1, the Company will be the designee of the Fund for receipt of such orders from each Account and receipt by such designee will constitute receipt by the Fund; provided that the Fund receives notice of such order by 11:00 a.m. Eastern Time on the next following Business Day or such later time as permitted by Section 1.8 hereof. “Business Day” will mean any day on which the New York Stock Exchange is open for trading and on which the Fund calculates its net asset value pursuant to the rules of the Securities and Exchange Commission.
1.2 The Fund agrees to redeem for cash, upon the Company’s request, any full or fractional shares of the Fund held by the Company (based on orders placed by Contract owners on that Business Day), executing such requests on a daily basis at the net asset value next computed after receipt and acceptance by the Fund or its agent of the request for redemption. For purposes of this Section 1.2, the Company will be the designee of the Fund for receipt of requests for redemption from each Account and receipt by such designee will constitute receipt by the Fund; provided the Fund receives notice of such requests for redemption by 11:00 a.m. Eastern Time on the next following Business Day or such later time as permitted by Section 1.8 hereof. After consulting with the Company, the Fund reserves the right to delay payment of redemption proceeds, but in no event may any such delay by the Fund in paying redemption proceeds cause Company or any Account to fail to meet its obligations under Section 22(e) of the 1940 Act.
1.3(a) Fund/SERV Transactions. If the parties choose to use the National Securities Clearing Corporation’s Mutual Fund Settlement, Entry and Registration Verification (“Fund/SERV”) or any other NSCC service, the following provisions shall apply:
The Company and the Fund or their respective designees will each be bound by the rules of the National Securities Clearing Corporation (“NSCC”) and the terms of any NSCC agreement filed by it or their respective designees with the NSCC. Without limiting the generality of the following provisions of this section, the Company and the Fund or its designee will each perform any and all duties, functions, procedures and responsibilities assigned to it and as otherwise established by the NSCC applicable to Fund/SERV, the Mutual Fund Profile Service, the Networking Matrix Level utilized and any other relevant NSCC service or system (collectively, the “NSCC Systems”).
Any information transmitted through the NSCC Systems by any party or its designee to the other or its designee and pursuant to this Agreement will be accurate, complete, and in the format prescribed by the NSCC. Each party or its designee will adopt, implement and maintain procedures reasonably designed to ensure the accuracy of all transmissions through the NSCC Systems and to limit the access to, and the inputting of data into, the NSCC Systems to persons specifically authorized by such party.
On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company in good form on each Business Day. The Company shall communicate to the Fund or its designee for that Business Day, by the NSCC, the net aggregate purchase or redemption orders (if any) for each Account received by the Closing Time on such Business Day in accordance with Section 1.1 (for net purchases) or Section 1.2 (for net redemptions), as applicable. All orders received by the Company after the Closing Time on a Business Day shall not be transmitted to the NSCC prior to the following Business Day. The
2
Company will wire payment for net purchase orders in immediately available funds, to an NSCC settling bank account designated by the Fund, in accordance with NSCC rules and procedures on the Business Day following the Business Day on which such purchase orders are communicated in proper form to the NSCC. The Fund will wire payment for net redemption orders in immediately available funds, to an NSCC settling bank account designated by the Company, in accordance with NSCC rules and procedures no later than on the Business Day following the Business Day on which such purchase orders are communicated in proper form to the NSCC.
(b) Manual Transactions. If the parties choose not to use Fund/SERV, if there are technical problems with Fund/SERV, or if the parties are not able to transmit or receive information through Fund/SERV, the following provisions shall apply:
On each Business Day, the Company shall aggregate and calculate the net purchase and redemption orders for each Account received by the Company in good form on such Business Day. The Company will place separate orders to purchase or redeem shares of each Designated Portfolio. Each order shall describe the net amount of shares and dollar amount of each Designated Portfolio to be purchased or redeemed. In the event of net purchases, the Company shall pay for net purchase orders by wiring federal funds to Fund or its designated custodial account (by 2:00 pm EST) on the next Business Day after an order to purchase Designated Portfolio shares is made in accordance with the provisions of Section 1.1 hereof (or such later time as permitted by Section 1.8 hereof). Upon receipt by the Fund of the payment, such funds shall cease to be the responsibility of the Company and shall become the responsibility of the Fund. In the event of net redemptions, the Fund shall pay the net redemption proceeds by wiring federal funds to the Company or its designated custodial account (by 2:00 pm EST) on the next Business Day after an order to redeem a Designated Portfolio’s shares is made in accordance with the provision of Section 1.2 hereof. Upon receipt by the Company of the payment, such funds shall cease to be the responsibility of the Fund and shall become the responsibility of the Company.
1.4 The Fund agrees to make shares of the Designated Portfolios available continuously for purchase at the applicable net asset value per share by the Company on behalf of the Accounts on those days on which the Fund calculates its Designated Portfolio net asset value pursuant to rules of the Commission and the Fund shall calculate such net asset value on each day which the NYSE is open for regular trading; provided, however, that the Board of Directors of the Fund (the “Fund Board”) may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund Board, acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio.
1.5 The Company agrees to purchase and redeem the shares of the Designated Portfolios offered by the then current prospectus and statement of additional information of the Fund in accordance with the provisions of such prospectus and statement of additional information to the extent not inconsistent with the terms and conditions of this Agreement.
1.6 Issuance and transfer of the Fund’s shares will be by book entry only. Stock certificates will not be issued to the Company or to any Account. Purchase and redemption orders for Fund shares will be recorded in an appropriate title for each Account or the appropriate sub-account of each Account.
1.7 The Fund will furnish same day notice to the Company of the declaration of any income, dividends or capital gain distributions payable on each Designated Portfolio’s shares. The Company hereby elects to receive all such dividends and distributions as are payable on the Portfolio shares in the form of additional
3
shares of that Portfolio at the ex-dividend date net asset values. The Company reserves the right to revoke this election and to receive all such dividends and distributions in cash. The Fund will notify the Company of the number of shares so issued as payment of such income, dividends and distributions.
1.8 The Fund will make the net asset value per share for each Designated Portfolio available to the Company via electronic means on each Business Day as soon as reasonably practical after the net asset value per share is calculated and will use its best efforts to make such net asset value per share available by 7:00 p.m., Eastern Time, each Business Day. In the event that the Fund is unable to meet the 7:00 p.m. time stated herein, it shall provide additional time for the Company to place orders for the purchase and redemption of Fund shares and wire net payments for the purchase of Fund shares. Such additional time shall be equal to the additional time which the Fund takes to make the net asset value available to the Company. If the Fund provides the Company materially incorrect net asset value per share information (as determined under SEC guidelines), the Fund shall make an adjustment to the number of shares purchased or redeemed for the Accounts to reflect the correct net asset value per share, and the Adviser shall bear the cost of correcting such errors and shall reimburse the Company for any expenses incurred related to correction of the net asset value (including correcting Contract owner accounts). Any material error in the calculation or reporting of net asset value per share, dividend or capital gain information shall be reported to the Company upon discovery by the Fund. Upon timely notification of any overpayment by the Fund to a Contract owner due to a materially incorrect net asset value calculation (as determined by SEC guidelines), the Company shall reasonably cooperate with the Fund and Adviser to remit back to the Fund any such overpayment that has not been paid or credited to the Contract owner, subject to the Adviser’s obligation to reimburse the Company for any reasonable costs and expenses associated with such correction.
ARTICLE II: REPRESENTATIONS AND WARRANTIES
2.1 The Company represents and warrants that interests under the Contracts are or will be registered under the Securities Act of 1933 (the “1933 Act”), or are exempt from registration thereunder, and that the Contracts will be issued and sold and distributed in compliance with all applicable federal and state laws. The Company further represents and warrants that it is an insurance company duly organized and in good standing under applicable law and that it has legally and validly established each Account as a separate account under applicable law and that each Account is or will be registered as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts, or is exempt from registration thereunder, and that it will maintain such registration for so long as any Contracts are outstanding, as applicable. The Company will amend the registration statement under the 1933 Act for the Contracts and the registration statement under the 1940 Act for the Account from time to time as required in order to effect the continuous offering of the Contracts or as may otherwise be required by applicable law. The Company will register and qualify the Contracts for sale in accordance with the securities laws of the various states only if and to the extent deemed necessary by the Company.
2.2 Subject to compliance by each Designated Portfolio with the requirements of Subchapter M and Section 817(h) of the Internal Revenue Code of 1986, as amended (“Code”), the regulations thereunder, or any successor provision, the Company represents and warrants that the Contracts are currently and at the time of issuance will be treated as life insurance, or annuity contracts under applicable provisions of the Code, that it will maintain such treatment and that it will notify the Fund immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.
2.3 The Company is, and shall carry out its activities under this Agreement, in compliance with all applicable anti-money laundering laws, rules and regulations including, but not limited to, the U.S.A. PATRIOT Act of 2001, P.L. 107-56. The Company further represents that it has policies and procedures in place reasonably designed to detect money laundering and terrorist financing, including the reporting of suspicious activity.
4
2.4 The Fund and Adviser each represents and warrants that shares of the Designated Portfolio(s) sold pursuant to this Agreement will be registered under the 1933 Act and duly authorized for issuance in accordance with applicable law and that the Fund is and will remain registered as an open-end management investment company under the 1940 Act for as long as such shares of the Designated Portfolio(s) are sold. The Fund will amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares. The Fund will register and qualify the shares of the Designated Portfolio(s) for sale in accordance with the laws of the various states only if and to the extent deemed advisable by the Fund.
2.5 The Fund currently intends for one or more classes of shares of the Portfolios (each, a “Class”) to make payments pursuant to a plan (“Plan”) adopted pursuant to Rule 12b-1 under the 1940 Act, although it may determine to discontinue such practice in the future. To the extent that any Class of the Fund finances its distribution expenses pursuant to a Plan adopted under Rule 12b-1, the Fund undertakes to comply, in all material respects, with any then current SEC interpretations concerning Rule 12b-1 or any successor provisions.
2.6 The Fund and Adviser represent and warrant that the Fund is lawfully organized and validly existing under the laws of the State of Massachusetts and that the Fund does and will comply in all material respects with applicable provisions of the 1940 Act and any applicable regulations thereunder. The Fund and Adviser represent and warrant that the Fund’s operations, and that of each Designated Portfolio, does and will comply with applicable federal and state law.
2.7 The Fund and Adviser represent and warrant that all of the Fund’s directors, officers, employees, investment advisers, and other individuals/entities having access to the funds and/or securities of the Fund are and continue to be at all times covered by a blanket fidelity bond or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage as required currently by Rule 17g-(1) of the 1940 Act or related provisions as may be promulgated from time to time. The aforesaid bond includes coverage for larceny and embezzlement and is issued by a reputable bonding company.
2.8 The Fund is, and shall carry out its activities under this Agreement, in compliance with all applicable anti-money laundering laws, rules and regulations including, but not limited to, the U.S.A. PATRIOT Act of 2001, P.L. 107-56. The Fund further represents that it has policies and procedures in place reasonably designed to detect money laundering and terrorist financing, including the reporting of suspicious activity.
2.9 The Adviser represents and warrants that it is lawfully organized and validly existing under the laws of its state of organization; it is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and will remain duly registered under all applicable federal and state securities laws; and that it will perform its obligations for the Fund in accordance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
2.10 The Fund represents and warrants that the Distributor is lawfully organized and validly existing under the laws of its state of organization; it is registered as a broker-dealer under the Securities Exchange Act of 1934, as amended (the “1934 Act”) and will remain duly registered under all applicable federal and state securities laws, and is a member in good standing of the Financial Industry Regulatory Authority (“FINRA”) and serves as principal underwriter of the Fund and that it will perform its obligations for the Fund in accordance in all material respects with the laws of the State of Delaware and any applicable state and federal securities laws.
5
ARTICLE III: FUND COMPLIANCE
3.1 The Fund and Adviser represent and warrant that each Designated Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that they will maintain such qualification (under Subchapter M or any successor or similar provision), and that they will notify the Company immediately upon having a reasonable basis for believing that it has ceased to so qualify or that it might not so qualify in the future.
3.2 The Fund and the Adviser acknowledge that the Fund has obtained the SEC Order granting exemptions from various provisions of the 1940 Act and the rules thereunder to separate accounts supporting variable life insurance policies to the extent necessary to permit them to hold Fund shares when Fund shares also are sold to and held by variable annuity and variable life insurance separate accounts of both affiliated and unaffiliated insurance companies supporting either variable annuity contracts or variable life insurance policies, or both, investment adviser or sub-advisers, or by qualified pension and retirement plans.
3.3 The Fund and Adviser acknowledge that currently or in the future, the Fund’s shares may become available for investment by separate accounts for other insurance companies, which may or may not be affiliated persons (as that term is defined in the 1940 Act) of the Company (collectively with the Company, “Participating Insurers”). In such event, (a) the Fund shall undertake that its Board of Trustees (“Board”) will monitor the Fund for existence of material irreconcilable conflicts that may arise between the contract owners of Participating Insurers, for the purpose of identify and remedying any such conflict and (b) Sections 3.4, 3.5, and 3.6 shall apply. In discharging its responsibilities under Sections 3.4, 3.5, and 3.6 hereinafter, the Company will cooperate and coordinate, to the extent necessary, with the Board and with other Participating Insurers. The Fund agrees that it will require, as a condition to participation, that all Participating Insurers shall have obligations and responsibilities regarding conflicts of interest corresponding to those that are agreed to herein by the Company pursuant to Sections 3.4, 3.5, 3.6 and this Section 3.3.
3.4 Upon request by the Fund’s Board, the Company will report any potential or existing conflicts of which it is or becomes aware between any of its Contract owners or between any of its Contract owners and contract owners of other Participating Insurers. The Company will be responsible for assisting the Fund’s Board in carrying out its responsibilities to identify material conflicts by providing the Board with all information available to it that is reasonably necessary for the Board to consider any issues raised, including information as to a decision by the Company to disregard voting instructions of its Contract owners.
3.5 The Board’s determination of the existence of an irreconcilable material conflict and its implications shall be made known promptly by it to the Company and other Participating Insurers. An irreconcilable material conflict may arise of a variety of reasons, including: (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance tax, or securities laws or regulations, or a public ruling, private letter ruling, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the investments of any Portfolio are being managed; (e) a difference in voting instructions given by variable annuity contract owners and variable life insurance contract owners or by contract owners of different Participating Insurers; or (f) a decision by a Participating Insurer to disregard the voting instructions of variable contract owners.
3.6 If it is determined by a majority of the Board or a majority of its disinterested Trustees that a material irreconcilable conflict exists that affects the interests of the Company Contract owners, the Company shall, in cooperation with other Participating Insurers whose contract owners’ interests are also affected by the conflict, take whatever steps are necessary to remedy or eliminate the irreconcilable material-conflict, which
6
steps could include: (a) withdrawing the assets allocable to the separate accounts named in Schedule A from the Fund or any portfolio and reinvesting such assets in a different investment medium, including another Portfolio of the Fund, or submitting the question of whether such segregation should be implemented to a vote of all affected Contract owners and, as appropriate, segregating the assets of any particular group (e.g., annuity contract owners or life insurance contract owners) that votes in favor of such segregation, or offering to the affected contract owners of the option of making such a change; and (b) establishing a new registered management investment company or managed separate account. The Company shall take such steps at its expense if the conflict affects solely the interests of the owners of the Company Contracts, but shall bear only its equitable portion of any such expense if the conflict also affects the interest of the contract owners of one or more Participating Insurers other than the Company, provided, that this sentence shall not be construed to require the Fund to bear any portion of such expense. If a material irreconcilable conflict arises because of the Company’s decision to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at Fund’s election, to withdraw the separate accounts named in Schedule A invested in the Fund, and no charge or penalty will be imposed against the separate accounts named in Schedule A as a result of such a withdrawal. The Company agrees to take such remedial action as may be required under this Section 3.6 with a view only to the interests of its Contract owners. For purposes of this Section 3.6, a majority of the disinterested members of the Board shall determine whether or not any proposed action adequately remedies any irreconcilable conflict, but in no event will Fund be required to establish a new funding medium for any variable contracts. The Company shall not be required by this Section 3.6 to establish a new funding medium for any variable contract if an offer to do so has been declined by vote of a majority of affected contract owners.
3.7 The Trust and Adviser represent and warrant that each Designated Portfolio is currently, or, if newly organized, will be, qualified as a regulated investment company under Subchapter M of the Code, and that each Designated Portfolio will maintain such qualification (under Subchapter M or any successor or similar provision) and that no other Participating Insurance Companies will purchase shares in any Designated Portfolio for any purpose or under any circumstances that would preclude the Company from “looking through” to the investments of each Designated Portfolio in which it invests, pursuant to the “look through” rules found in Treasury Regulation Section 1.817-5. The Trust, its designee, or the Adviser will notify the Company immediately upon having a reasonable basis for believing that any Designated Portfolio has ceased to so qualify, or that any might not so qualify in the future, within the grace periods afforded by the Code or regulations (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting the Code or the regulations).
The Trust and Adviser represent and warrant that for each quarter each Designated Portfolio does and will at all times invest money from the Contracts in such a manner as to ensure that the Contracts will be treated as variable contracts under the Code and the regulations issued thereunder; including, but not limited to, that the Trust will at all times comply with the diversification requirements of Section 817(h) of the Code and any regulations thereunder applicable to variable contracts as defined in Section 817(d) of the Code and any amendments or other modifications or successor provisions to such Sections or regulations (and any revenue rulings, revenue procedures, notices, and other published announcements of the Internal Revenue Service interpreting those Sections or regulations), as if those requirements applied directly to each such Portfolio. The Trust will notify the Company immediately upon having a reasonable basis for believing that the Trust or a Portfolio thereunder has ceased to comply with the diversification requirements or that the Trust or Portfolio might not comply with the diversification requirements in the future. In the event of a breach of this representation and warranty the Trust will take all reasonable steps to adequately diversify the Trust so as to achieve compliance within the grace period afforded by Treasury Regulation Section 1.817-5.
3.8 The Fund and Adviser represent and warrant that the Fund is and shall maintain compliance with Rule
7
38a-1 under the 1940 Act and Adviser represents and warrants that the Adviser is and shall maintain compliance with Rule 206(4)-7 under the Advisers Act.
ARTICLE IV: PROSPECTUS AND PROXY STATEMENTS/VOTING
4.1 At least annually (or in the case of a prospectus supplement, when that supplement is issued), the Fund will timely provide the Company with as many copies of the current Fund prospectus and statement of additional information (describing only the Designated Portfolio(s)) and any supplements thereto as the Company may reasonably request for distribution, at the Fund’s expense, to Contract owners at the time of Contract fulfillment and confirmation. To the extent that the Designated Portfolio(s) are one or more of several Portfolios of the Fund, the Fund shall bear the cost of providing the Company only with disclosure related to the Designated Portfolio(s).
4.2 The Fund on behalf of one or more Designated Portfolios will provide the Company upon its request with copies of summary prospectuses and supplements thereto in the same manner and at the same time that the Fund provides the Company with statutory prospectuses. The Fund represents and warrants that the summary prospectuses and any supplements provided thereto will comply with the requirements of Rule 498 applicable to its Designated Portfolios.
4.3 The Company represents and warrants that its use of the summary prospectuses and supplements, its website and the manner and procedures related to its hosting of the summary prospectuses and supplements on its website will at all times comply with the requirements of Rule 498. The Fund, at its sole cost and expense, shall provide the Company with summary prospectuses containing the appropriate hyperlinks required by Rule 498 and such other documentation that may be required by Rule 498.
4.4 The Fund may require the Company to terminate the use of the summary prospectuses by providing the Company with at least one hundred and thirty-five (135) days’ prior written notice. The Fund agrees that the Company is not required to distribute the summary prospectuses to its Contract owners and that any use will be in the discretion of the Company. The Company shall provide the Fund with at least thirty (30) days’ prior written notice of its intended use of the summary prospectuses and at least sixty (60) days’ prior written notice of its intent to terminate use of the summary prospectuses.
4.5 The Fund shall be responsible for preparing, hosting on its website, and providing to the Company upon request, the materials required by Rule 30e-1 (“Rule 30e-1”) under the 1940 Act and Item 27A(i) of Form N-1A (collectively, the “Required Materials”) which may include, among other things:
| (a) | Current Annual and Semi-Annual Reports to Shareholders (i.e., Tailored Shareholder Reports); |
| (b) | Current Annual and Semi-Annual Financial Statements; and |
| (c) | Portfolio Holdings for Most Recent First and Third Fiscal Quarters. |
4.6 The Fund shall host and maintain the website specified in paragraph (b)(2)(i) of Rule 30e-1, so that the relevant Required Materials are publicly accessible, free of charge, at that website, in accordance with the conditions set forth in that paragraph.
4.7 The Fund shall be responsible for the content and substance of the Required Materials as provided to the Company, including, but not limited to, the accuracy and completeness of the Required Materials. Without limiting the generality of the foregoing in any manner, the Fund shall be responsible for ensuring that the Required Materials as provided to the Company:
8
| (a) | Meet the applicable standards of the 1933 Act, the 1934 Act, the 1940 Act, and all rules and regulations under those Acts; and |
| (b) | Do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. |
4.8 The Fund, or its designee, shall, at its expense, as the Company may reasonably request from time to time, provide the Company with sufficient paper copies of the then current Required Materials, so that the Company may maintain a supply of such current paper documents sufficient in its reasonable judgment to meet anticipated requests from Contract owners pursuant to Rule 30e-1. Such Company requests shall be fulfilled reasonably promptly, but in no event more than seven (7) business days after the request from the Company is received by the Fund.
4.9 Alternatively, if requested by the Company in lieu thereof, the Fund or its designee shall provide such electronic or other documentation (including “camera ready” copies of the current Required Materials as set in type), and such other assistance as is reasonably necessary to have the then current Required Materials printed for distribution (pursuant to requests from Contract owners; see paragraph (b)(3) of Rule 30e-1, as applicable); the reasonable costs of providing the electronic documentation and of such printing to be borne by the Fund.
4.10 The Fund shall be responsible for preparing and providing the following “Fund Documents,” as specified in paragraph (j)(1)(iii) of Rule 498A:
| (a) | Summary Prospectus for the Designated Portfolios; |
| (b) | Statutory Prospectus for the Designated Portfolios; |
| (c) | Statement of Additional Information (“SAI”) for the Designated Portfolios; and |
| (d) | Most Recent Annual and Semi-Annual Reports to Shareholders (under Rule 30e-1 under the 1940 Act) for the Designated Portfolios. |
4.11 The Fund shall provide the Fund Documents specified in Sections 4.10(a), (b), and (c) above to the Company (or its designee) on a timely basis (to facilitate the required website posting) and provide updated versions as necessary, to facilitate a continuous offering of the Fund’s securities and the Contracts. The Fund shall provide the Shareholder Reports specified in Section 4.10(d) above within 60 days after the close of each of the Fund’s reporting periods (in accordance with Rule 30e-1 under the 1940 Act).
4.12 The Fund shall provide the Fund Documents to the Company (or its designee) in an electronic format that is suitable for website posting, and in a format, or formats, that:
| (a) | are both human-readable and capable of being printed on paper in human-readable format (in accordance with paragraph (h)(2)(i) of Rule 498A); |
| (b) | permit persons accessing the Statutory Prospectus and SAI to move directly back and forth between each section heading in a table of contents of such document and the section of the document referenced in that section heading (that is, these documents must include linking, in accordance with paragraph (h)(2)(ii) of Rule 498A); and |
9
| (c) | permit persons accessing the Fund Documents to permanently retain, free of charge, an electronic version of such materials that meet the requirements of subsections (a) and (b) above (in accordance with paragraph (h)(3) of Rule 498A). |
4.13 The Company shall host and maintain the website specified in paragraph (j)(1)(iii) of Rule 498A, so that the Fund Documents are publicly accessible, free of charge, at that website, in accordance with the conditions set forth in that paragraph, provided that the Fund fulfills its obligations under this Agreement. The Fund shall pay the Company a reasonable fee as compensation for the Company hosting the website specified in (j)(1)(iii) of Rule 498A. As of the Effective Date, the Fund and/or the Advisor shall pay the Company quarterly 50% of the Company’s hosting fees paid under the Company’s website hosting service provider agreement to host the website specified in paragraph (j)(1)(iii) of Rule 498A.
Within six (6) months from the Effective Date, the Company and the Adviser shall collaborate in good faith to determine whether an alternative solution to the website specified in paragraph (j)(1)(iii) of Rule 498A is feasible. If the parties mutually agree that an alternative solution is feasible and cost effective, they shall: (i) equally share the costs of implementation; (ii) equally share any cost savings resulting from such implementation; and (iii) negotiate in good faith appropriate terms regarding the Company’s customer experience standards and indemnification requirements.
4.14 The Company shall ensure that an Initial Summary Prospectus is used for each currently offered Contract described under the related registration statement, in accordance with paragraph (j)(1)(i) of Rule 498A. The Fund shall ensure that a summary prospectus is used for the Designated Portfolios, in accordance with paragraph (j)(1)(ii) of Rule 498A.
4.15 The Fund shall be responsible for the content and substance of the Fund Documents as provided to the Company, including, but not limited to, the accuracy and completeness of the Fund Documents. Without limiting the generality of the foregoing in any manner, the Fund shall be responsible for ensuring that the Fund Documents as provided to the Company:
| (a) | Meet the applicable standards of the 1933 Act, the 1934 Act, the 1940 Act, and all rules and regulations under those Acts; and |
| (b) | Do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading. |
4.16 The Fund shall, at its expense, as the Company may reasonably request from time to time, provide the Company with sufficient paper copies of the then current Fund Documents, so that the Company may maintain a supply of such current paper documents sufficient in its reasonable judgment to meet anticipated requests from existing Contract owners (see paragraphs (i)(1) and (j)(3) of Rule 498A). Such Company requests shall be fulfilled reasonably promptly, but in no event more than three (3) business days after the request from the Company is received by the Fund.
| (a) | Alternatively, if requested by the Company in lieu thereof, the Fund or its designee shall provide such electronic or other documentation (including “camera ready” copies of the current Fund Documents as set in type), and such other assistance as is reasonably necessary to have the then current Fund Documents printed for distribution; the reasonable costs of providing the electronic documentation and of such printing and mailing to be borne by the Fund with respect to existing Contract owners only. |
10
| (b) | The Fund shall reimburse the Company for the reasonable costs of printing and mailing the Fund Documents to existing Contract owners. |
The Company shall bear any costs associated with the printing and mailing of Fund Documents to prospective Contract owners.
4.17 The Fund shall provide such data regarding each Designated Portfolio’s expense ratios and investment performance as the Company shall reasonably request, to facilitate the registration and sale of the Contracts. Without limiting the generality of the foregoing, the Fund shall provide the following Fund expense and performance data on a timely basis to facilitate the Company’s preparation of its annually updated registration statements for the Contracts (and as otherwise reasonably requested by the Company), but in no event later than eighty (80) calendar days after the close of each Designated Portfolio’s fiscal year:
| (a) | the gross “Annual Fund Company Expenses” for each Designated Portfolio calculated in accordance with Item 3 of Form N-1A, before any expense reimbursements or fee waiver arrangements; and |
| (b) | the net “Annual Fund Company Expenses” (aka “Total Annual Fund Operating Expenses”) for each Designated Portfolio calculated in accordance with Item 3 of Form N-1A, that include any expense reimbursements or fee waiver arrangements, and the period for which the expense reimbursements or fee waiver arrangement is expected to continue and whether it can be terminated by the Fund; and |
| (c) | the “Average Annual Total Returns” for each Designated Portfolio (before taxes) as calculated pursuant to Item 4(b)(2)(iii) of Form N-1A (for the 1, 5, and 10-year periods). |
4.18 The Fund, at its expense, will provide the Company or its mailing agent with copies of its proxy material, if any, reports to shareholders/Contract owners and other permissible communications to shareholders/Contract owners in such quantity as the Company will reasonably require. The Company will distribute this proxy material, reports and other communications to existing Contract owners, and will bill the Fund for the reasonable cost of such distribution.
4.19 If and to the extent required by law, the Company will:
(a) solicit voting instructions from Contract owners;
(b) vote the shares of the Designated Portfolios held in the Account in accordance with instructions received from Contract owners; and
(c) vote shares of the Designated Portfolios held in the Account for which no timely instructions have been received, in the same proportion as shares of such Designated Portfolio for which instructions have been received from the Company’s Contract owners,
so long as and to the extent that the Commission continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners. The Company reserves the right to vote Fund shares held in any segregated asset account in its own right, to the extent permitted by law. The Company will be responsible for assuring that the Accounts participating in the Fund calculates voting privileges in a manner consistent with all legal requirements.
11
4.20 The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular, the Fund either will provide for annual meetings (except insofar as the Commission may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, to comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of the 1940 Act) as well as with Sections 16(a) and, if and when applicable, 16(b). Further, the Fund will act in accordance with the Commission’s interpretation of the requirements of Section 16(a) with respect to periodic elections of directors and with whatever rules the Commission may promulgate with respect thereto.
ARTICLE V: SALES MATERIAL AND INFORMATION
5.1 The Company will furnish, or will cause to be furnished, to the Fund or the Adviser, each piece of sales literature or other promotional material in which the Fund or the Adviser is named, at least ten (10) Business Days prior to its use. No such material will be used if the Fund or the Adviser reasonably objects to such use within five (5) Business Days after receipt of such material.
5.2 The Company will not give any information or make any representations or statements on behalf of the Fund, Adviser, or Distributor, or concerning the Fund, Adviser, or Distributor, in connection with the sale of the Contracts other than the information or representations contained in the registration statement, prospectus or SAI for Fund shares, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Fund, or in published reports for the Fund which are in the public domain or approved by the Fund or the Adviser or their designees for distribution, or in sales literature or other material provided by the Fund or by the Adviser, except with permission of the Fund or the Adviser or their designees. The Fund and the Adviser agree to respond to any request for approval on a prompt and timely basis.
5.3 The Fund or the Adviser will furnish, or will cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company or its separate account is named, at least ten (10) Business Days prior to its use. No such material will be used if the Company or its designee reasonably objects to such use within five (5) Business Days after receipt of such material.
5.4 The Fund and the Adviser will not give any information or make any representations or statements on behalf of the Company or concerning the Company, each Account, or the Contracts other than the information or representations contained in a registration statement, prospectus or SAI for the Contracts, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in published reports for each Account or the Contracts which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other material provided by the Company, except with written permission of the Company. The Company agrees to respond to any request for approval on a prompt and timely basis.
5.5 The Fund will provide to the Company at least one complete copy of all registration statements, prospectuses, SAIs, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Fund or its shares, within a reasonable time after filing of each such document with the Commission or FINRA.
5.6 The Company will provide to the Fund at least one complete copy of all definitive prospectuses, definitive SAI, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no action letters, and all amendments to any of the above, that relate to the Contracts or each Account, within a reasonable time after filing of each such document with the
12
Commission or FINRA (except that with respect to post-effective amendments to such prospectuses and SAIs and sales literature and promotional material, only those prospectuses and SAIs and sales literature and promotional material that relate to or refer to the Fund will be provided.) In addition, the Company will provide to the Fund at least one complete copy of (i) a registration statement that relates to the Contracts or each Account, containing representative and relevant disclosure concerning the Fund; and (ii) any post-effective amendments to any registration statements relating to the Contracts or such Account that refer to or relate to the Fund.
5.7 The Fund and Adviser will provide the Company with as much notice as is reasonably practicable of any proxy solicitation for any Designated Portfolio, and of any material change in the Fund’s registration statement, particularly any material change resulting in a material change to the registration statement or prospectus or statement of additional information for any Account. The Fund and Adviser will cooperate with the Company so as to enable the Company to solicit proxies from Contract owners or to make changes to its prospectus, statement of additional information or registration statement, in an orderly manner. The Fund and Adviser will make reasonable efforts to attempt to have changes affecting Contract prospectuses become effective simultaneously with the annual updates for such prospectuses.
5.8 For purposes of this Article V, the phrase “sales literature or other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media, (i.e., on-line networks such as the Internet or other electronic messages)), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, registration statements, prospectuses, SAIs, shareholder reports, and proxy materials and any other material constituting sales literature or advertising under FINRA rules, the 1933 Act or the 1940 Act.
5.9 The Fund, the Adviser and the Company agree to adopt and implement procedures reasonably designed to ensure that information concerning the Company, the Fund, the Adviser or the Distributor, respectively, and their respective affiliated companies, that is intended for use only by brokers or agents selling the Contracts is properly marked as “Not For Use With The Public” and that such information is only so used.
ARTICLES VI: FEES, COSTS AND EXPENSES
6.1 The Fund will pay no fee or other compensation to the Company under this Agreement, except as provided below: (a) if the Fund or any Designated Portfolio adopts and implements a plan pursuant to Rule 12b-1 under the 1940 Act to finance distribution and shareholder servicing expenses, then, subject to obtaining any required exemptive orders or other regulatory approvals, the Fund may make payments to the Company or to the underwriter for the Contracts if and in such amounts agreed to by the Fund in writing; (b) the Fund may pay fees to the Company for administrative services provided to Contract owners that are not primarily intended to result in the sale of shares of the Designated Portfolio or of underlying Contracts as separately agreed to in writing.
6.2 The Fund shall bear its expenses relating to the Fund’s performance of its obligations under this Agreement to the extent permitted by law, except as expressly provided otherwise herein. The Company shall bear its expenses relating to the performance of the Company’s obligations under this Agreement to the extent permitted by law, except as expressly provided otherwise herein. All shares of the Designated Portfolios will be duly authorized for issuance and registered in accordance with applicable federal law and, to the extent deemed advisable by the Fund, in accordance with applicable state law, prior to sale.
13
ARTICLE VII: RULE 22c-2 AGREEMENT
7.1 Definitions. As used in this section of the Agreement relating to Rule 22c-2 under the 1940 Act (the “Rule”), the following terms shall have the following meanings, unless a different meaning is clearly required by the contexts:
| (a) | The term “Fund” does not include any “excepted funds” as defined in the Rule, which includes any: (i) money market fund; (ii) fund that issues securities that are listed on a national exchange; or (iii) fund that affirmatively permits short-term trading of its securities, if its prospectus clearly and prominently discloses that the fund permits short-term trading of its securities and that such trading may result in additional costs for the fund. The term “Fund” shall also include the Fund’s designee (i.e., principal underwriter or transfer agent). |
| (b) | The term “Fund Policies” means policies established by the Fund for the purpose of eliminating or reducing any dilution of the value of the outstanding shares issued by the Designated Portfolio resulting from short-term trading, as described in the applicable Designated Portfolio’s current prospectus. |
| (c) | The term “Shares” means the interests of Shareholders corresponding to the redeemable securities of record issued by a Designated Portfolio under the 1940 Act that are held through Accounts established by the Company. |
| (d) | The term “Shareholders” shall mean those contract or policy owners of the Company that hold an interest in a Designated Portfolio, directly or indirectly through Contracts issued by the Company on behalf of the Accounts. |
| (e) | The term “Shareholder-Initiated Transfer Purchase” means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract to a Designated Portfolio, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollment such as transfer of assets within a Contract to a Designated Portfolio as a result of “dollar cost averaging” programs, asset allocation programs or any other automatic rebalancing programs; (ii) required transactions pursuant to a Contract living or death benefit; (iii) one-time step-up in Contract value pursuant to a Contract death or living benefit; (iv) transactions that are executed as a result of allocation of assets to a Designated Portfolio through a Contract as a result of payments such as loan repayments, scheduled contributions, retirement plan salary reduction contributions, or planned premium payments to the Contract; or (v) pre-arranged transfers at the conclusion of a required free look period. |
| (f) | The term “Shareholder-Initiated Transfer Redemption” means a transaction that is initiated or directed by a Shareholder that results in a transfer of assets within a Contract out of a Designated Portfolio, but does not include the following: (i) transactions that are executed automatically pursuant to a contractual or systematic program or enrollments such as transfers of assets within a Contract out of a Designated Portfolio as a result of annuity payouts, loans, systematic withdrawal programs, asset allocation programs and automatic rebalancing programs; (ii) transactions that are executed as a result of any deduction of charges or fees under a Contract; (iii) transactions within a Contract out of a Designated Portfolio as a result of scheduled withdrawals or surrenders from a Contract; (iv) transactions |
14
| that are executed as a result of payment of a death benefit from a Contract; or (v) transactions that are executed as a result of minimum distributions required by applicable federal tax law. |
| (g) | The term “written” includes electronic and facsimile writings and transmissions and such other means as the Parties may agree from time-to-time. |
7.2. Agreement to Provide Information. Company agrees to provide the Fund the taxpayer identification number (“TIN”), the Individual/International Taxpayer Identification Number (“ITIN”) or other government-issued identifier, (or an equivalent identifying number), of any or all Shareholder(s) of the Account, and the amount, date and transaction type (purchase, redemption, transfer, or exchange) of every purchase, redemption, transfer, or exchange of Shares held through an Account maintained by the Company (“Transaction Information”). It is understood that Company intends to provide the Transaction Information regarding each Designated Portfolio daily, but the Fund may, from time to time, make a written request (“Request”) regarding a specific Designated Portfolio or for a specific period in accordance with this Agreement.
Unless otherwise specifically requested by the Fund, Company shall only be required to provide information relating to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions.
7.3 Period Covered by Request. Any Request must set forth a specific period for which the Transaction Information is being sought (the “Covered Period”), but the Covered Period shall not include any day that is earlier than 90 days prior to the day Company received the Request. The Fund may request Transaction Information older than 90 days from the date of the Request as it deems necessary to investigate compliance with Fund Policies.
7.4 Form and Timing of Response/Indirect Intermediaries. Requests must be in “Good Form.” Good Form means the Request (i) is made using the “Request for Information” form attached as Exhibit A, (ii) includes all the information required by the form, except as noted therein; (iii) is signed by a duly authorized officer of the Fund; and (iv) is received by Company.
Company agrees to transmit the Transaction Information on its books and records to the Fund promptly, but in any event not later than five (5) business days, or as otherwise agreed to by the Parties, after receipt of a Request. The format for the Transaction Information provided to the Fund (either daily or as part of a Request) shall be via file transfer protocol (FTP) formal or other agreed upon method.
If requested by the Fund in writing, Company agrees to use best efforts to determine whether any specific Shareholder about whom it has Transaction Information is itself a financial intermediary (“Indirect Intermediary”) and, upon further request by the Fund, to promptly either (i) provide (or arrange to have provided) the Transaction Information for those Shareholders who hold an account with an Indirect Intermediary, or (ii) restrict or prohibit the Indirect Intermediary from purchasing, in nominee name on behalf of others, Shares of the Designated Portfolio. Company additionally agrees to inform the Fund whether it plans to perform (i) or (ii).
7.5 Limitations on Use of Information. The Fund agrees not to use the information received pursuant to this Agreement for any purpose other than as necessary to comply with the provisions of the Rule without prior written consent of Company, or for any purpose not permitted under the privacy provisions of Title V of the Gramm-Leach-Bliley Act (Public Law 106-102) and comparable state laws.
7.6 Agreement to Restrict Trading. Company agrees to execute written instructions from the Fund to restrict or prohibit further purchases or exchanges of Shares by a Shareholder that has been identified by the
15
Fund as having engaged in transactions of the Fund’s Shares (directly or indirectly through the Company’s Account) that violate Fund Policies.
Any such restrictions or prohibitions shall only apply to Shareholder-Initiated Transfer Purchases or Shareholder-Initiated Transfer Redemptions as set forth in Section 7.2. Company will execute such instructions with respect to the Shareholder, but only for the Contract through which such transactions in the Designated Portfolio’s Shares occurred in violation of the Fund’s Policies.
7.7 Form of Instructions. Instructions to restrict trading must be in “Good Form.” Good Form means that the instructions (i) are made using the “Instructions to Restrict Trading” form attached at Exhibit B; (ii) include all the information required by the form; (iii) are signed by a duly authorized officer of the Fund; and (iv) are received by Company. Upon request of the Company, the Fund agrees to provide to the Company, along with the Instructions to Restrict Trading form, information regarding those trades of the Contract holder that violated the Fund’s Policies.
7.8 Timing of Response. Company agrees to execute instructions as soon as reasonably practicable, but not later than five (5) business days, or as otherwise agreed to by the Parties, after receipt of the instructions by the Company.
7.9 Confirmation by Company. Company will provide written confirmation regarding any instructions executed on behalf of the Fund pursuant to this Agreement. The confirmation will be provided via FTP format as soon as reasonably practicable, but not later than ten (10) business days, or as otherwise agreed to by the Parties, after the instructions have been executed.
ARTICLE VIII: INDEMNIFICATION
8.1 INDEMNIFICATION BY THE COMPANY
(a) The Company agrees to indemnify and hold harmless the Fund and the Adviser, and each person, if any, who controls the Fund or the Adviser within the meaning of such terms under the federal securities laws and any director, trustee, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.1) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Company) or actions in respect thereof (including reasonable legal and other expenses), to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale, acquisition, or holding of the Fund shares or the Contracts and:
(1) arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement, prospectus or SAI for the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Fund or the Adviser for use in the registration statement, prospectus or SAI for the Contracts or in the Contracts or sales literature (or any amendment or supplement) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
16
(2) arise out of or as a result of statements or representations by or on behalf of the Company (other than statements or representations contained in the Fund registration statement, prospectus, SAI or sales literature or other promotional material of the Fund, or any amendment or supplement to the foregoing, not supplied by the Company or its designee) or wrongful conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of untrue statement or alleged untrue statement of a material fact contained in the Fund registration statement, prospectus, SAI or sales literature or other promotional material of the Fund (or amendment or supplement) or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make such statements not misleading in light of the circumstances in which they were made, if such a statement or omission was made in reliance upon and in conformity with information furnished to the Fund by or on behalf of the Company or its designee; or
(4) arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to meet the qualifications specified in Section 2.2 of this Agreement); or
(5) arise out of any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach by the Company of this Agreement;
except to the extent provided in Sections 8.1(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Company otherwise may have.
(b) No party will be entitled to indemnification under Section 8.1(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard of its obligations or duties under this Agreement.
(c) The Indemnified Parties promptly will notify the Company of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Fund shares or the Contracts or the operation of the Fund.
8.2 INDEMNIFICATION BY THE ADVISER
(a) The Adviser agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of such terms under the federal securities laws and any director, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of the Adviser) or actions in respect thereof (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale, acquisition, or holding of the Fund shares or the Contracts and:
(1) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or SAI for the Fund or sales literature or other promotional material of the Fund (or any amendment or supplement to any of the foregoing), or arise
17
out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Adviser or Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature of the Fund (or any amendment or supplement thereto) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(2) arise out of or as a result of statements or representations (other than statements or representations contained in the Contracts or in the Contract or Fund registration statements, prospectuses or statements of additional information or sales literature or other promotional material for the Contracts, or any amendment or supplement to the foregoing, not supplied by the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively) or wrongful conduct of the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI or sales literature or other promotional material covering the Contracts (or any amendment or supplement thereto), or the omission or alleged omission to state therein a material fact required to be stated or necessary to make such statement or statements not misleading in light of the circumstances in which they were made, if such statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Adviser or the Fund or persons under the control of the Adviser or the Fund; or
(4) arise as a result of any failure by the Adviser or Fund to provide the services and furnish the materials under the terms of this Agreement; or
(5) arise out of or result from any material breach of any representation and/or warranty made by the Adviser or the Fund in this Agreement, or arise out of or result from any other material breach of this Agreement by the Adviser or the Fund;
except to the extent provided in Sections 8.2(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Adviser otherwise may have.
(b) No party will be entitled to indemnification under Section 8.2(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard or its obligations or duties under this Agreement.
(c) The Indemnified Parties will promptly notify the Adviser and the Fund of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Contracts or the operation of the Account.
8.3 INDEMNIFICATION BY THE FUND
(a) The Fund agrees to indemnify and hold harmless the Company and each person, if any, who controls the Company within the meaning of such terms under the federal securities laws and any director, officer, employee or agent of the foregoing (collectively, the “Indemnified Parties” for purposes of this Section 8.3) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with
18
the written consent of the Fund) or action in respect thereof (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute, regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements, are related to the sale, acquisition, or holding of the Fund shares or the Contracts, or operations of the Fund and:
(1) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement, prospectus or SAI for the Fund or sales literature or other promotional material of the Fund (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated or necessary to make such statements not misleading in light of the circumstances in which they were made; provided that this agreement to indemnify will not apply as to any Indemnified Party if such statement or omission of such alleged statement or omission was made in reliance upon and in conformity with information furnished to the Adviser or Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature of the Fund (or any amendment or supplement thereto) or otherwise for use in connection with the sale of the Contracts or Fund shares; or
(2) arise out of or as a result of statements or representations (other than statements or representations contained in the Contracts or in the Contract or Fund registration statements, prospectuses or statements of additional information or sales literature or other promotional material for the Contracts or of the Fund, or any amendment or supplement to the foregoing, not supplied by the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively) or wrongful conduct of the Adviser or the Fund or persons under the control of the Adviser or the Fund respectively, with respect to the sale or distribution of the Contracts or Fund shares; or
(3) arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI or sales literature or other promotional material covering the Contracts (or any amendment or supplement thereto), or the omission or alleged omission to state therein a material fact required to be stated or necessary to make such statement or statements not misleading in light of the circumstances in which they were made, if such statement or omission was made in reliance upon and in conformity with information furnished to the Company by or on behalf of the Adviser or the Fund or persons under the control of the Adviser or the Fund; or
(4) arise as a result of any failure by the Fund to provide the services and furnish the materials under the terms of this Agreement; or
(5) arise out of or result from any material breach of any representation and/or warranty made by the Fund in this Agreement or arise out of or result from any other material breach of this Agreement by the Fund; or
(6) arise out of or result from the incorrect or untimely calculation or reporting of daily net asset value per share or dividend or capital gain distribution rate;
except to the extent provided in Sections 8.3(b) and 8.4 hereof. This indemnification will be in addition to any liability that the Fund otherwise may have.
(b) No party will be entitled to indemnification under Section 8.3(a) if such loss, claim, damage, liability or action is due to the willful misfeasance, bad faith, or gross negligence in the performance of such party’s duties under this Agreement, or by reason of such party’s reckless disregard of its obligations and duties under this Agreement.
19
(c) The Indemnified Parties will promptly notify the Fund of the commencement of any litigation, proceedings, complaints or actions by regulatory authorities against them in connection with the issuance, holding or sale of the Contracts or the operation of the Account.
8.4 INDEMNIFICATION PROCEDURE
Any person obligated to provide indemnification under this Article VIII (“Indemnifying Party”) for the purpose of this Section 8.4) will not be liable under the indemnification provisions of this Article VIII with respect to any claim made against a party entitled to indemnification under this Article VIII (“Indemnified Party”) for the purpose of this Section 8.4) unless such Indemnified Party will have notified the Indemnifying Party in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim will have been served upon such Indemnified Party (or after such party will have received notice of such service on any designated agent), but failure to notify the Indemnifying Party of any such claim will not relieve the Indemnifying Party from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of the indemnification provision of this Article VIII, except to the extent that the failure to notify results in the failure of actual notice to the Indemnifying Party and such Indemnifying Party is damaged solely as a result of failure to give such notice. In case any such action is brought against the Indemnified Party, the Indemnifying Party will be entitled to participate, at its own expense, in the defense thereof. The Indemnifying Party also will be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action. After notice from the Indemnifying Party to the Indemnified Party of the Indemnifying Party’s election to assume the defense thereof, the Indemnified Party will bear the fees and expenses of any additional counsel retained by it, and the Indemnifying Party will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation, unless:
(a) the Indemnifying Party and the Indemnified Party will have mutually agreed to the retention of such counsel; or
(b) the named parties to any such proceeding (including any impleaded parties) include both the Indemnifying Party and the Indemnified Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. The Indemnifying Party will not be liable for any settlement of any proceeding effected without its written consent but if settled with such consent or if there is a final judgment for the plaintiff, the Indemnifying Party agrees to indemnify the Indemnified Party from and against any loss or liability by reason of such settlement or judgment. A successor by law of the parties to this Agreement will be entitled to the benefits of the indemnification contained in this Article VIII. The indemnification provisions contained in this Article VIII will survive any termination of this Agreement.
ARTICLE IX: APPLICABLE LAW
9.1 This Agreement will be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New York without reference to its conflicts of law provisions. To the extent that the applicable laws of the State of New York or any of the provisions herein conflict with the applicable provisions of the Act or other federal laws and regulations which may be applicable, the latter shall control. The parties to this Agreement hereby irrevocably agree to submit to the jurisdiction of the courts located in the State of New York for any action or proceeding arising out of this Agreement, and hereby irrevocably agree that all claims in respect of such action or proceeding shall be heard or determined in such courts.
20
9.2 This Agreement will be subject to the provisions of the 1933 Act, the 1934 Act and the 1940 Act, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the Commission may grant and the terms hereof will be interpreted and construed in accordance therewith.
ARTICLE X: TERMINATION
10.1 This Agreement will terminate:
(a) at the option of any party, with or without cause, with respect to one, some or all of the Designated Portfolios, upon six (6) month’s advance written notice to the other parties or, if later, upon receipt of any required exemptive relief or orders from the SEC, unless otherwise agreed in a separate written agreement among the parties; or
(b) at the option of the Company, upon written notice to the other parties, with respect to any Portfolio if shares of the Designated Portfolio are not reasonably available to meet the requirements of the Contracts as determined in good faith by the Company; or
(c) at the option of the Company, upon written notice to the other parties, with respect to any Portfolio in the event any of the Portfolio’s shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by Company; or
(d) at the option of the Fund, upon written notice to the other parties, upon institution of formal proceedings against the Company by FINRA, the Commission or any other regulatory body regarding the Company’s duties under this Agreement or related to the sale of the Contracts, the administration of the Contracts, the operation of the Account, or the purchase of the Fund shares, provided that the Fund determines in its sole judgment, exercised in good faith, that any such proceeding would have a material adverse effect on the Company’s ability to perform its obligations under this Agreement; or
(e) at the option of the Company, upon written notice to the other parties, upon institution of formal proceedings against the Fund, the Adviser, or the Distributor by FINRA, the Commission or any other regulatory body, provided that the Company determines in its sole judgment, exercised in good faith, that any such proceeding would have a material adverse effect on the Fund’s or the Adviser’s ability to perform its obligations under this Agreement; or
(f) at the option of the Company, upon written notice to the other parties, with respect to any Designated Portfolio, if a Designated Portfolio ceases to qualify as a Regulated Investment Company under Subchapter M of the Code, or under any successor or similar provision, or if the Company reasonably and in good faith believes that the Designated Portfolio may fail to so qualify; or
(g) at the option of any party to this Agreement, upon written notice to the other parties, upon another party’s material breach of any provision of this Agreement; or
(h) at the option of the Company, if the Company determines in its sole judgment exercised in good faith that the Fund, the Adviser or Distributor has suffered a material adverse change in its business, operations or financial condition since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Fund, Adviser or Distributor and hence to the Company; or
21
(i) at the option of the Fund or the Adviser, if the Fund or Adviser respectively, determines in its sole judgment exercised in good faith that the Company has suffered a material adverse change in its business, operations or financial condition since the date of this Agreement or is the subject of material adverse publicity which is likely to have a material adverse impact upon the business and operations of the Fund or the Adviser, such termination to be effective sixty (60) days’ after receipt by the other parties of written notice of the election to terminate.
10.2 NOTICE REQUIREMENT
No termination of this Agreement will be effective unless and until the party terminating this Agreement gives prior written notice to all other parties of its intent to terminate, which notice will set forth the basis for the termination.
10.3 EFFECT OF TERMINATION
Notwithstanding any termination of this Agreement, the Fund, the Adviser and the Distributor will, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”). Specifically, without limitation, the owners of the Existing Contracts will be permitted to reallocate investments in the Designated Portfolios (as in effect on such date), redeem investments in the Designated Portfolios and/or invest in the Designated Portfolios upon the making of additional purchase payments under the Existing Contracts.
10.4 SURVIVING PROVISIONS
Notwithstanding any termination of this Agreement, each party’s obligations under Article VIII to indemnify other parties will survive and not be affected by any termination of this Agreement. In addition, with respect to Existing Contracts, all provisions of this Agreement also will survive and not be affected by any termination of this Agreement.
ARTICLE XI: NOTICES
Any notice will be deemed duly given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other parties.
22
If to the Company:
American General Life Insurance Company
2727-A Allen Parkway
Houston, TX 77019
Attn: Legal Department
If to the Fund:
SunAmerica Series Trust
One World Trade Center
285 Fulton Street, Suite 49M
New York, NY 10007
Attention: General Counsel
If to the Adviser:
SunAmerica Asset Management, LLC
One World Trade Center
285 Fulton Street, Suite 49M
New York, NY 10007
Attention: General Counsel
ARTICLE XII: MISCELLANEOUS
12.1 All persons dealing with the Fund must look solely to the property of the Fund for the enforcement of any claims against the Fund as neither the directors, officers, agents or shareholders assume any personal liability for obligations entered into on behalf of the Fund.
12.2 The Fund and the Adviser acknowledge that the identities of the customers of the Company or any of its affiliates (collectively the “Protected Parties” for purposes of this Section 12.2), information maintained regarding those customers, and all computer programs and procedures developed by the Protected Parties or any of their employees or agents in connection with the Company’s performance of its duties under this Agreement are the valuable property of the Protected Parties. The Fund and the Adviser agree that if they come into possession of any list or compilation of the identities of or other information about the Protected Parties’ customers, or any other property of the Protected Parties, other than such information as may be independently developed or compiled by the Fund or the Adviser from information supplied to them by the Protected Parties’ customers who also maintain accounts directly with the Fund or the Adviser, the Fund and the Adviser will hold such information or property in confidence and refrain from using, disclosing or distributing any of such information or other property except: (a) with the Company’s prior written consent; or (b) as required by law or judicial process. The Fund and the Adviser acknowledge that any breach of the agreements in this Section 12.2 would result in immediate and irreparable harm to the Protected Parties for which there would be no adequate remedy at law and agree that in the event of such a breach, the Protected Parties will be entitled to equitable relief by way of temporary and permanent injunctions, as well as such other relief as any court of competent jurisdiction deems appropriate.
12.3 The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.
23
12.4 This Agreement may be executed simultaneously in two or more counterparts, each of which taken together will constitute one and the same instrument.
12.5 If any provision of this Agreement will be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement will not be affected thereby.
12.6 This Agreement will not be assigned by any party hereto without the prior written consent of all the parties hereto.
12.7 The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal law.
12.8 The parties to this Agreement acknowledge and agree that this Agreement shall not be exclusive in any respect.
12.9 Each party to this Agreement will cooperate with each other party and all appropriate governmental authorities (including without limitation the Commission, FINRA and state insurance regulators) and will permit each other and such authorities reasonable access to its books and records in connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.
12.10 Each party represents that the execution and delivery of this Agreement and the consummation of the transactions contemplated herein have been duly authorized by all necessary corporate or board action, as applicable, by such party and when so executed and delivered this Agreement will be the valid and binding obligation of such party enforceable in accordance with its terms.
12.11 The schedules to this Agreement (each, a “Schedule,” collectively, the “Schedules”) form an integral part hereof and are incorporated herein by reference. The parties to this Agreement may agree in writing to amend the Schedules to this Agreement from time to time to reflect changes in or relating to the Contracts, the Accounts or the Designated Portfolios of the Fund or other applicable terms of this Agreement. References herein to any Schedule are to the Schedule then in effect, taking into account any amendments thereto.
12.12 Each Designated Portfolio agrees to consult in advance with the Company concerning any decision to elect or not to pass through the benefit of any foreign tax credits to the Designated Portfolio’s shareholders pursuant to Section 853 of the Code.
24
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and behalf by its duly authorized representative as of the date first above-written.
| SUNAMERICA SERIES TRUST | ||
| By: | /s/ Kate Fuentes | |
| Name: Kate Fuentes | ||
| Title: Chief Legal Officer, Vice President and Secretary | ||
| SUNAMERICA ASSET MANAGEMENT, LLC | ||
| By: | /s/ John Genoy | |
| Name: John Genoy | ||
| Title: President and Chief Operating Officer | ||
| AMERICAN GENERAL LIFE INSURANCE COMPANY | ||
| By: | ||
| Name: Bryan Pinsky | ||
| Title: President | ||
IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and behalf by its duly authorized representative as of the date first above-written.
| SUNAMERICA SERIES TRUST | ||
| By: | ||
| Name: Kate Fuentes | ||
| Title: Chief Legal Officer, Vice President and Secretary | ||
| SUNAMERICA ASSET MANAGEMENT, LLC | ||
| By: | ||
| Name: John Genoy | ||
| Title: President and Chief Operating Officer | ||
| AMERICAN GENERAL LIFE INSURANCE COMPANY | ||
| By: | /s/ Bryan Pinsky | |
| Name: Bryan Pinsky | ||
| Title: President | ||
Exhibit A
Request for Information Form
We hereby request that American General Life Insurance Company provide the Transaction Information indicated below.
Please provide the following information about the Transaction Information requested:
| Contract Number* |
| |||
| Tax Identification Number**: |
| |||
| Fund Name: |
| |||
| Portfolio Name: |
| |||
| Portfolio Manager: |
| |||
| Covered Period***: |
| |||
| Requesting Person****: |
| |
| Signature: |
| |
| Date: |
| |
| Telephone Number: |
| |
| Facsimile Number: |
| |
| * | or participant account number if applicable. Failure to complete this item shall not prevent this Form from being in Good Form. |
| ** | or Individual/International Taxpayer Identification Number (ITIN), other government-issued identifier or equivalent identifying number. Failure to complete this item shall not prevent this Form from being in Good Form. |
| *** | the covered period shall not include any day that is earlier than 180 days prior to the day Intermediary received this form in Good Form. |
| **** | person must be duly authorized person as previously provided by the Fund. |
PLEASE E-MAIL THIS FORM TO SaamcoLegal@venerable.com,
ATTENTION “RULE 22C-2 INFORMATION REQUEST”
PLEASE COMPLETE EACH ITEM.
INCOMPLETE FORMS WILL NOT BE PROCESSED.
Exhibit B
Instructions to Restrict Trading Form
American General Life Insurance Company is hereby instructed to restrict purchase or exchanges into the Fund indicated below by the Contract indicated below.
Please provide the following information about the Contract to be restricted:
| Contract Number* |
| |||
| Tax Identification Number**: |
| |||
Please provide the following information about the Portfolio to be restricted:
| Fund Name: |
| |||
| Portfolio Name: |
| |||
| Portfolio Manager: |
| |||
Please provide the following information about the time period for which trading should be restricted:
| Start Date***: |
| |||
| End Date: |
| |||
| Requesting Person****: |
| |
| Signature: |
| |
| Date: |
| |
| Telephone Number: |
| |
| Facsimile Number: |
| |
| * | or participant account number if applicable. |
| ** | or Individual/International Taxpayer Identification Number (ITIN), other government-issued identifier or equivalent identifying number. |
| *** | Start date will be no earlier than 48 hours after receipt of form in “Good Form.” |
| **** | person must be duly authorized person as previously provided by the Fund. |
PLEASE E-MAIL THIS FORM TO SaamcoLegal@venerable.com,
ATTENTION “RULE 22C-2 RESTRICTION”
PLEASE COMPLETE EACH ITEM.
INCOMPLETE FORMS WILL NOT BE PROCESSED.
Schedule A
The following Separate Accounts and associated Contracts of American General Life Insurance Company are permitted in accordance with the provisions of this Agreement to invest in Designated Portfolios of the Fund shown in Schedule B:
NAME OF SEPARATE ACCOUNT CONTRACTS FUNDED BY SEPARATE ACCOUNT
Variable Separate Account
Variable Annuity Account Five
Variable Annuity Account Seven
Variable Annuity Account Nine
AGL Separate Account VL-R
Schedule B
The Separate Account(s) shown on Schedule A may invest in the following Portfolio(s) of the Fund.
| SA AB Growth Portfolio | SA JPMorgan Mid-Cap Growth Portfolio | |
| SA AB Small & Mid Cap Value Portfolio | SA JPMorgan Diversified Balanced Portfolio | |
| SA American Funds Asset Allocation Portfolio | SA JPMorgan Emerging Markets Portfolio | |
| SA American Funds Global Growth Portfolio | SA JPMorgan Equity-Income Portfolio | |
| SA American Funds Growth Portfolio | SA JPMorgan Large Cap Core Portfolio | |
| SA American Funds Growth-Income Portfolio | SA JPMorgan MFS Core Bond Portfolio | |
| SA American Funds VCP Managed Allocation Portfolio | SA JP Morgan Ultra-Short Bond Portfolio | |
| SA BlackRock Multi-Factor 70/30 Portfolio | SA Large Cap Growth Index Portfolio | |
| SA Emerging Markets Equity Index Portfolio | SA Large Cap Index Portfolio | |
| SA Federated Hermes Corporate Bond Portfolio | SA Large Cap Value Index Portfolio | |
| SA Fidelity Institutional AM® Global Equities Portfolio | SA MFS Large Cap Growth Portfolio | |
| SA Fidelity Institutional AM® International Growth Portfolio | SA MFS Massachusetts Investors Trust Portfolio | |
| SA Fidelity Institutional AM® Real Estate Portfolio | SA MFS Total Return Portfolio | |
| SA Fixed Income Index Portfolio | SA Mid Cap Index Portfolio | |
| SA Fixed Income Intermediate Index Portfolio | SA Morgan Stanley International Equities Portfolio | |
| SA Franklin BW U.S. Large Cap Value Portfolio | SA PIMCO Global Bond Opportunities Portfolio | |
| SA Franklin Small Company Value Portfolio | SA PIMCO RAE International Value Portfolio | |
| SA Franklin Systematic U.S. Large Cap Core Portfolio | SA PineBridge High-Yield Bond Portfolio | |
| SA Franklin Systematic U.S. Large Cap Value Portfolio | SA Putnam International Value Portfolio | |
| SA Franklin Tactical Opportunities Portfolio | SA Schroders VCP Global Allocation Portfolio | |
| SA Global Index Allocation 60/40 Portfolio | SA Small Cap Index Portfolio | |
| SA Global Index Allocation 75/25 Portfolio | SA T. Rowe Price Allocation Moderately Aggressive Portfolio | |
| SA Global Index Allocation 90/10 Portfolio | SA T. Rowe Price VCP Balanced Portfolio | |
| SA Goldman Sachs Government and Quality Bond Portfolio | SA VCP Dynamic Allocation Portfolio | |
| SA Goldman Sachs Multi-Asset Insights Portfolio | SA VCP Dynamic Strategy Portfolio | |
| SA Index Allocation 60/40 Portfolio | SA VCP Index Allocation Portfolio | |
| SA Index Allocation 80/20 Portfolio | SA Wellington Capital Appreciation Portfolio | |
| SA Index Allocation 90/10 Portfolio | SA Wellington Strategic Multi-Asset Portfolio | |
| SA International Index Portfolio | ||
| SA Invesco Growth Opportunities Portfolio | ||
| SA Janus Focused Growth Portfolio |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Post-Effective Amendment No. 23 to the Registration Statement on Form N-6 (No. 333-196172) (the “Registration Statement”) of our report dated March 20, 2026 relating to the statutory basis financial statements of American General Life Insurance Company and consent to the incorporation by reference in the Registration Statement of our report dated April 20, 2026 relating to the financial statements of each of the subaccounts of Separate Account VL-R indicated in our report. We also consent to the references to us under the headings “Financial Statements” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
New York, New York
April 23, 2026
Description of American General Life Insurance Company’s
Issuance, Transfer and Redemption Procedures
for the Variable Universal Life Insurance Policies
Pursuant to Rule 6e-3(T)(b)(12)(iii)
under the Investment Company Act of 1940
As of May 1, 2026
Set forth below is the information called for under Rule 6e-3(T)(b)(12)(iii) under the Investment Company Act of 1940 (“1940 Act”). That rule provides an exemption for separate accounts, their investment advisers, principal underwriters and sponsoring insurance companies from Sections 22(c), 22(d), 22(e), and 27(c)(1) of the 1940 Act, and Rule 22(c)-1 promulgated thereunder, for issuance, transfer and redemption procedures under flexible premium variable life insurance policies to the extent necessary to comply with Rule 6e-3(T), state administrative law or established administrative procedures of the life insurance company. In order to qualify for the exemption, procedures must be reasonable, fair and nondiscriminatory and they must be disclosed in the registration statement filed by the separate account.
Net premiums received by American General Life Insurance Company (“AGL”) under its flexible premium variable universal life insurance policies (the “Policies”) are invested in Separate Account VL-R (the “Account”) of AGL. The Account is registered under the 1940 Act. Within the Account are investment divisions. New investment divisions may be added and investment divisions may be removed. Procedures apply equally to each investment division and for purposes of this description are defined in terms of the Account, except where a discussion of both the Account and its investment divisions is necessary. Each investment division invests in shares of a corresponding portfolio from among 150 funds (individually, a “Fund,” and collectively, the “Funds”), each a “series” type of mutual fund registered under the 1940 Act. All of the Funds in the Account are not available under all of the Policies. The investment experience of the investment divisions of the Account depends upon the market performance of the corresponding Fund portfolios. Although the Policies may also provide for fixed benefits supported by AGL’s General Account, except as otherwise explicitly stated herein, this description assumes that net premiums are allocated exclusively to the Account and that all transactions involve only the investment divisions of the Account.
AGL believes its procedures meet the requirements of Rule 6e-3(T)(b)(12)(iii) and states the following:
1. Because of the insurance nature of the Policies and due to the requirements of state insurance laws, the procedures necessarily differ in significant respects from procedures for mutual funds and contractual plans for which the 1940 Act was designed.
2. In structuring its procedures to comply with Rule 6e-3(T) and state insurance laws, AGL has attempted to comply with the intent of the 1940 Act to the extent deemed feasible.
3. In general, state insurance laws require that AGL’s procedures be reasonable, fair and nondiscriminatory.
1
4. Because of the nature of the insurance product, it is often difficult to determine precisely when AGL’s procedures deviate from those required under Sections 22(c), 22(d), 22(e) or 27(c)(1) of the 1940 Act or Rule 22c-1 thereunder. Accordingly, set out below is a summary of the principal Policy provisions and procedures which may be deemed to constitute, either directly or indirectly, such a deviation. The summary, while extensive, does not attempt to treat each and every procedure or variation which might occur and does include certain procedural steps which do not constitute deviations from the above-cited sections or rule.
I. “PUBLIC OFFERING PRICE”: PURCHASE AND RELATED TRANSACTIONS – SECTION 22(d) AND RULE 22c-1
This section outlines those principal Policy provisions and administrative procedures which might be deemed to constitute, either directly or indirectly, a “purchase” transaction. Because of the insurance nature of the Policies, the procedures involved necessarily differ in certain significant respects from the purchase procedures for mutual funds and contractual plans. The chief differences revolve around the structure of the cost of insurance charges and the insurance underwriting (i.e., evaluation of risk) process. There are also certain Policy provisions--such as reinstatement and loan repayment -- which do not result in the issuance of a Policy but which require certain payments by the Policy owner and involve a transfer of assets supporting the Policy reserve into the Account.
| a. | INSURANCE CHARGES AND UNDERWRITING STANDARDS |
Cost of insurance charges for AGL’s Policies will not be the same for all Policy owners. The chief reason is that the principle of pooling and distribution of mortality risks is based upon the assumption that each Policy owner pays a cost of insurance charge commensurate with the insured’s mortality risk which is actuarially determined based upon factors such as age, sex and risk class of the insured and the face amount size band of the Policy. In the context of life insurance, a uniform mortality charge (the “cost of insurance charge”) for all insureds would discriminate unfairly in favor of those insureds representing greater mortality risks to the disadvantage of those representing lesser risks. Accordingly, although there will be a uniform “public offering price” for all Policy owners, because premiums are flexible and amounts allocated to the Account will be subject to the same charges as described above), there will be a different “price” for each actuarial category of Policy owners because different cost of insurance rates will apply. The “price” will also vary based on net amount at risk. The Policies will be offered and sold pursuant to this cost of insurance schedule and AGL’s underwriting standards and in accordance with state insurance laws. Such laws prohibit unfair discrimination among insureds, but recognize that premiums must be based upon factors such as age, sex, health and occupation. A table showing the maximum cost of insurance charges will be delivered as part of the Policy.
| b. | APPLICATION AND INITIAL PREMIUM PROCESSING |
This section is no longer described as a procedure because the flexible premium variable universal life insurance Policies are no longer sold.
2
| c. | ANNIVERSARY AND PREMIUM PROCESSING |
At each monthly anniversary, AGL will credit the unloaned portion of the declared fixed interest account with any interest accrued on loan amounts during the previous Policy month. Charges against the cash value for administrative expenses, additional benefits and cost of insurance charges will also be made. These deductions cover the cost of the Policy for the next month.
Net premiums are credited to the cash value as of the date the premium payments are received by AGL. The initial net premium is allocated to the Money Market division until 15 days after the issue date, regardless of the Policy owner’s premium allocation instructions. Net premiums are equal to the gross premiums minus deductions for applicable state and local taxes and sales expenses.
Premium payments may be made at any time and for any amount, within certain limits. Premium payments must generally be at least $50 (some states may have lower limits) and may not be more than those allowed under the Internal Revenue Code for the Policy to continue to qualify as life insurance. AGL makes deductions from each premium for sales expenses (a percent of each premium paid during any Policy year until total premiums for that Policy year equal the target premium for the particular Policy) and for any applicable premium tax, the amount of which varies from jurisdiction to jurisdiction.
AGL will apply as much of each premium it receives as possible to the Policy without allowing a violation of the “seven-pay test.” AGL will refund the remainder of the premium to the Policy owner within 10 days, unless the owner contacts the Administrative Center during a 30 day notice period expressing that it is the owner’s intent to have the Policy classified as a modified endowment contract. AGL will then apply the remainder of the premium to the Policy effective on the date that the Administrative Center receives such notification.
| d. | REINSTATEMENT |
If the Policy has lapsed, it may be reinstated while the insured person is alive if the Policy owner 1) requests reinstatement within 5 years from the end of the grace period, 2) provides satisfactory evidence of insurability and 3) makes a premium payment sufficient to satisfy any overdue monthly cost of insurance charges and also sufficient to keep the Policy in force for at least 2 months after reinstatement. The effective date of the reinstated Policy will be the beginning of the Policy month which coincides with, or next follows the date AGL approves the reinstatement application. Upon reinstatement, the maximum surrender charge for the Policy will be reduced by the amount of all surrender charges previously imposed on the Policy, and for purposes of determining any future surrender charges on the Policy, the Policy will be deemed to have been in effect since the original effective date. The Policy owner has the option to reinstate or pay any Policy indebtedness.
3
| e. | REPAYMENT OF LOAN |
A loan made under the Policy may be repaid with an amount equal to the original loan plus loan interest.
| f. | CORRECTION OF MISSTATEMENT OF AGE OR SEX |
If AGL discovers that the age or sex of the insured has been misstated, the death benefit and any rider benefits will be those which would be purchased by the most recent deduction for the cost of insurance and the cost of rider benefits at the correct age and sex.
| g. | CONTESTABILITY |
The Policy is contestable for two years, measured from the issue date, during the lifetime of the insured for material misstatements made in the initial application for the Policy. Policy changes (including Policy increases) may be contested for two years after the effective date of the change, and a reinstatement for two years after the effective date of the reinstatement. No statement will be used to contest a Policy unless it is contained in an application. AGL may not be restricted by the foregoing time limitations in the event of fraud.
| h. | REDUCTION IN COST OF INSURANCE RATE CLASSIFICATION |
By administrative practice, where contractually allowed AGL will reduce the cost of insurance rate classification for an outstanding Policy if new evidence of insurability demonstrates that the Policy owner qualifies for a lower classification. After the reduced rating is determined, the Policy owner will pay a lower monthly cost of insurance charge.
II. “REDEMPTION PROCEDURES”: SURRENDER AND RELATED TRANSACTIONS
This section will outline those procedures which differ in certain significant respects from redemption procedures for mutual funds and contractual plans. AGL’s Policies provide for the payment of monies to a Policy owner or beneficiary upon presentation of a Policy. Generally, except for the payment of death benefits, the imposition of cost of insurance, administrative and transaction charges and the effects of the surrender charge, the payee will receive a pro rata or proportionate share of the Account’s assets within the meaning of the 1940 Act in any transaction involving “redemption procedures.” The amount received by the payee will depend upon the particular benefit for which the Policy is presented, including, for example, the cash surrender value or death benefit. There are also certain Policy provisions — such as partial withdrawals and the loan privilege — under which the Policy will not be presented to AGL but which will affect the Policy owner’s benefits and may involve a transfer of the assets supporting the Policy reserve out of the Account. Any combined transactions on the same day which counteract the effect of each other will be allowed. AGL will assume the Policy owner is aware of the conflicting nature of these transactions and desires their combined result. In addition, if a transaction is requested which AGL will not allow (for example, a request for a decrease in face amount which lowers the face amount below AGL’s minimum) AGL will reject the whole request and not just the portion which causes the disallowance. Policy owners will be informed
4
of the rejection and will have an opportunity to give new instructions. Finally, state insurance laws may require that certain requirements be met before AGL is permitted to make payments to the payee.
A portion of Policy owner requests for full surrender of Policy cash values are currently processed by staff at DXC and Accenture. DXC and Accenture operate as a TPA for Corebridge with the work performed in Manila, Philippines. All transactions processed by a TPA are held to the same internal controls and quality levels and are completed following procedures that are identical to those completed at our domestic Corebridge Administrative Center, however DXC is only able to approve disbursements up to $500k Accenture up to $1,000,000 with the rest coming to Corebridge for approval. Oversight for the transactions processed at any TPA remains the responsibility of Corebridge management.
| a. | SURRENDER FOR CASH VALUES |
AGL will generally pay the net cash surrender value within seven days after receipt, at its Administrative Center, of the Policy and a signed request for surrender in Good Order. Computations with respect to the investment experience of each investment division will be made at the close of trading on the composite tape for each Business Day that the New York Stock Exchange is open (“Business Day”). This will enable AGL to pay a net cash value on surrender as of the date a request for surrender and the Policy are received based on the next computed value after a request is received. The surrender is effective on the Business Day AGL receives the request at its Administrative Center and insurance coverage ends on that Business Day.
The Policy’s value (which is equal to the cash surrender value plus any applicable surrender charge) may increase or decrease from day to day depending on the investment experience of the Account. Calculation of the cash value for any given day will reflect the actual premiums paid, expenses charged and deductions taken.
If a Policy is totally surrendered AGL will pay the Policy owner an amount equal to the net cash surrender value of the Policy. The net cash surrender value of a Policy is equal to the cash surrender value of the Policy less the amount of any outstanding Policy loan and accrued interest. The cash surrender value of a Policy will equal the amount of the cash value less the surrender charge. AGL will make the payment of net cash surrender value out of its General Account and, at the same time, transfer assets from the Account to the General Account in an amount equal to the Policy reserves in the Account for the surrendered Policy, or the portion of the face amount that was reduced.
In lieu of payment of the net cash surrender value in a single sum upon surrender of a Policy, where policy contracts allow, an election may be made to apply all or a portion of the proceeds under one of the fixed benefit payment options described in the Policies. The election may be made by the Policy owner during the insured person’s lifetime, or, if no election is in effect at the insured person’s death, by the beneficiary. An option in effect at death may not be changed to another form of benefit after death. The settlement options are subject to the restrictions and limitations set forth in the Policies.
5
The Policy contains a partial withdrawal feature after the first Policy year, subject to a minimum withdrawal amount and other conditions. Any request for a partial withdrawal must be in writing to AGL’s Administrative Center and will take effect as of the day it is received. A partial withdrawal will reduce the death benefit, cash value and cash surrender value associated with the Policy by the amount of the withdrawal plus a charge for administrative expenses associated with it. After such a withdrawal, the Policy must meet minimum face amount requirements and must continue to qualify as life insurance under applicable tax law.
| b. | DEATH CLAIMS |
AGL will pay a death benefit to the beneficiary generally within seven days after receipt, at its Administrative Center, of the Policy, due proof of death of the insured, and all other requirements necessary to make payment.1
The death benefit payable will depend on the option in effect at the time of death. Under Option 1, the death benefit is the greater of the face amount of insurance and a percentage multiple of the accumulation value. Under Option 2, the death benefit is the greater of the face amount of insurance plus the accumulation value and a percentage multiple of the accumulation value. Under Option 3, the death benefit is the greater of (1) the sum of the death benefit under Option 1 plus the cumulative amount of premiums paid for the Policy and any riders, and (2) and a percentage multiple of the accumulation value. The percentage referred to is the applicable percentage from a table published for the insured person’s age (as of his or her nearest birthday) at the beginning of the Policy year of determination.
The proceeds payable to the beneficiary will be adjusted to reflect any outstanding indebtedness and any overdue monthly charges if death occurs during the grace period described below under “Default and Options on Lapse.” The proceeds payable on death also reflect interest from the date of death to the date of payment.
AGL will make payment of the death benefit out of its General Account, and will transfer assets from the Account to the General Account in an amount equal to the reserve for that Policy in the Account. The excess, if any, of the death benefit over the amount transferred will be paid out of the General Account reserve maintained for that purpose.
In lieu of payment of the death benefit in a single sum, a settlement option may be selected as described immediately above with respect to cash surrender values.
| c. | DEFAULT AND OPTIONS ON LAPSE |
The duration of insurance coverage depends upon either: (1) the net cash surrender value of a Policy being sufficient to cover the monthly charges, or (2) any applicable no lapse
1 State insurance laws impose various requirements before payment of the death benefit may be made. In addition, payment of the death benefit is subject to the provisions of the Policies regarding suicide and incontestability.
6
guarantee provision, provided its terms are satisfied. If the net cash surrender value at the beginning of a month is less than the charges for that month and/or the Policy’s no lapse guarantee provision has not been met (if the policy has such a provision), a grace period of 6l days will begin. Written notice will be sent to the Policy owner, any assignee, and secondary addressee, as applicable, on AGL’s records stating that such a grace period has begun and giving the approximate amount of premium payments necessary to keep the Policy in force for a reasonable period of time. If this amount is not received during the grace period, any amount of cash value will be withdrawn and applied to applicable charges and the Policy will end without value. If the insured should die during the grace period, an amount sufficient to cover the overdue monthly charges and other charges will be deducted from the death benefit.
| d. | POLICY LOAN |
AGL’s Policies provide that a Policy owner may take a loan of up to 100% of the cash surrender value less AGL’s estimate of three month’s charges and less the interest payable on the Policy loan that is payable through the next Policy anniversary, upon assignment to AGL of the Policy as sole security. The cash surrender value, for this purpose will be computed on the Business Day after receipt, at AGL’s Administrative Center, of a signed loan request in Good Order. Payment of the loan out of AGL’s General Account will be made to the Policy owner within seven days after such receipt.
Interest on a loan accrues daily at an effective annual interest rate, which is adjusted annually. A rate will be determined as of the beginning of each Policy year and will apply to a new or outstanding loan during that Policy year. The maximum annual loan interest rate varies by product.2
Loan interest is due on each Policy anniversary. If not paid when due, it is added to the existing indebtedness and bears interest at the loan rate. Failure to repay a loan will not necessarily terminate the Policy. If the net cash surrender value of the Policy is not sufficient to cover the monthly charges for the cost of insurance and administrative expenses, the Policy will go into a grace period, as described above (subject to any applicable no lapse guarantee provision).
2 Platinum Investor III and Platinum Choice VUL 2 will generally be no greater than 4.75%; EquiBuilder III will be the greater of 51⁄2% or the Monthly Average Corporate yield published by Moody’s Investor Services, Inc., as an annualized percentage of the outstanding loan amount and unpaid loan interest.
7
| e. | TRANSFERS AMONG DIVISIONS |
Amounts may be transferred, upon request, on any Business Day from any investment division of the Account to one or more other divisions of the Account. The minimum amount allowed for a transfer is the lesser of the minimum amount shown in a Policy (usually $500) and the total value in the investment division. Subject to current market timing restrictions, the first 12 transfers in any one Policy year are free of charge. AGL will charge $25 for each transfer in excess of 12 per year.
Transfer charges, if any, will be subtracted equally among the divisions from which transfers are made.
Transfers from an investment division of the Account will take effect as of the receipt of a request at AGL’s Administrative Center.
| f. | MARKET TIMING PROCEDURES AND FUND-INITIATED RESTRICTIONS |
Market timing. The Policy is not designed for professional market timing organizations or other entities or individuals using programmed and frequent transfers involving large amounts. Market timing carries risk with it, including:
| | dilution in the value of Fund shares underlying investment options of other Policy owners; |
| | interference with the efficient management of the Fund’s portfolio; and |
| | increased administrative costs. |
We have policies and procedures that require us to monitor the Policies to determine if a Policy owner requests:
| | an exchange out of a variable investment option, other than the money market investment option, within two calendar weeks of an earlier exchange into that same variable investment option; |
| | an exchange into a variable investment option, other than the money market investment option, within two calendar weeks of an earlier exchange out of that same variable investment option; or |
| | exchanges into or out of the same variable investment option, other than the money market investment option, more than twice in any one calendar quarter. |
If any of the above transactions occurs, we will suspend such Policy owner’s same day or overnight delivery transfer privileges (including website, email and facsimile communications) with prior notice to prevent market timing efforts that could be harmful to other Policy owners or
8
beneficiaries. Such notice of suspension will take the form of either a letter mailed to your last known address, or a telephone call from our Administrative Center to inform you that effective immediately, your same day or overnight delivery transfer privileges have been suspended. A Policy owner’s first violation of this policy will result in the suspension of Policy transfer privileges for ninety days. A Policy owner’s subsequent violations of this policy will result in the suspension of Policy transfer privileges for six months. Transfers under dollar cost averaging, automatic rebalancing or any other automatic transfer arrangements to which we have agreed are not affected by these procedures.
The procedures above will be followed in all circumstances and we will treat all Policy owners the same.
Restrictions initiated by the Funds. The Funds have policies and procedures restricting transfers into the Fund. For this reason or for any other reason the Fund deems necessary, a Fund may instruct us to reject a Policy owner’s transfer request. Additionally, a Fund may instruct us to restrict all purchases or transfers by a particular Policy owner, whether into or out of the Fund. We will follow the Fund’s instructions.
| g. | RIGHT OF WITHDRAWAL PROCEDURES |
This section is omitted because no new flexible premium variable universal life insurance policies are issued.
9